col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

MDPI AG: Viruses
  original article Date Title Authors   All Authors
1 [GO] 2022―Jan―21 Distinguishing Incubation and Acute Disease Stages of Mild-to-Moderate COVID-19 Michael Müller, Johann Volzke, Behnam Subin, Christian Johann Schmidt, Hilte Geerdes-Fenge, Emil Christian Reisinger, Brigitte Müller-Hilke
2 [GO] 2022―Jan―21 Using an Administrative and Clinical Database to Determine the Early Spread of COVID-19 at the US Department of Veterans Affairs during the Beginning of the 2019-2020 Flu Season: A Retrospective Longitudinal Study Lilia R. Lukowsky, Claudia Der-Martirosian, William Neil Steers, Kiran S. Kamble, Aram Dobalian
3 [GO] 2022―Jan―21 Developing Immunity Testing for SARS-CoV-2 and Other Novel Vaccines-Correlates of Immunogenicity Parameters with Protection Zoltan Vajo
4 [GO] 2022―Jan―21 SARS-CoV-2: Ultrastructural Characterization of Morphogenesis in an In Vitro System Debora Ferreira Barreto-Vieira, Marcos Alexandre Nunes da Silva, Ana Luisa Teixeira de Almeida, Arthur da Costa Rasinhas, Maria Eduarda Monteiro, Milene Dias Miranda, et al. (+9)
5 [GO] 2022―Jan―20 Structure Based Affinity Maturation and Characterizing of SARS-CoV Antibody CR3022 against SARS-CoV-2 by Computational and Experimental Approaches Wei Yu, Nan Zhong, Xin Li, Jiayi Ren, Yueming Wang, Chengming Li, et al. (+10)
6 [GO] 2022―Jan―20 Assessment of Inter-Laboratory Differences in SARS-CoV-2 Consensus Genome Assemblies between Public Health Laboratories in Australia Charles S. P. Foster, Sacha Stelzer-Braid, Ira W. Deveson, Rowena A. Bull, Malinna Yeang, Jane-Phan Au, et al. (+6)
7 [GO] 2022―Jan―20 Induction of Innate Immune Response by TLR3 Agonist Protects Mice against SARS-CoV-2 Infection Hadas Tamir, Sharon Melamed, Noam Erez, Boaz Politi, Yfat Yahalom-Ronen, Hagit Achdout, et al. (+6)
8 [GO] 2022―Jan―20 Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence Daniele Focosi, Fabrizio Maggi, Arturo Casadevall
9 [GO] 2022―Jan―19 Distinct Outcomes in COVID-19 Patients with Positive or Negative RT-PCR Test Maria Clara Saad Menezes, Diego Vinicius Santinelli Pestana, Juliana Carvalho Ferreira, Carlos Roberto Ribeiro de Carvalho, Marcelo Consorti Felix, Izabel Oliva Marcilio, et al. (+7)
10 [GO] 2022―Jan―19 Presence of Recombinant Bat Coronavirus GCCDC1 in Cambodian Bats Feng Zhu, Veasna Duong, Xiao Fang Lim, Vibol Hul, Tanu Chawla, Lucy Keatts, et al. (+8)
11 [GO] 2022―Jan―19 Identifying Inhibitors of -1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses Sneha Munshi, Krishna Neupane, Sandaru M. Ileperuma, Matthew T. J. Halma, Jamie A. Kelly, Clarissa F. Halpern, et al. (+3)
12 [GO] 2022―Jan―19 Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry Behnood Bikdeli, David Jiménez, Pablo Demelo-Rodriguez, Francisco Galeano-Valle, José Antonio Porras, Raquel Barba, et al. (+10)
13 [GO] 2022―Jan―19 Versatile SARS-CoV-2 Reverse-Genetics Systems for the Study of Antiviral Resistance and Replication Ulrik Fahnøe, Long V. Pham, Carlota Fernandez-Antunez, Rui Costa, Lizandro René Rivera-Rangel, Andrea Galli, et al. (+6)
14 [GO] 2022―Jan―18 Immune Profiling of COVID-19 in Correlation with SARS and MERS Bariaa A. Khalil, Sarra B. Shakartalla, Swati Goel, Bushra Madkhana, Rabih Halwani, Azzam A. Maghazachi, et al. (+3)
15 [GO] 2022―Jan―17 Prevalence of SARS-CoV-2 Variants of Concern and Variants of Interest in COVID-19 Breakthrough Infections in a Hospital in Monterrey, Mexico Kame A. Galán-Huerta, Samantha Flores-Treviño, Daniel Salas-Treviño, Paola Bocanegra-Ibarias, Ana M. Rivas-Estilla, Eduardo Pérez-Alba, et al. (+3)
16 [GO] 2022―Jan―17 Detection of Porcine Respirovirus 1 (PRV1) in Poland: Incidence of Co-Infections with Influenza A Virus (IAV) and Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) in Herds with a Respiratory Disease Aleksandra Woźniak, Piotr Cybulski, Lilla Denes, Gyula Balka, Tomasz Stadejek
17 [GO] 2022―Jan―17 Modeling the Transmission of the SARS-CoV-2 Delta Variant in a Partially Vaccinated Population Ugo Avila-Ponce de León, Eric Avila-Vales, Kuanlin Huang
18 [GO] 2022―Jan―17 Bayesian Inference of State-Level COVID-19 Basic Reproduction Numbers across the United States Abhishek Mallela, Jacob Neumann, Ely F. Miller, Ye Chen, Richard G. Posner, Yen Ting Lin, William S. Hlavacek
19 [GO] 2022―Jan―14 Antigenicity of the Mu (B.1.621) and A.2.5 SARS-CoV-2 Spikes Debashree Chatterjee, Alexandra Tauzin, Annemarie Laumaea, Shang Yu Gong, Yuxia Bo, Aurélie Guilbault, et al. (+8)
20 [GO] 2022―Jan―12 SARS-CoV-2 Reverse Zoonoses to Pumas and Lions, South Africa Katja Natalie Koeppel, Adriano Mendes, Amy Strydom, Lia Rotherham, Misheck Mulumba, Marietjie Venter
21 [GO] 2022―Jan―12 Discriminatory Weight of SNPs in Spike SARS-CoV-2 Variants: A Technically Rapid, Unambiguous, and Bioinformatically Validated Laboratory Approach Nicolò Musso, Paolo Giuseppe Bonacci, Dafne Bongiorno, Stefano Stracquadanio, Dalida Angela Bivona, Concetta Ilenia Palermo, et al. (+3)
22 [GO] 2022―Jan―12 GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition Eloïne Bestion, Keivan Zandi, Sandrine Belouzard, Julien Andreani, Hubert Lepidi, Marie Novello, et al. (+9)
23 [GO] 2022―Jan―12 miR-541-3p Promoted Porcine Reproductive and Respiratory Syndrome Virus 2 (PRRSV-2) Replication by Targeting Interferon Regulatory Factor 7 Xibao Shi, Yuanhao Yang, Xiaozhuan Zhang, Xiaobo Chang, Jing Chen, Chao Wang, et al. (+6)
24 [GO] 2022―Jan―11 Simulation of Molecular Dynamics of SARS-CoV-2 S-Protein in the Presence of Multiple Arbidol Molecules: Interactions and Binding Mode Insights Sophia S. Borisevich, Edward M. Khamitov, Maxim A. Gureev, Olga I. Yarovaya, Nadezhda B. Rudometova, Anastasiya V. Zybkina, et al. (+4)
25 [GO] 2022―Jan―10 The Remarkable Evolutionary Plasticity of Coronaviruses by Mutation and Recombination: Insights for the COVID-19 Pandemic and the Future Evolutionary Paths of SARS-CoV-2 Grigorios D. Amoutzias, Marios Nikolaidis, Eleni Tryfonopoulou, Katerina Chlichlia, Panayotis Markoulatos, Stephen G. Oliver
26 [GO] 2022―Jan―10 Investigation of a Limited but Explosive COVID-19 Outbreak in a German Secondary School Sigrid Baumgarte, Felix Hartkopf, Martin Hölzer, Max von Kleist, Sabine Neitz, Martin Kriegel, Kirsten Bollongino
27 [GO] 2022―Jan―10 Patient and Clinical Factors at Admission Affect the Levels of Neutralizing Antibodies Six Months after Recovering from COVID-19 Xinjie Li, Ling Pang, Yue Yin, Yuqi Zhang, Shuyun Xu, Dong Xu, Tao Shen
28 [GO] 2022―Jan―10 Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19 Jesús Zepeda-Cervantes, Daniel Martínez-Flores, Josué Orlando Ramírez-Jarquín, Ángeles C. Tecalco-Cruz, Noé Santiago Alavez-Pérez, Luis Vaca, Rosa Elena Sarmiento-Silva
29 [GO] 2022―Jan―10 Evaluation of Clinical and Immune Responses in Recovered Children with Mild COVID-19 Xiaodong Tian, Zhihua Bai, Ying Cao, Haizhou Liu, Di Liu, Wenjun Liu, Jing Li
30 [GO] 2022―Jan―10 SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron Syed Faraz Ahmed, Ahmed Abdul Q귮r, Matthew R. McKay
31 [GO] 2022―Jan―10 Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays Francesca Curreli, Shahad Ahmed, Sofia M. B. Victor, Aleksandra Drelich, Siva S. Panda, Andrea Altieri, et al. (+4)
32 [GO] 2022―Jan―10 The Prevalence of Acute Respiratory Distress Syndrome (ARDS) and Outcomes in Hospitalized Patients with COVID-19-A Study Based on Data from the Polish National Hospital Register Mariusz Gujski, Mateusz Jankowski, Daniel Rabczenko, Paweł Goryński, Grzegorz Juszczyk
33 [GO] 2022―Jan―10 Photodynamic Inactivation of Human Coronaviruses Brett A. Duguay, Adrian Herod, Eric S. Pringle, Susan M. A. Monro, Marc Hetu, Colin G. Cameron, et al. (+2)
34 [GO] 2022―Jan―10 A Cross Sectional Sampling Reveals Novel Coronaviruses in Bat Populations of Georgia Lela Urushadze, George Babuadze, Mang Shi, Luis E. Escobar, Matthew R. Mauldin, Ioseb Natradeze, et al. (+5)
35 [GO] 2022―Jan―10 SARS-like Coronaviruses in Horseshoe Bats (Rhinolophus spp.) in Russia, 2020 Sergey Alkhovsky, Sergey Lenshin, Alexey Romashin, Tatyana Vishnevskaya, Oleg Vyshemirsky, Yulia Bulycheva, et al. (+2)
36 [GO] 2022―Jan―10 Intra-Host SARS-CoV-2 Evolution in the Gut of Mucosally-Infected Chlorocebus aethiops (African Green Monkeys) Lori A. Rowe, Brandon J. Beddingfield, Kelly Goff, Stephanie Z. Killeen, Nicole R. Chirichella, Alexandra Melton, et al. (+2)
37 [GO] 2022―Jan―10 A Pre-Vaccination Baseline of SARS-CoV-2 Genetic Surveillance and Diversity in the United States Adam A. Capoferri, Wei Shao, Jon Spindler, John M. Coffin, Jason W. Rausch, Mary F. Kearney
38 [GO] 2022―Jan―10 The Petasites hybridus CO2 Extract (Ze 339) Blocks SARS-CoV-2 Replication In Vitro Lorena Urda, Matthias Heinrich Kreuter, Jürgen Drewe, Georg Boonen, Veronika Butterweck, Thomas Klimkait
39 [GO] 2022―Jan―10 High SARS-CoV-2 Seroprevalence among Healthcare Workers in Bamako, Mali Anou M. Somboro, Yacouba Cissoko, Issiaka Camara, Ousmane Kodio, Mohamed Tolofoudie, Etienne Dembele, et al. (+21)
40 [GO] 2021―Dec―31 Symptom-Based Predictive Model of COVID-19 Disease in Children Jesús M. Antoñanzas, Aida Perramon, Cayetana López, Mireia Boneta, Cristina Aguilera, Ramon Capdevila, et al. (+11)
41 [GO] 2021―Dec―31 The Thiazole-5-Carboxamide GPS491 Inhibits HIV-1, Adenovirus, and Coronavirus Replication by Altering RNA Processing/Accumulation Subha Dahal, Ran Cheng, Peter K. Cheung, Terek Been, Ramy Malty, Melissa Geng, et al. (+17)
42 [GO] 2021―Dec―31 Timeline of SARS-CoV-2 Spread in Italy: Results from an Independent Serological Retesting Emanuele Montomoli, Giovanni Apolone, Alessandro Manenti, Mattia Boeri, Paola Suatoni, Federica Sabia, et al. (+4)
43 [GO] 2021―Dec―31 Comparison of Plaque Size, Thermal Stability, and Replication Rate among SARS-CoV-2 Variants of Concern Gi Uk Jeong, Gun Young Yoon, Hyun Woo Moon, Wooseong Lee, Insu Hwang, Haesoo Kim, et al. (+6)
44 [GO] 2021―Dec―29 Expansion of CD56dimCD16neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients José L. Casado, Elisa Moraga, Pilar Vizcarra, Héctor Velasco, Adrián Martín-Hondarza, Johannes Haemmerle, et al. (+3)
45 [GO] 2021―Dec―28 Association between SARS-CoV-2 Seroprevalence in Nursing Home Staff and Resident COVID-19 Cases and Mortality: A Cross-Sectional Study Ania Wisniak, Lakshmi Krishna Menon, Roxane Dumont, Nick Pullen, Simon Regard, Richard Dubos, et al. (+10)
46 [GO] 2021―Dec―28 miRNAs, from Evolutionary Junk to Possible Prognostic Markers and Therapeutic Targets in COVID-19 Brandon Bautista-Becerril, Guillermo Pérez-Dimas, Paola C. Sommerhalder-Nava, Alejandro Hanono, Julio A. Martínez-Cisneros, Bárbara Zarate-Maldonado, et al. (+6)
47 [GO] 2021―Dec―28 Identification of Virulence Associated Region during Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus during Attenuation In Vitro: Complex Question with Different Strain Backgrounds Yifeng Jiang, Wu Tong, Lingxue Yu, Liwei Li, Fei Gao, Guoxin Li, et al. (+6)
48 [GO] 2021―Dec―27 COVID-19: Multiorgan Dissemination of SARS-CoV-2 Is Driven by Pulmonary Factors Akmaljon Odilov, Alexey Volkov, Adhamjon Abdullaev, Tatiana Gasanova, Tatiana Lipina, Igor Babichenko
49 [GO] 2021―Dec―27 Complement Inhibitors Vitronectin and Clusterin Are Recruited from Human Serum to the Surface of Coronavirus OC43-Infected Lung Cells through Antibody-Dependent Mechanisms Candace R. Fox, Griffith D. Parks
50 [GO] 2021―Dec―27 SARS-CoV-2 Variants of Concern Infect the Respiratory Tract and Induce Inflammatory Response in Wild-Type Laboratory Mice Shannon Stone, Hussin Alwan Rothan, Janhavi Prasad Natekar, Pratima Kumari, Shaligram Sharma, Heather Pathak, et al. (+3)
51 [GO] 2021―Dec―27 Antiviral Strategies Using Natural Source-Derived Sulfated Polysaccharides in the Light of the COVID-19 Pandemic and Major Human Pathogenic Viruses Bimalendu Ray, Imran Ali, Subrata Jana, Shuvam Mukherjee, Saikat Pal, Sayani Ray, et al. (+2)
52 [GO] 2021―Dec―24 Vaccination Hesitancy among Health-Care-Workers in Academic Hospitals Is Associated with a 12-Fold Increase in the Risk of COVID-19 Infection: A Nine-Month Greek Cohort Study Fotinie Ntziora, Evangelia Georgia Kostaki, Ioannis Grigoropoulos, Amalia Karapanou, Ismini Kliani, Maria Mylona, et al. (+7)
53 [GO] 2021―Dec―24 Emerging SARS-CoV-2 Genotypes Show Different Replication Patterns in Human Pulmonary and Intestinal Epithelial Cells Gabriel Augusto Pires de Souza, Marion Le Bideau, Celine Boschi, Lorène Ferreira, Nathalie Wurtz, Christian Devaux, et al. (+2)
54 [GO] 2021―Dec―24 Presence of SARS-CoV-2 RNA on Surfaces of Public Places and a Transportation System Located in a Densely Populated Urban Area in South America Juan José Guadalupe, María I. Rojas, Gabriela Pozo, Maria P. Erazo-Garcia, Pamela Vega-Polo, Martín Terán-Velástegui, et al. (+2)
55 [GO] 2021―Dec―24 Pandemics of the 21st Century: The Risk Factor for Obese People Miriam Hancková, Tatiana Betáková
56 [GO] 2021―Dec―23 Comparison of Antigen Tests and qPCR in Rapid Diagnostics of Infections Caused by SARS-CoV-2 Virus Adrianna Klajmon, Aldona Olechowska-Jarząb, Dominika Salamon, Agnieszka Sroka-Oleksiak, Monika Brzychczy-Włoch, Tomasz Gosiewski
57 [GO] 2021―Dec―22 Activity of Galidesivir in a Hamster Model of SARS-CoV-2 Ray Taylor, Richard Bowen, James F. Demarest, Michael DeSpirito, Airn Hartwig, Helle Bielefeldt-Ohmann, et al. (+3)
58 [GO] 2021―Dec―22 Expression of Concern: Jiang, H.; Mei, Y.-F. SARS-CoV-2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro. Viruses 2021, 13, 2056 Eric O. Freed, Oliver Schildgen
59 [GO] 2021―Dec―22 Modeling SARS-CoV-2 Infection in Mice Using Lentiviral hACE2 Vectors Infers Two Modes of Immune Responses to SARS-CoV-2 Infection Chaja Katzman, Tomer Israely, Sharon Melamed, Boaz Politi, Assa Sittner, Yfat Yahalom-Ronen, et al. (+7)
60 [GO] 2021―Dec―22 Tracking SARS-CoV-2 Spike Protein Mutations in the United States (January 2020-March 2021) Using a Statistical Learning Strategy Lue Ping Zhao, Terry P. Lybrand, Peter B. Gilbert, Thomas R. Hawn, Joshua T. Schiffer, Leonidas Stamatatos, et al. (+4)
61 [GO] 2021―Dec―21 Microarray-Based Detection of Antibodies against SARS-CoV-2 Proteins, Common Respiratory Viruses and Type I Interferons Elena Savvateeva, Marina Filippova, Vladimir Valuev-Elliston, Nurana Nuralieva, Marina Yukina, Ekaterina Troshina, et al. (+3)
62 [GO] 2021―Dec―21 SARS-CoV-2 Spike Expression at the Surface of Infected Primary Human Airway Epithelial Cells Shilei Ding, Damien Adam, Guillaume Beaudoin-Bussières, Alexandra Tauzin, Shang Yu Gong, Romain Gasser, et al. (+10)
63 [GO] 2021―Dec―21 RBD Double Mutations of SARS-CoV-2 Strains Increase Transmissibility through Enhanced Interaction between RBD and ACE2 Receptor Siddharth Sinha, Benjamin Tam, San Ming Wang
64 [GO] 2021―Dec―20 Intrauterine Fetal Demise After Uncomplicated COVID-19: What Can We Learn from the Case? Pavel Babal, Lucia Krivosikova, Lucia Sarvaicova, Ivan Deckov, Tomas Szemes, Tatiana Sedlackova, et al. (+3)
65 [GO] 2021―Dec―20 Epigallocatechin Gallate (EGCG), a Green Tea Polyphenol, Reduces Coronavirus Replication in a Mouse Model Rackhyun Park, Minsu Jang, Yea-In Park, Yeonjeong Park, Woochul Jung, Jayhyun Park, Junsoo Park
66 [GO] 2021―Dec―20 Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity Mizanur Rahman, Martin Irmler, Sandeep Keshavan, Micol Introna, Johannes Beckers, Lena Palmberg, et al. (+3)
67 [GO] 2021―Dec―20 Prediction of SARS-CoV-2 Variant Lineages Using the S1-Encoding Region Sequence Obtained by PacBio Single-Molecule Real-Time Sequencing Sébastien Lhomme, Justine Latour, Nicolas Jeanne, Pauline Trémeaux, Noémie Ranger, Marion Migueres, et al. (+3)
68 [GO] 2021―Dec―20 A Novel High-Throughput Nanopore-Sequencing-Based Strategy for Rapid and Automated S-Protein Typing of SARS-CoV-2 Variants Gabriel E. Wagner, Massimo G. Totaro, André Volland, Michaela Lipp, Sabine Saiger, Sabine Lichtenegger, et al. (+4)
69 [GO] 2021―Dec―20 Modeling the Influence of Vaccine Administration on COVID-19 Testing Strategies Jonathan E. Forde, Stanca M. Ciupe
70 [GO] 2021―Dec―20 Coronavirus RNA Synthesis Takes Place within Membrane-Bound Sites Nicole Doyle, Jennifer Simpson, Philippa C. Hawes, Helena J. Maier
71 [GO] 2021―Dec―17 Incidence and Outcome of Coinfections with SARS-CoV-2 and Rhinovirus Elisabeth Le Glass, Van Thuan Hoang, Céline Boschi, Laetitia Ninove, Christine Zandotti, Aurélie Boutin, et al. (+9)
72 [GO] 2021―Dec―17 First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in Spain Leira Fernández-Bastit, Jordi Rodon, Edwards Pradenas, Silvia Marfil, Benjamin Trinité, Mariona Parera, et al. (+11)
73 [GO] 2021―Dec―17 Nanopore-Based Direct RNA-Sequencing Reveals a High-Resolution Transcriptional Landscape of Porcine Reproductive and Respiratory Syndrome Virus Riteng Zhang, Peixin Wang, Xin Ma, Yifan Wu, Chen Luo, Li Qiu, et al. (+4)
74 [GO] 2021―Dec―16 sTREM-1 Predicts Disease Severity and Mortality in COVID-19 Patients: Involvement of Peripheral Blood Leukocytes and MMP-8 Activity Pedro V. da Silva-Neto, Jonatan C. S. de Carvalho, Vinícius E. Pimentel, Malena M. Pérez, Diana M. Toro, Thais F. C. Fraga-Silva, et al. (+33)
75 [GO] 2021―Dec―16 Decreased Fetal Movements: A Sign of Placental SARS-CoV-2 Infection with Perinatal Brain Injury Guillaume Favre, Sara Mazzetti, Carole Gengler, Claire Bertelli, Juliane Schneider, Bernard Laubscher, et al. (+9)
76 [GO] 2021―Dec―15 High-Fat High-Sugar Diet-Induced Changes in the Lipid Metabolism Are Associated with Mildly Increased COVID-19 Severity and Delayed Recovery in the Syrian Hamster Julia R. Port, Danielle R. Adney, Benjamin Schwarz, Jonathan E. Schulz, Daniel E. Sturdevant, Brian J. Smith, et al. (+8)
77 [GO] 2021―Dec―15 Inflammasomes and SARS-CoV-2 Infection Juha Kaivola, Tuula Anneli Nyman, Sampsa Matikainen
78 [GO] 2021―Dec―15 Role of Q675H Mutation in Improving SARS-CoV-2 Spike Interaction with the Furin Binding Pocket Anna Bertelli, Pasqualina D’Ursi, Giovanni Campisi, Serena Messali, Maria Milanesi, Marta Giovanetti, et al. (+3)
79 [GO] 2021―Dec―15 Porcine Reproductive and Respiratory Syndrome (PRRS) Epidemiology in an Integrated Pig Company of Northern Italy: A Multilevel Threat Requiring Multilevel Interventions Giovanni Franzo, Giacomo Barbierato, Patrizia Pesente, Matteo Legnardi, Claudia Maria Tucciarone, Giampietro Sandri, Michele Drigo
80 [GO] 2021―Dec―14 Development of an Indirect ELISA Based on Spike Protein to Detect Antibodies against Feline Coronavirus Bo Dong, Gaoqiang Zhang, Xiaodong Zhang, Xufei Chen, Meiling Zhang, Linglin Li, Weiming Lin
81 [GO] 2021―Dec―13 Iron Related Biomarkers Predict Disease Severity in a Cohort of Portuguese Adult Patients during COVID-19 Acute Infection Ana C. Moreira, Maria Jose Teles, Tânia Silva, Clara M. Bento, Inês Simões Alves, Luisa Pereira, et al. (+4)
82 [GO] 2021―Dec―13 Antibody-Dependent Enhancement of SARS-CoV-2 Infection of Human Immune Cells: In Vitro Assessment Provides Insight in COVID-19 Pathogenesis Xu-Rui Shen, Qian Li, Hui-Ling Li, Xi Wang, Qi Wang, Xiao-Shuang Zheng, et al. (+10)
83 [GO] 2021―Dec―13 Synergistic Interferon-Alpha-Based Combinations for Treatment of SARS-CoV-2 and Other Viral Infections Aleksandr Ianevski, Rouan Yao, Eva Zusinaite, Laura Sandra Lello, Sainan Wang, Eunji Jo, et al. (+22)
84 [GO] 2021―Dec―13 SARS-CoV-2 and Variant Diagnostic Testing Approaches in the United States Emmanuel Thomas, Stephanie Delabat, Yamina L. Carattini, David M. Andrews
85 [GO] 2021―Dec―13 SARS-CoV-2 Delta Variant Displays Moderate Resistance to Neutralizing Antibodies and Spike Protein Properties of Higher Soluble ACE2 Sensitivity, Enhanced Cleavage and Fusogenic Activity Sabari Nath Neerukonda, Russell Vassell, Sabrina Lusvarghi, Richard Wang, Fernando Echegaray, Lisa Bentley, et al. (+5)
86 [GO] 2021―Dec―13 The SARS-CoV-2 Reproduction Number R0 in Cats Jose L. Gonzales, Mart C. M. de Jong, Nora M. Gerhards, Wim H. M. Van der Poel
87 [GO] 2021―Dec―13 Heparin and SARS-CoV-2: Multiple Pathophysiological Links Pierpaolo Di Micco, Egidio Imbalzano, Vincenzo Russo, Emilio Attena, Vincenzo Mandaliti, Luana Orlando, et al. (+7)
88 [GO] 2021―Dec―10 Nucleocapsid (N) Gene Mutations of SARS-CoV-2 Can Affect Real-Time RT-PCR Diagnostic and Impact False-Negative Results Jéssika Cristina Chagas Lesbon, Mirele Daiana Poleti, Elisângela Chicaroni de Mattos Oliveira, José Salvatore Leister Patané, Luan Gaspar Clemente, Vincent Louis Viala, et al. (+38)
89 [GO] 2021―Dec―10 Characteristics and Factors Associated with SARS-CoV-2 Infections in Individuals That Attended Referral Hospitals from Southern Region of Bahia State, Brazil: A Surveillance Network Retrospective Study Fabrício Barbosa Ferreira, Galileu Barbosa Costa, Anaiá da Paixão Sevá, George Rego Albuquerque, Ana Paula Melo Mariano, Amanda Teixeira Sampaio Lopes, et al. (+10)
90 [GO] 2021―Dec―10 SARS-CoV-2 ORF3a Induces Incomplete Autophagy via the Unfolded Protein Response Wenqing Su, Xuejie Yu, Chuanmin Zhou
91 [GO] 2021―Dec―10 Evolutionary Dynamics of Type 2 Porcine Reproductive and Respiratory Syndrome Virus by Whole-Genome Analysis Jiahui Guo, Zimin Liu, Xue Tong, Zixin Wang, Shangen Xu, Qian Chen, et al. (+4)
92 [GO] 2021―Dec―08 Plasma Proteome Fingerprints Reveal Distinctiveness and Clinical Outcome of SARS-CoV-2 Infection Wolfgang Bauer, Marcus Weber, Eva Diehl-Wiesenecker, Noa Galtung, Monika Prpic, Rajan Somasundaram, et al. (+4)
93 [GO] 2021―Dec―07 Excess Body Mass-A Factor Leading to the Deterioration of COVID-19 and Its Complications-A Narrative Review Weronika Gryczyńska, Nikita Litvinov, Bezawit Bitew, Zuzanna Bartosz, Weronika Kośmider, Paweł Bogdański, Damian Skrypnik
94 [GO] 2021―Dec―07 The Impact of COVID-19 on Mortality in Spain: Monitoring Excess Mortality (MoMo) and the Surveillance of Confirmed COVID-19 Deaths Inmaculada León-Gómez, Clara Mazagatos, Concepción Delgado-Sanz, Luz Frías, Lorena Vega-Piris, Ayelén Rojas-Benedicto, Amparo Larrauri
95 [GO] 2021―Dec―07 COVID-19 Modulates Inflammatory and Renal Markers That May Predict Hospital Outcomes among African American Males Wendy Fonseca, Nobuhiro Asai, Kazuma Yagi, Carrie-Anne Malinczak, Gina Savickas, Christine C. Johnson, et al. (+5)
96 [GO] 2021―Dec―07 Single-Cell and Bulk RNASeq Profiling of COVID-19 Patients Reveal Immune and Inflammatory Mechanisms of Infection-Induced Organ Damage Alexandrea Bass, Yiran Liu, Sivanesan Dakshanamurthy
97 [GO] 2021―Dec―07 Soliris to Stop Immune-Mediated Death in COVID-19 (SOLID-C19)-A Compassionate-Use Study of Terminal Complement Blockade in Critically Ill Patients with COVID-19-Related Adult Respiratory Distress Syndrome Thomas C. Pitts
98 [GO] 2021―Dec―07 Mid-Regional Pro-Adrenomedullin, Methemoglobin and Carboxyhemoglobin as Prognosis Biomarkers in Critically Ill Patients with COVID-19: An Observational Prospective Study Crhistian-Mario Oblitas, Francisco Galeano-Valle, Jesús Ramírez-Navarro, Jorge López-Cano, Ángel Monterrubio-Manrique, Mercedes García-Gámiz, et al. (+4)
99 [GO] 2021―Dec―07 Fast, Reliable, and Simple Point-of-Care-like Adaptation of RT-qPCR for the Detection of SARS-CoV-2 for Use in Hospital Emergency Departments Martina Pavletić, Marija Mazor, Mate Lerga, Tatjana Mileta, Jelena Železnjak, Tina Ružić, et al. (+9)
100 [GO] 2021―Dec―07 Semi-Supervised Pipeline for Autonomous Annotation of SARS-CoV-2 Genomes Kristen L. Beck, Edward Seabolt, Akshay Agarwal, Gowri Nayar, Simone Bianco, Harsha Krishnareddy, et al. (+4)
101 [GO] 2021―Dec―07 Propagation of SARS-CoV-2 in Calu-3 Cells to Eliminate Mutations in the Furin Cleavage Site of Spike John James Baczenas, Hanne Andersen, Sujatha Rashid, David Yarmosh, Nikhita Puthuveetil, Michael Parker, et al. (+5)
102 [GO] 2021―Dec―07 ZRC3308 Monoclonal Antibody Cocktail Shows Protective Efficacy in Syrian Hamsters against SARS-CoV-2 Infection Pragya D. Yadav, Sanjeev Kumar Mendiratta, Sreelekshmy Mohandas, Arun K. Singh, Priya Abraham, Anita Shete, et al. (+11)
103 [GO] 2021―Dec―07 Clinical Manifestation of Subacute Thyroiditis Triggered by SARS-CoV-2 Infection Can Be HLA-Dependent Magdalena Stasiak, Katarzyna Zawadzka-Starczewska, Andrzej Lewiński
104 [GO] 2021―Dec―07 Atovaquone and Berberine Chloride Reduce SARS-CoV-2 Replication In Vitro Bruno A. Rodriguez-Rodriguez, Maria G. Noval, Maria E. Kaczmarek, Kyung Ku Jang, Sara A. Thannickal, Angelica Cifuentes Kottkamp, et al. (+4)
105 [GO] 2021―Dec―07 Protective Immunity against Gamma and Zeta Variants after Inactivated SARS-CoV-2 Virus Immunization Marcilio Jorge Fumagalli, Luiza Antunes Castro-Jorge, Thais Fernanda de Campos Fraga-Silva, Patrick Orestes de Azevedo, Carlos Fabiano Capato, Bruna Amanda Cruz Rattis, et al. (+8)
106 [GO] 2021―Dec―01 Clinical Picture and Risk Factors of Severe Respiratory Symptoms in COVID-19 in Children Anna Mania, Kamil Faltin, Katarzyna Mazur-Melewska, Paweł Małecki, Katarzyna Jończyk-Potoczna, Karol Lubarski, et al. (+5)
107 [GO] 2021―Dec―01 The Role of Serology Testing in the Context of Immunization Policies for COVID-19 in Latin American Countries Carlos E. dos Santos Ferreira, Hector Gómez-Dantés, Nancy C. Junqueira Bellei, Eduardo López, Katya A. Nogales Crespo, Miguel O’Ryan, Julieta Villegas
108 [GO] 2021―Dec―01 COVID-19 In-Hospital Mortality in People with Diabetes Is Driven by Comorbidities and Age-Propensity Score-Matched Analysis of Austrian National Public Health Institute Data Faisal Aziz, Felix Aberer, Alexander Bräuer, Christian Ciardi, Martin Clodi, Peter Fasching, et al. (+26)
109 [GO] 2021―Dec―01 Limited Impact of Delta Variant’s Mutations on the Effectiveness of Neutralization Conferred by Natural Infection or COVID-19 Vaccines in a Latino Population Carlos A. Sariol, Crisanta Serrano-Collazo, Edwin J. Ortiz, Petraleigh Pantoja, Lorna Cruz, Teresa Arana, et al. (+3)
110 [GO] 2021―Dec―01 Emerging Trends in the Epidemiology of COVID-19: The Croatian ‘One Health’ Perspective Tatjana Vilibic-Cavlek, Vladimir Stevanovic, Diana Brlek-Gorski, Ivana Ferencak, Thomas Ferenc, Magdalena Ujevic-Bosnjak, et al. (+13)
111 [GO] 2021―Dec―01 Clinical Application of Ultraviolet C Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 in Contaminated Hospital Environments Wen-Lin Su, Chih-Pei Lin, Hui-Ching Huang, Yao-Kuang Wu, Mei-Chen Yang, Sheg-Kang Chiu, et al. (+3)
112 [GO] 2021―Dec―01 Inhibiting ACSL1-Related Ferroptosis Restrains Murine Coronavirus Infection Huawei Xia, Zeming Zhang, Fuping You
113 [GO] 2021―Dec―01 Sampling for SARS-CoV-2 Aerosols in Hospital Patient Rooms Morgan A. Lane, Maria Walawender, Andrew S. Webster, Erik A. Brownsword, Jessica M. Ingersoll, Candace Miller, et al. (+4)
114 [GO] 2021―Dec―01 Long-Term Humoral Immune Response against SARS-CoV-2 after Natural Infection and Subsequent Vaccination According to WHO International Binding Antibody Units (BAU/mL) Natalia Ruetalo, Bertram Flehmig, Michael Schindler, Lutz Pridzun, Angelika Haage, Marija Reichenbächer, et al. (+5)
115 [GO] 2021―Dec―01 A Large Cohort Study of SARS-CoV-2 Detection in Saliva: A Non-Invasive Alternative Diagnostic Test for Patients with Bleeding Disorders Josiane Iole França Lopes, Carlos Alexandre da Costa Silva, Rodrigo Guimarães Cunha, Alexandra Martins Soares, Maria Esther Duarte Lopes, Orlando Carlos da Conceição Neto, et al. (+4)
116 [GO] 2021―Dec―01 Letter to the Editor: SFlt-1 and PlGF Levels in Pregnancies Complicated by SARS-CoV-2 Infection Valentina Giardini, Sara Ornaghi, Eleonora Acampora, Maria Viola Vasarri, Francesca Arienti, Carlo Gambacorti-Passerini, et al. (+3)
117 [GO] 2021―Dec―01 SARS-CoV-2 Infection and C-Section: A Prospective Observational Study Eva Morán Antolín, José Román Broullón Molanes, María Luisa de la Cruz Conty, María Begoña Encinas Pardilla, María del Pilar Guadix Martín, José Antonio Sainz Bueno, et al. (+5)
118 [GO] 2021―Dec―01 Dynamics of Neutralizing Antibody Responses Following Natural SARS-CoV-2 Infection and Correlation with Commercial Serologic Tests. A Reappraisal and Indirect Comparison with Vaccinated Subjects Constant Gillot, Julien Favresse, Vincent Maloteau, Jean-Michel Dogné, Jonathan Douxfils
119 [GO] 2021―Dec―01 Hydroxypropyl Methylcellulose-Based Nasal Sprays Effectively Inhibit In Vitro SARS-CoV-2 Infection and Spread Kirsten Bentley, Richard J. Stanton
120 [GO] 2021―Dec―01 Systemic Inflammation and Complement Activation Parameters Predict Clinical Outcome of Severe SARS-CoV-2 Infections Silke Huber, Mariam Massri, Marco Grasse, Verena Fleischer, Sára Kellnerová, Verena Harpf, et al. (+8)
121 [GO] 2021―Dec―01 A Routine Sanger Sequencing Target Specific Mutation Assay for SARS-CoV-2 Variants of Concern and Interest Sin Hang Lee
122 [GO] 2021―Dec―01 Eurasian Avian-like M1 Plays More Important Role than M2 in Pathogenicity of 2009 Pandemic H1N1 Influenza Virus in Mice Lixiang Xie, Guanlong Xu, Lingxiang Xin, Zhaofei Wang, Rujuan Wu, Mingqing Wu, et al. (+5)
123 [GO] 2021―Nov―22 Indications of Persistent Glycocalyx Damage in Convalescent COVID-19 Patients: A Prospective Multicenter Study and Hypothesis Richard Vollenberg, Phil-Robin Tepasse, Kevin Ochs, Martin Floer, Markus Strauss, Florian Rennebaum, et al. (+3)
124 [GO] 2021―Nov―22 Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leonians Rodrigo Borrega, Diana K. S. Nelson, Anatoliy P. Koval, Nell G. Bond, Megan L. Heinrich, Megan M. Rowland, et al. (+36)
125 [GO] 2021―Nov―22 Molecular and Serological Characterization of the SARS-CoV-2 Delta Variant in Bangladesh in 2021 Asish Kumar Ghosh, Marco Kaiser, Md. Maruf Ahmed Molla, Tasnim Nafisa, Mahmuda Yeasmin, Rifat Hossain Ratul, et al. (+9)
126 [GO] 2021―Nov―22 Persistence of SARS-CoV-2-Specific Antibodies for 13 Months after Infection Indrė Kučinskaitė-Kodzė, Martynas Simanavičius, Aistis Šimaitis, Aurelija Žvirblienė
127 [GO] 2021―Nov―19 Kite-Shaped Molecules Block SARS-CoV-2 Cell Entry at a Post-Attachment Step Shiu-Wan Chan, Talha Shafi, Robert C. Ford
128 [GO] 2021―Nov―19 An Overview of Recent Insights into the Response of TLR to SARS-CoV-2 Infection and the Potential of TLR Agonists as SARS-CoV-2 Vaccine Adjuvants Mohammad Enamul Hoque Kayesh, Michinori Kohara, Kyoko Tsukiyama-Kohara
129 [GO] 2021―Nov―18 Deciphering the Role of Humoral and Cellular Immune Responses in Different COVID-19 Vaccines-A Comparison of Vaccine Candidate Genes in Roborovski Dwarf Hamsters Jakob Trimpert, Susanne Herwig, Julia Stein, Daria Vladimirova, Julia M. Adler, Azza Abdelgawad, et al. (+8)
130 [GO] 2021―Nov―18 Impact of the Double Mutants on Spike Protein of SARS-CoV-2 B.1.617 Lineage to the Human ACE2 Receptor Binding: A Structural Insight Mohd Imran Khan, Mohammad Hassan Baig, Tanmoy Mondal, Mohammed Alorabi, Tanuj Sharma, Jae-June Dong, Jae Yong Cho
131 [GO] 2021―Nov―16 Validation of a Prognostic Score to Identify Hospitalized Patients with COVID-19 at Increased Risk for Bleeding Pablo Demelo-Rodriguez, Francisco Galeano-Valle, Lucía Ordieres-Ortega, Carmine Siniscalchi, Mar Martín Del Pozo, Ángeles Fidalgo, et al. (+4)
132 [GO] 2021―Nov―16 Peering into Avian Influenza A(H5N8) for a Framework towards Pandemic Preparedness Joshua Yi Yeo, Samuel Ken-En Gan
133 [GO] 2021―Nov―15 Persistence of Neutralizing Antibodies to SARS-CoV-2 in First Wave Infected Individuals at Ten Months Post-Infection: The UnIRSA Cohort Study Gloria Griffante, Shikha Chandel, Daniela Ferrante, Valeria Caneparo, Daniela Capello, Valentina Bettio, et al. (+11)
134 [GO] 2021―Nov―15 Major Vault Protein Inhibits Porcine Reproductive and Respiratory Syndrome Virus Infection in CRL2843CD163 Cell Lines and Primary Porcine Alveolar Macrophages Xiaoping Wu, Junyang Fang, Qiuping Huang, Xu Chen, Zhongyi Guo, Lingyujia Tian, et al. (+4)
135 [GO] 2021―Nov―12 Robust and Persistent B- and T-Cell Responses after COVID-19 in Immunocompetent and Solid Organ Transplant Recipient Patients Federica Zavaglio, Vanessa Frangipane, Monica Morosini, Elisa Gabanti, Paola Zelini, Josè Camilla Sammartino, et al. (+16)
136 [GO] 2021―Nov―12 Common Laboratory Mice Are Susceptible to Infection with the SARS-CoV-2 Beta Variant Ravi Kant, Lauri Kareinen, Teemu Smura, Tobias L. Freitag, Sawan Kumar Jha, Kari Alitalo, et al. (+6)
137 [GO] 2021―Nov―10 Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course Jiří Beran, Marián Špajdel, Jiří Slíva
138 [GO] 2021―Nov―10 Development of a Hamster Natural Transmission Model of SARS-CoV-2 Infection Stuart Dowall, Francisco J. Salguero, Nathan Wiblin, Susan Fotheringham, Graham Hatch, Simon Parks, et al. (+10)
139 [GO] 2021―Nov―09 Circulation and Evolution of SARS-CoV-2 in India: Let the Data Speak Sanket Limaye, Sunitha M. Kasibhatla, Mukund Ramtirthkar, Meenal Kinikar, Mohan M. Kale, Urmila Kulkarni-Kale
140 [GO] 2021―Nov―09 Killing Two Birds with One Stone by Administration of Soluble ACE2: A Promising Strategy to Treat Both Cardiovascular Diseases and SARS-CoV-2 Infection Fengling Feng, Jiaoshan Chen, Jin Zhao, Yanjun Li, Minchao Li, Caijun Sun
141 [GO] 2021―Nov―09 Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 Infections Allison E. Kennedy, Laura Cook, Jessica A. Breznik, Braeden Cowbrough, Jessica G. Wallace, Angela Huynh, et al. (+18)
142 [GO] 2021―Nov―08 Epidemiological and Immunological Features of Obesity and SARS-CoV-2 Eric J. Nilles, Sameed M. Siddiqui, Stephanie Fischinger, Yannic C. Bartsch, Michael de St. Aubin, Guohai Zhou, et al. (+26)
143 [GO] 2021―Nov―05 COVID-19 Anosmia: High Prevalence, Plural Neuropathogenic Mechanisms, and Scarce Neurotropism of SARS-CoV-2? Fengyi Liang, De Yun Wang
144 [GO] 2021―Nov―05 Rapid Response to SARS-CoV-2 in Aotearoa New Zealand: Implementation of a Diagnostic Test and Characterization of the First COVID-19 Cases in the South Island Blair Lawley, Jenny Grant, Rhodri Harfoot, Jackson M. Treece, Robert Day, Leonor C. Hernández, et al. (+3)
145 [GO] 2021―Nov―04 Single-Cell RNAseq Profiling of Human γδ T Lymphocytes in Virus-Related Cancers and COVID-19 Disease Juan Pablo Cerapio, Marion Perrier, Fréderic Pont, Marie Tosolini, Camille Laurent, Stéphane Bertani, Jean-Jacques Fournie
146 [GO] 2021―Nov―04 Structural Biology of Nanobodies against the Spike Protein of SARS-CoV-2 Qilong Tang, Raymond J. Owens, James H. Naismith
147 [GO] 2021―Nov―04 SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism Nitin Kumar, Yu Zuo, Srilakshmi Yalavarthi, Kristina L. Hunker, Jason S. Knight, Yogendra Kanthi, et al. (+2)
148 [GO] 2021―Nov―03 A Review of COVID-19 Modelling Strategies in Three Countries to Develop a Research Framework for Regional Areas Azizur Rahman, Md Abdul Kuddus, Ryan H. L. Ip, Michael Bewong
149 [GO] 2021―Nov―03 Mental Health and Substance Use Associated with Hospitalization among People with COVID-19: A Population-Based Cohort Study Héctor Alexander Velásquez Velásquez García, James Wilton, Kate Smolina, Mei Chong, Drona Rasali, Michael Otterstatter, et al. (+7)
150 [GO] 2021―Nov―03 Apoptosis Enhances the Replication of Human Coronavirus OC43 Sony Maharjan, Mijeong Kang, Jinsoo Kim, Dongbum Kim, Sangkyu Park, Minyoung Kim, et al. (+3)
151 [GO] 2021―Nov―03 Interspecies Jumping of Bat Coronaviruses Antonio C. P. Wong, Susanna K. P. Lau, Patrick C. Y. Woo
152 [GO] 2021―Nov―03 Comparative Sensitivity of Rapid Antigen Tests for the Delta Variant (B.1.617.2) of SARS-CoV-2 Yuko Sakai-Tagawa, Seiya Yamayoshi, Peter J. Halfmann, Yoshihiro Kawaoka
153 [GO] 2021―Nov―03 Peritoneal Administration of a Subunit Vaccine Encapsulated in a Nanodelivery System Not Only Augments Systemic Responses against SARS-CoV-2 but Also Stimulates Responses in the Respiratory Tract Tuksin Jearanaiwitayakul, Suttikarn Apichirapokey, Runglawan Chawengkirttikul, Jitra Limthongkul, Mathurin Seesen, Phissinee Jakaew, et al. (+4)
154 [GO] 2021―Nov―03 Monoclonal Human Antibodies That Recognise the Exposed N and C Terminal Regions of the Often-Overlooked SARS-CoV-2 ORF3a Transmembrane Protein Tyng Hwey Tan, Elizabeth Patton, Carol A. Munro, Dora E. Corzo-Leon, Andrew J. Porter, Soumya Palliyil
155 [GO] 2021―Nov―03 Comparison of SARS-CoV-2 Receptors Expression in Primary Endothelial Cells and Retinoic Acid-Differentiated Human Neuronal Cells Francesca Benedetti, Giovannino Silvestri, Carla Mavian, Matthew Weichseldorfer, Arshi Munawwar, Melanie N. Cash, et al. (+6)
156 [GO] 2021―Nov―03 The Evolutionary Landscape of SARS-CoV-2 Variant B.1.1.519 and Its Clinical Impact in Mexico City Alberto Cedro-Tanda, Laura Gómez-Romero, Nicolás Alcaraz, Guillermo de Anda-Jauregui, Fernando Peñaloza, Bernardo Moreno, et al. (+19)
157 [GO] 2021―Oct―29 Macrophages and Monocytes: “Trojan Horses” in COVID-19 Elena Percivalle, Josè Camilla Sammartino, Irene Cassaniti, Eloisa Arbustini, Mario Urtis, Alexandra Smirnova, et al. (+6)
158 [GO] 2021―Oct―29 High Individual Heterogeneity of Neutralizing Activities against the Original Strain and Nine Different Variants of SARS-CoV-2 Rita Jaafar, Celine Boschi, Sarah Aherfi, Audrey Bancod, Marion Le Bideau, Sophie Edouard, et al. (+6)
159 [GO] 2021―Oct―28 Successive Inoculations of Pigs with Porcine Reproductive and Respiratory Syndrome Virus 1 (PRRSV-1) and Swine H1N2 Influenza Virus Suggest a Mutual Interference between the Two Viral Infections Juliette Bougon, Céline Deblanc, Patricia Renson, Stéphane Quéguiner, Stéphane Gorin, Sophie Mahé, et al. (+5)
160 [GO] 2021―Oct―27 Genetic Analysis of SARS-CoV-2 Variants in Mexico during the First Year of the COVID-19 Pandemic Blanca Taboada-Ramírez, Selene Zárate, Pavel Iša, Celia Boukadida, Joel Armando Vázquez-Pérez, José Esteban Muñoz-Medina, et al. (+17)
161 [GO] 2021―Oct―27 Retraction: Samaha et al. Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon. Viruses 2021, 13, 989 Ali A. Samaha, Hussein Mouawia, Mirna Fawaz, Hamad Hassan, Ali Salami, Ali Al Bazzal, et al. (+10)
162 [GO] 2021―Oct―26 COVEVOL: Natural Evolution at 6 Months of COVID-19 Louise Messin, Marc Puyraveau, Yousri Benabdallah, Quentin Lepiller, Vincent Gendrin, Souheil Zayet, et al. (+4)
163 [GO] 2021―Oct―26 Dynamics of Viral Shedding and Symptoms in Patients with Asymptomatic or Mild COVID-19 Seongman Bae, Ji Yeun Kim, So Yun Lim, Heedo Park, Hye Hee Cha, Ji-Soo Kwon, et al. (+13)
164 [GO] 2021―Oct―26 PICO Questions and DELPHI Methodology for the Management of Venous Thromboembolism Associated with COVID-19 Antoni Riera-Mestre, Luis Jara-Palomares, Ramón Lecumberri, Javier Trujillo-Santos, Enric Grau, Angeles Blanco-Molina, et al. (+7)
165 [GO] 2021―Oct―26 Impairment of CD4+ T and Memory B Cell Responses but Normal Memory CD8+T-Cell Activation on Crohn’s Disease after COVID-19 Vaccination: A Twin Case Fabiana Gil Melgaço, Tamiris Azamor, Livia Melo Villar, Ana Paula Dinis Ano Bom, Juliana Gil Melgaço
166 [GO] 2021―Oct―26 Abnormal Blood Coagulation and Kidney Damage in Aged Hamsters Infected with Severe Acute Respiratory Syndrome Coronavirus 2 Marumi Ohno, Michihito Sasaki, Yasuko Orba, Toshiki Sekiya, Md. Abdul Masum, Osamu Ichii, et al. (+6)
167 [GO] 2021―Oct―26 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Dog in Connecticut in February 2021 Dong-Hun Lee, Zeinab H. Helal, Junwon Kim, Amelia Hunt, Alyza Barbieri, Natalie Tocco, et al. (+5)
168 [GO] 2021―Oct―26 Current Understanding of the Innate Control of Toll-Like Receptors in Response to SARS-CoV-2 Infection Hi Eun Jung, Heung Kyu Lee
169 [GO] 2021―Oct―26 Clusters of SARS-CoV-2 Lineage B.1.1.7 Infection after Vaccination with Adenovirus-Vectored and Inactivated Vaccines William M. de Souza, Stéfanie P. Muraro, Gabriela F. Souza, Mariene R. Amorim, Renata Sesti-Costa, Luciana S. Mofatto, et al. (+28)
170 [GO] 2021―Oct―22 Genotypic Variants of Pandemic H1N1 Influenza A Viruses Isolated from Severe Acute Respiratory Infections in Ukraine during the 2015/16 Influenza Season Oksana Zolotarova, Anna Fesenko, Olga Holubka, Larysa Radchenko, Eric Bortz, Iryna Budzanivska, Alla Mironenko
171 [GO] 2021―Oct―21 A Perspective on Nanotechnology and COVID-19 Vaccine Research and Production in South Africa Admire Dube, Samuel Egieyeh, Mohammed Balogun
172 [GO] 2021―Oct―21 How Antibodies Recognize Pathogenic Viruses: Structural Correlates of Antibody Neutralization of HIV-1, SARS-CoV-2, and Zika Morgan E. Abernathy, Kim-Marie A. Dam, Shannon R. Esswein, Claudia A. Jette, Pamela J. Bjorkman
173 [GO] 2021―Oct―21 Impact of SARS-CoV-2 Epidemic on Antimicrobial Resistance: A Literature Review Francesco Vladimiro Segala, Davide Fiore Bavaro, Francesco Di Gennaro, Federica Salvati, Claudia Marotta, Annalisa Saracino, et al. (+2)
174 [GO] 2021―Oct―21 Analysis of SARS-CoV-2 Genomes from West Java, Indonesia Azzania Fibriani, Rebecca Stephanie, Afifah Alifia Alfiantie, Agust Leo Fany Siregar, Gusti Ayu Prani Pradani, Nicholas Yamahoki, et al. (+6)
175 [GO] 2021―Oct―21 Direct RNA Sequencing Reveals SARS-CoV-2 m6A Sites and Possible Differential DRACH Motif Methylation among Variants João H. C. Campos, Juliana T. Maricato, Carla T. Braconi, Fenando Antoneli, Luiz Mario R. Janini, Marcelo R. S. Briones
176 [GO] 2021―Oct―21 Mutational Hotspot in the SARS-CoV-2 Spike Protein N-Terminal Domain Conferring Immune Escape Potential Slawomir Kubik, Nils Arrigo, Jaume Bonet, Zhenyu Xu
177 [GO] 2021―Oct―21 COVID-19 in 2021 Kenneth Lundstrom, Alaa A. A. Aljabali
178 [GO] 2021―Oct―21 Near-Complete Genome of SARS-CoV-2 Delta (AY.3) Variant Identified in a Dog in Kansas, USA Tyler Doerksen, Andrea Lu, Lance Noll, Kelli Almes, Jianfa Bai, David Upchurch, Rachel Palinski
179 [GO] 2021―Oct―18 The Potential Role of COVID-19 in the Pathogenesis of Multiple Sclerosis-A Preliminary Report Noothan J. Satheesh, Salam Salloum-Asfar, Sara A. Abdulla
180 [GO] 2021―Oct―18 Viral Shedding among Re-Positive Severe Acute Respiratory Syndrome Coronavirus-2 Positive Individuals in Republic of Korea Jeong-Min Kim, Boyeong Ryu, Young June Choe, Hye-Jun Jo, Hyeokjin Lee, Heui Man Kim, et al. (+15)
181 [GO] 2021―Oct―18 Efficacy of Ion-Channel Inhibitors Amantadine, Memantine and Rimantadine for the Treatment of SARS-CoV-2 In Vitro Yuyong Zhou, Karen A. Gammeltoft, Andrea Galli, Anna Offersgaard, Ulrik Fahnøe, Santseharay Ramirez, et al. (+2)
182 [GO] 2021―Oct―18 Effect of Ivermectin and Atorvastatin on Nuclear Localization of Importin Alpha and Drug Target Expression Profiling in Host Cells from Nasopharyngeal Swabs of SARS-CoV-2- Positive Patients Valeria Inés Segatori, Juan Garona, Lorena Grisel Caligiuri, Juan Bizzotto, Rosario Lavignolle, Ayelén Toro, et al. (+5)
183 [GO] 2021―Oct―15 Methods to Measure Antibody Neutralization of Live Human Coronavirus OC43 Jim Boonyaratanakornkit, Anton M. Sholukh, Matthew Gray, Emily L. Bossard, Emily S. Ford, Kizzmekia S. Corbett, et al. (+2)
184 [GO] 2021―Oct―15 High-Throughput Next-Generation Sequencing Respiratory Viral Panel: A Diagnostic and Epidemiologic Tool for SARS-CoV-2 and Other Viruses Nikhil S. Sahajpal, Ashis K. Mondal, Allan Njau, Zachary Petty, Jiani Chen, Sudha Ananth, et al. (+8)
185 [GO] 2021―Oct―15 Feasibility and Effectiveness Assessment of SARS-CoV-2 Antigenic Tests in Mass Screening of a Pediatric Population and Correlation with the Kinetics of Viral Loads Marcello Lanari, Giovanni Battista Biserni, Matteo Pavoni, Eva Caterina Borgatti, Marta Leone, Ilaria Corsini, Tiziana Lazzarotto
186 [GO] 2021―Oct―15 An Update on Innate Immune Responses during SARS-CoV-2 Infection Yu Zhang, Shuaiyin Chen, Yuefei Jin, Wangquan Ji, Weiguo Zhang, Guangcai Duan
187 [GO] 2021―Oct―14 Rapid and Successful Implementation of a COVID-19 Convalescent Plasma Programme-The South African Experience Tanya Nadia Glatt, Caroline Hilton, Cynthia Nyoni, Avril Swarts, Ronel Swanevelder, James Cowley, et al. (+12)
188 [GO] 2021―Oct―14 Pre-Exposure Prophylaxis with Hydroxychloroquine Does Not Prevent COVID-19 nor Virus Related Venous Thromboembolism Alessandro Perrella, Valentina Orlando, Ugo Trama, Francesca F. Bernardi, Enrica Menditto, Enrico Coscioni
189 [GO] 2021―Oct―14 SARS-CoV-2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro Hui Jiang, Ya-Fang Mei
190 [GO] 2021―Oct―11 The Current Evidence Regarding COVID-19 and Pregnancy: Where Are We Now and Where Should We Head to Next? Theodoros Kalampokas, Anna Rapani, Maria Papageorgiou, Sokratis Grigoriadis, Evangelos Maziotis, George Anifandis, et al. (+6)
191 [GO] 2021―Oct―11 Imbalanced Immune Response of T-Cell and B-Cell Subsets in Patients with Moderate and Severe COVID-19 Alexey Golovkin, Olga Kalinina, Vadim Bezrukikh, Arthur Aquino, Ekaterina Zaikova, Tatyana Karonova, et al. (+3)
192 [GO] 2021―Oct―11 Function Is More Reliable than Quantity to Follow Up the Humoral Response to the Receptor-Binding Domain of SARS-CoV-2-Spike Protein after Natural Infection or COVID-19 Vaccination Carlos A. Sariol, Petraleigh Pantoja, Crisanta Serrano-Collazo, Tiffany Rosa-Arocho, Albersy Armina-Rodríguez, Lorna Cruz, et al. (+9)
193 [GO] 2021―Oct―11 An Opportunistic Survey Reveals an Unexpected Coronavirus Diversity Hotspot in North America Hon S. Ip, Kathryn M. Griffin, Jeffrey D. Messer, Megan E. Winzeler, Susan A. Shriner, Mary Lea Killian, et al. (+11)
194 [GO] 2021―Oct―11 Genomic Characterization of Diverse Bat Coronavirus HKU10 in Hipposideros Bats Ning Wang, Chu-Ming Luo, Xing-Lou Yang, Hai-Zhou Liu, Li-Biao Zhang, Wei Zhang, et al. (+5)
195 [GO] 2021―Oct―11 SDAV, the Rat Coronavirus-How Much Do We Know about It in the Light of Potential Zoonoses Michalina Bartak, Anna Słońska, Marcin W Bańbura, Joanna Cymerys
196 [GO] 2021―Oct―11 Cell Entry of Animal Coronaviruses Yang-Ran Cheng, Xinglin Li, Xuesen Zhao, Hanxin Lin
197 [GO] 2021―Oct―11 The Value of Rapid Antigen Tests for Identifying Carriers of Viable SARS-CoV-2 Elena Shidlovskaya, Nadezhda Kuznetsova, Elizaveta Divisenko, Maria Nikiforova, Andrei Siniavin, Daria Ogarkova, et al. (+5)
198 [GO] 2021―Oct―11 Spike Proteins of SARS-CoV-2 Induce Pathological Changes in Molecular Delivery and Metabolic Function in the Brain Endothelial Cells Eun Seon Kim, Min-Tae Jeon, Kyu-Sung Kim, Suji Lee, Suji Kim, Do-Geun Kim
199 [GO] 2021―Oct―11 Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area Marianna Fabi, Emanuele Filice, Carlotta Biagi, Laura Andreozzi, Daniela Palleri, Bianca Elisa Mattesini, et al. (+7)
200 [GO] 2021―Oct―11 Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals David A. Meekins, Natasha N. Gaudreault, Juergen A. Richt
201 [GO] 2021―Oct―11 Evolution of SARS-CoV-2 Key Mutations in Vienna Detected by Large Scale Screening Program Jakob Thannesberger, Anna Edermayr, Alireza Karimi, Mathias Mueller, Ursula Karnthaler, Richard Gauss, et al. (+3)
202 [GO] 2021―Oct―11 Inhibition of SARS-CoV-2 Replication by a Small Interfering RNA Targeting the Leader Sequence Beatrice Tolksdorf, Chuanxiong Nie, Daniela Niemeyer, Viola Röhrs, Johanna Berg, Daniel Lauster, et al. (+6)
203 [GO] 2021―Oct―11 Xeno-Nucleic Acid (XNA) 2’-Fluoro-Arabino Nucleic Acid (FANA) Aptamers to the Receptor-Binding Domain of SARS-CoV-2 S Protein Block ACE2 Binding Irani Alves Ferreira-Bravo, Jeffrey J. DeStefano
204 [GO] 2021―Oct―11 Robust Neutralizing Antibody Levels Detected after Either SARS-CoV-2 Vaccination or One Year after Infection Stefan Glöckner, Franziska Hornung, Michael Baier, Sebastian Weis, Mathias Pletz, Stefanie Deinhardt-Emmer, Bettina Löffler
205 [GO] 2021―Oct―11 Development of a Multiplex Tandem PCR (MT-PCR) Assay for the Detection of Emerging SARS-CoV-2 Variants Richard Hale, Peter Crowley, Samir Dervisevic, Lindsay Coupland, Penelope R. Cliff, Saidat Ebie, et al. (+6)
206 [GO] 2021―Oct―11 An Antigenic Space Framework for Understanding Antibody Escape of SARS-CoV-2 Variants Nathaniel L. Miller, Thomas Clark, Rahul Raman, Ram Sasisekharan
207 [GO] 2021―Oct―11 Neutralization of SARS-CoV-2 Variants by Serum from BNT162b2 Vaccine Recipients Fabrizia Valleriani, Elisa Mancuso, Giacomo Vincifori, Liana Teodori, Lisa Di Marcantonio, Massimo Spedicato, et al. (+5)
208 [GO] 2021―Oct―11 Best Molecular Tools to Investigate Coronavirus Diversity in Mammals: A Comparison Petra Drzewnioková, Francesca Festa, Valentina Panzarin, Davide Lelli, Ana Moreno, Barbara Zecchin, et al. (+2)
209 [GO] 2021―Oct―11 Pericarditis after SARS-CoV-2 Infection: Another Pebble in the Mosaic of Long COVID? Francesco Carubbi, Alessia Alunno, Silvia Leone, Nicoletta Di Gregorio, Bernardina Mancini, Angelo Viscido, et al. (+4)
210 [GO] 2021―Oct―11 Turnover of SARS-CoV-2 Lineages Shaped the Pandemic and Enabled the Emergence of New Variants in the State of Rio de Janeiro, Brazil Ronaldo da Silva Francisco Junior, Alessandra P Lamarca, Luiz G P de Almeida, Liliane Cavalcante, Douglas Terra Machado, Yasmmin Martins, et al. (+21)
211 [GO] 2021―Oct―11 Global Prevalence of Adaptive and Prolonged Infections’ Mutations in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein Johan Lennerstrand, Navaneethan Palanisamy
212 [GO] 2021―Sep―29 IgG Antibodies Develop to Spike but Not to the Nucleocapsid Viral Protein in Many Asymptomatic and Light COVID-19 Cases Maria Tutukina, Anna Kaznadzey, Maria Kireeva, Ilya Mazo
213 [GO] 2021―Sep―28 Novel Ratio Soluble Fms-like Tyrosine Kinase-1/Angiotensin-II (sFlt-1/ANG-II) in Pregnant Women Is Associated with Critical Illness in COVID-19 Salvador Espino-y-Sosa, Raigam Jafet Martinez-Portilla, Johnatan Torres-Torres, Juan Mario Solis-Paredes, Guadalupe Estrada-Gutierrez, Jose Antonio Hernandez-Pacheco, et al. (+8)
214 [GO] 2021―Sep―28 Prognostic Role of Metabolic Syndrome in COVID-19 Patients: A Systematic Review Meta-Analysis Marco Zuin, Gianluca Rigatelli, Claudio Bilato, Carlo Cervellati, Giovanni Zuliani, Loris Roncon
215 [GO] 2021―Sep―28 Identification, Mechanism, and Treatment of Skin Lesions in COVID-19: A Review Diego Fernández-Lázaro, Manuel Garrosa
216 [GO] 2021―Sep―28 Lack of Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spillover in Free-Living Neotropical Non-Human Primates, Brazil Lívia Sacchetto, Bárbara Aparecida Chaves, Edson Rodrigues Costa, Aline Souza de Menezes Medeiros, Marcelo Gordo, Danielle Bastos Araújo, et al. (+8)
217 [GO] 2021―Sep―28 Evolutionary Dynamics and Epidemiology of Endemic and Emerging Coronaviruses in Humans, Domestic Animals, and Wildlife Ariful Islam, Jinnat Ferdous, Shariful Islam, Md. Abu Sayeed, Shusmita Dutta Choudhury, Otun Saha, et al. (+2)
218 [GO] 2021―Sep―28 Development of a Recombinant RBD Subunit Vaccine for SARS-CoV-2 Yi-Sheng Sun, Jing-Jing Zhou, Han-Ping Zhu, Fang Xu, Wen-Bin Zhao, Hang-Jing Lu, et al. (+5)
219 [GO] 2021―Sep―28 The Immune Response to SARS-CoV-2 and Variants of Concern Elham Torbati, Kurt L. Krause, James E. Ussher
220 [GO] 2021―Sep―28 Potential Molecular Mechanisms of Rare Anti-Tumor Immune Response by SARS-CoV-2 in Isolated Cases of Lymphomas Debmalya Barh, Sandeep Tiwari, Lucas Gabriel Rodrigues Gabriel Rodrigues Gomes, Marianna E. Weener, Khalid J. Alzahrani, Khalaf F. Alsharif, et al. (+12)
221 [GO] 2021―Sep―28 Turmeric Root and Its Bioactive Ingredient Curcumin Effectively Neutralize SARS-CoV-2 In Vitro Maren Bormann, Mira Alt, Leonie Schipper, Lukas van de Sand, Vu Thuy Khanh Le-Trilling, Lydia Rink, et al. (+12)
222 [GO] 2021―Sep―28 SARS-CoV-2 Subgenomic RNAs: Characterization, Utility, and Perspectives Samuel Long
223 [GO] 2021―Sep―28 Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission David A. Swan, Ashish Goyal, Chloe Bracis, Mia Moore, Elizabeth Krantz, Elizabeth Brown, et al. (+9)
224 [GO] 2021―Sep―23 COVID-19 Vaccines for HIV-Infected Patients Maria M. Plummer, Charles S. Pavia
225 [GO] 2021―Sep―23 Monoclonal Antibodies to S and N SARS-CoV-2 Proteins as Probes to Assess Structural and Antigenic Properties of Coronaviruses Rinki Kumar, Neil D. Christensen, Rebecca J. Kaddis Maldonado, Maria C. Bewley, Alexandria Ostman, Malgorzata Sudol, et al. (+13)
226 [GO] 2021―Sep―22 COVID-19 Infection in Pregnancy: PCR Cycle Thresholds, Placental Pathology, and Perinatal Outcomes Estibalitz Laresgoiti-Servitje, Jorge Arturo Cardona-Pérez, Rosa Gabriela Hernández-Cruz, Addy Cecilia Helguera-Repetto, María Yolotzin Valdespino-Vázquez, Elsa Romelia Moreno-Verduzco, et al. (+18)
227 [GO] 2021―Sep―22 Increased sHLA-G Is Associated with Improved COVID-19 Outcome and Reduced Neutrophil Adhesion Daria Bortolotti, Valentina Gentili, Sabrina Rizzo, Giovanna Schiuma, Silvia Beltrami, Savino Spadaro, et al. (+6)
228 [GO] 2021―Sep―22 COVID-19: Mechanistic Model of the African Paradox Supports the Central Role of the NF-κB Pathway Ralf Kircheis, Manfred Schuster, Oliver Planz
229 [GO] 2021―Sep―22 A Reverse Transcription Recombinase-Aided Amplification Method for Rapid and Point-of-Care Detection of SARS-CoV-2, including Variants Fengyun Li, Ping He, Dongyan Xiong, Yakun Lou, Qiaosheng Pu, Haixia Zhang, et al. (+2)
230 [GO] 2021―Sep―22 The Immunology of SARS-CoV-2 Infection and Vaccines in Solid Organ Transplant Recipients Dominika Dęborska-Materkowska, Dorota Kamińska
231 [GO] 2021―Sep―22 Cytokine Response to SARS-CoV-2 Infection in Children Antonietta Curatola, Antonio Chiaretti, Serena Ferretti, Giulia Bersani, Donatella Lucchetti, Lavinia Capossela, et al. (+2)
232 [GO] 2021―Sep―22 Multiple Occurrences of a 168-Nucleotide Deletion in SARS-CoV-2 ORF8, Unnoticed by Standard Amplicon Sequencing and Variant Calling Pipelines David Brandt, Marina Simunovic, Tobias Busche, Markus Haak, Peter Belmann, Sebastian Jünemann, et al. (+8)
233 [GO] 2021―Sep―22 Vertical Transmission of SARS-CoV-2: A Systematic Review of Systematic Reviews Salihu S. Musa, Umar M. Bello, Shi Zhao, Zainab U. Abdullahi, Muhammad A. Lawan, Daihai He
234 [GO] 2021―Sep―22 Myocardial Damage by SARS-CoV-2: Emerging Mechanisms and Therapies Huyen Tran Ho, Stefan Peischard, Nathalie Strutz-Seebohm, Karin Klingel, Guiscard Seebohm
235 [GO] 2021―Sep―22 Evolutionary Signatures Governing the Codon Usage Bias in Coronaviruses and Their Implications for Viruses Infecting Various Bat Species Naveen Kumar, Rahul Kaushik, Chandana Tennakoon, Vladimir N. Uversky, Anamika Mishra, Richa Sood, et al. (+4)
236 [GO] 2021―Sep―16 Kinetics of Nucleocapsid, Spike and Neutralizing Antibodies, and Viral Load in Patients with Severe COVID-19 Treated with Convalescent Plasma Thomas P. Thomopoulos, Margherita Rosati, Evangelos Terpos, Dimitris Stellas, Xintao Hu, Sevasti Karaliota, et al. (+22)
237 [GO] 2021―Sep―15 Type I Interferon Induction and Exhaustion during Viral Infection: Plasmacytoid Dendritic Cells and Emerging COVID-19 Findings Trever T. Greene, Elina I. Zuniga
238 [GO] 2021―Sep―15 Compassionate Use of GC5131 (Hyperimmunoglobulin) Therapy in Critically Ill Patients Diagnosed with COVID-19: A Case Series and Review of Literature Sunha Choi, Soyoon Hwang, Kitae Kwon
239 [GO] 2021―Sep―14 Just Seeing Is Not Enough for Believing: Immunolabelling as Indisputable Proof of SARS-CoV-2 Virions in Infected Tissue Andreja Erman, Karmen Wechtersbach, Daniel Velkavrh, Jerica Pleško, Maja Frelih, Nika Kojc
240 [GO] 2021―Sep―14 Potential Antiviral Properties of Industrially Important Marine Algal Polysaccharides and Their Significance in Fighting a Future Viral Pandemic Renu Geetha Bai, Rando Tuvikene
241 [GO] 2021―Sep―13 One Health Investigation of SARS-CoV-2 Infection and Seropositivity among Pets in Households with Confirmed Human COVID-19 Cases-Utah and Wisconsin, 2020 Grace W. Goryoka, Caitlin M. Cossaboom, Radhika Gharpure, Patrick Dawson, Cassandra Tansey, John Rossow, et al. (+35)
242 [GO] 2021―Sep―13 Variability in Codon Usage in Coronaviruses Is Mainly Driven by Mutational Bias and Selective Constraints on CpG Dinucleotide Josquin Daron, Ignacio G. Bravo
243 [GO] 2021―Sep―13 High Rate of Mutational Events in SARS-CoV-2 Genomes across Brazilian Geographical Regions, February 2020 to June 2021 Ueric José Borges de Souza, Raíssa Nunes dos Santos, Fabrício Souza Campos, Karine Lima Lourenço, Flavio Guimarães da Fonseca, Fernando Rosado Spilki
244 [GO] 2021―Sep―13 Acute HIV-1 and SARS-CoV-2 Infections Share Slan+ Monocyte Depletion-Evidence from an Hyperacute HIV-1 Case Report Guilherme B. Farias, Robert Badura, Carolina M. Conceição, André M. C. Gomes, Ana Godinho-Santos, Joel Laia, et al. (+7)
245 [GO] 2021―Sep―13 A Bioluminescent 3CLPro Activity Assay to Monitor SARS-CoV-2 Replication and Identify Inhibitors Cyrille Mathieu, Franck Touret, Clémence Jacquemin, Yves L. Janin, Antoine Nougairède, Manon Brailly, et al. (+11)
246 [GO] 2021―Sep―10 Disruption of the Golgi Apparatus and Contribution of the Endoplasmic Reticulum to the SARS-CoV-2 Replication Complex Ted Hackstadt, Abhilash I. Chiramel, Forrest H. Hoyt, Brandi N. Williamson, Cheryl A. Dooley, Paul A. Beare, et al. (+3)
247 [GO] 2021―Sep―09 Dating the Common Ancestor from an NCBI Tree of 83688 High-Quality and Full-Length SARS-CoV-2 Genomes Xuhua Xia
248 [GO] 2021―Sep―08 Clinical Characterization and Genomic Analysis of Samples from COVID-19 Breakthrough Infections during the Second Wave among the Various States of India Nivedita Gupta, Harmanmeet Kaur, Pragya Dhruv Yadav, Labanya Mukhopadhyay, Rima R. Sahay, Abhinendra Kumar, et al. (+44)
249 [GO] 2021―Sep―08 Quantifying T Cell Cross-Reactivity: Influenza and Coronaviruses Jessica Ann Gaevert, Daniel Luque Duque, Grant Lythe, Carmen Molina-París, Paul Glyndwr Thomas
250 [GO] 2021―Sep―07 Rasch Model of the COVID-19 Symptom Checklist-A Psychometric Validation Study Tanja A. Stamm, Valentin Ritschl, Maisa Omara, Margaret R. Andrews, Nils Mevenkamp, Angelika Rzepka, et al. (+4)
251 [GO] 2021―Sep―07 Clinical Evaluation of In-House-Produced 3D-Printed Nasopharyngeal Swabs for COVID-19 Testing Simon Grandjean Lapierre, Stéphane Bedwani, François DeBlois, Audray Fortin, Natalia Zamorano Cuervo, Karim Zerouali, et al. (+11)
252 [GO] 2021―Sep―07 SARS-CoV-2 Delta Variant Pathogenesis and Host Response in Syrian Hamsters Sreelekshmy Mohandas, Pragya Dhruv Yadav, Anita Shete, Dimpal Nyayanit, Gajanan Sapkal, Kavita Lole, Nivedita Gupta
253 [GO] 2021―Sep―07 Enrichment of SARS-CoV-2 Entry Factors and Interacting Intracellular Genes in Tissue and Circulating Immune Cells Abhinandan Devaprasad, Aridaman Pandit
254 [GO] 2021―Sep―07 The Evolving Faces of the SARS-CoV-2 Genome Maria Schmidt, Mamoona Arshad, Stephan H. Bernhart, Siras Hakobyan, Arsen Arakelyan, Henry Loeffler-Wirth, Hans Binder
255 [GO] 2021―Sep―07 Report of One-Year Prospective Surveillance of SARS-CoV-2 in Dogs and Cats in France with Various Exposure Risks: Confirmation of a Low Prevalence of Shedding, Detection and Complete Sequencing of an Alpha Variant in a Cat Emilie Krafft, Solène Denolly, Bertrand Boson, Sophie Angelloz-Pessey, Sophie Levaltier, Nicolas Nesi, et al. (+8)
256 [GO] 2021―Sep―07 Nafamostat-Interferon-α Combination Suppresses SARS-CoV-2 Infection In Vitro and In Vivo by Cooperatively Targeting Host TMPRSS2 Aleksandr Ianevski, Rouan Yao, Hilde Lysvand, Gunnveig Grødeland, Nicolas Legrand, Valentyn Oksenych, et al. (+4)
257 [GO] 2021―Sep―07 Doxycycline Inhibition of a Pseudotyped Virus Transduction Does Not Translate to Inhibition of SARS-CoV-2 Infectivity Luisa Diomede, Sara Baroni, Ada De Luigi, Arianna Piotti, Jacopo Lucchetti, Claudia Fracasso, et al. (+13)
258 [GO] 2021―Sep―01 The Impact of Risk-Adjusted Heparin Regimens on the Outcome of Patients with COVID-19 Infection. A Prospective Cohort Study Pierpaolo Di Micco, Antonella Tufano, Giuseppe Cardillo, Egidio Imbalzano, Maria Amitrano, Corrado Lodigiani, et al. (+8)
259 [GO] 2021―Sep―01 SARS-CoV-2 Infection Modulates ACE2 Function and Subsequent Inflammatory Responses in Swabs and Plasma of COVID-19 Patients Lucía Gutiérrez-Chamorro, Eva Riveira-Muñoz, Clara Barrios, Vanesa Palau, Maria Nevot, Sònia Pedreño-López, et al. (+9)
260 [GO] 2021―Sep―01 A Review of Treatment and Prevention of Coronavirus Disease 2019 among Solid Organ Transplant Recipients Deanna J. Buehrle, Robert R. Sutton, Erin L. McCann, Aaron E. Lucas
261 [GO] 2021―Sep―01 Antibody-Mediated Neutralization of Authentic SARS-CoV-2 B.1.617 Variants Harboring L452R and T478K/E484Q Alexander Wilhelm, Tuna Toptan, Christiane Pallas, Timo Wolf, Udo Goetsch, Rene Gottschalk, et al. (+3)
262 [GO] 2021―Sep―01 A Transient Increase in the Serum ANCAs in Patients with SARS-CoV-2 Infection: A Signal of Subclinical Vasculitis or an Epiphenomenon with No Clinical Manifestations? A Pilot Study Monica Gelzo, Sara Cacciapuoti, Biagio Pinchera, Annunziata De Rosa, Gustavo Cernera, Filippo Scialò, et al. (+8)
263 [GO] 2021―Sep―01 Substrate Specificity of SARS-CoV-2 Nsp10-Nsp16 Methyltransferase Roberto Benoni, Petra Krafcikova, Marek R. Baranowski, Joanna Kowalska, Evzen Boura, Hana Cahová
264 [GO] 2021―Sep―01 Processing Hundreds of SARS-CoV-2 Samples with an In-House PCR-Based Method without Robotics Theresa Mair, Maja Ivankovic, Christian Paar, Helmut J. F. Salzer, Angelika Heissl, Bernd Lamprecht, et al. (+2)
265 [GO] 2021―Sep―01 Breakthrough Infections with Multiple Lineages of SARS-CoV-2 Variants Reveals Continued Risk of Severe Disease in Immunosuppressed Patients Xufang Deng, Monika Evdokimova, Amornrat O’Brien, Cynthia L. Rowe, Nina M. Clark, Amanda Harrington, et al. (+3)
266 [GO] 2021―Sep―01 Influenza Antigens NP and M2 Confer Cross Protection to BALB/c Mice against Lethal Challenge with H1N1, Pandemic H1N1 or H5N1 Influenza A Viruses Nutan Mytle, Sonja Leyrer, Jon R. Inglefield, Andrea M. Harris, Thomas E. Hickey, Jacob Minang, et al. (+7)
267 [GO] 2021―Sep―01 Newly Discovered Archival Data Show Coincidence of a Peak of Sexually Transmitted Diseases with the Early Epicenter of Pandemic HIV-1 João Dinis Sousa, Philip J. Havik, Viktor Müller, Anne-Mieke Vandamme
268 [GO] 2021―Sep―01 Multi-Organ Histopathological Changes in a Mouse Hepatitis Virus Model of COVID-19 Michael J. Paidas, Adhar B. Mohamed, Michael D. Norenberg, Ali Saad, Ariel Faye Barry, Cristina Colon, et al. (+2)
269 [GO] 2021―Sep―01 Intracellular Life Cycle Kinetics of SARS-CoV-2 Predicted Using Mathematical Modelling Dmitry Grebennikov, Ekaterina Kholodareva, Igor Sazonov, Antonina Karsonova, Andreas Meyerhans, Gennady Bocharov
270 [GO] 2021―Aug―26 Monitoring Natural SARS-CoV-2 Infection in Lions (Panthera leo) at the Barcelona Zoo: Viral Dynamics and Host Responses Hugo Fernández-Bellon, Jordi Rodon, Leira Fernández-Bastit, Vanessa Almagro, Pilar Padilla-Solé, Cristina Lorca-Oró, et al. (+14)
271 [GO] 2021―Aug―26 SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants John Charles Rotondo, Fernanda Martini, Martina Maritati, Chiara Mazziotta, Giulia Di Mauro, Carmen Lanzillotti, et al. (+4)
272 [GO] 2021―Aug―25 Behavior of Eosinophil Counts in Recovered and Deceased COVID-19 Patients over the Course of the Disease Ricarda Cortés-Vieyra, Sergio Gutiérrez-Castellanos, Cleto Álvarez-Aguilar, Víctor Manuel Baizabal-Aguirre, Rosa Elvira Nuñez-Anita, Angélica Georgina Rocha-López, Anel Gómez-García
273 [GO] 2021―Aug―24 Peptide Platform as a Powerful Tool in the Fight against COVID-19 Michela Murdocca, Gennaro Citro, Isabella Romeo, Antonio Lupia, Shane Miersch, Bruno Amadio, et al. (+7)
274 [GO] 2021―Aug―24 Unique Severe COVID-19 Placental Signature Independent of Severity of Clinical Maternal Symptoms Marjolein F. Husen, Lotte E. van der Meeren, Robert M. Verdijk, Pieter L. A. Fraaij, Annemiek A. van der Eijk, Marion P. G. Koopmans, et al. (+6)
275 [GO] 2021―Aug―24 Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus Irina Leneva, Nadezhda Kartashova, Artem Poromov, Anastasiia Gracheva, Ekaterina Korchevaya, Ekaterina Glubokova, et al. (+6)
276 [GO] 2021―Aug―24 All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity Takeshi Morita, Kei Miyakawa, Sundararaj Stanleyraj Jeremiah, Yutaro Yamaoka, Mitsuru Sada, Tomoko Kuniyoshi, et al. (+3)
277 [GO] 2021―Aug―24 The Post-Acute Phase of SARS-CoV-2 Infection in Two Macaque Species Is Associated with Signs of Ongoing Virus Replication and Pathology in Pulmonary and Extrapulmonary Tissues Kinga P. Böszörményi, Marieke A. Stammes, Zahra C. Fagrouch, Gwendoline Kiemenyi-Kayere, Henk Niphuis, Daniella Mortier, et al. (+22)
278 [GO] 2021―Aug―23 Efficacy of Unsupervised Self-Collected Mid-Turbinate FLOQSwabs for the Diagnosis of Coronavirus Disease 2019 (COVID-19) Egildo Luca D’Andrea, Alessia Maria Cossu, Marianna Scrima, Vincenzo Messina, Pasquale Iuliano, Felice Di Perna, et al. (+14)
279 [GO] 2021―Aug―23 The Microvillar and Solitary Chemosensory Cells as the Novel Targets of Infection of SARS-CoV-2 in Syrian Golden Hamsters Jin-Seok Seo, Sun-Woo Yoon, Seung-Hyeon Hwang, Sung-Min Nam, Sang-Soep Nahm, Jei-Hyun Jeong, et al. (+4)
280 [GO] 2021―Aug―23 Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice Jeremy R. A. Paull, Carolyn A. Luscombe, Alex Castellarnau, Graham P. Heery, Michael D. Bobardt, Philippe A. Gallay
281 [GO] 2021―Aug―19 Serological Screening for Antibodies against SARS-CoV-2 in Dutch Shelter Cats W. J. R. van der Leij, Els M. Broens, Jan Willem Hesselink, Nancy Schuurman, Johannes C. M. Vernooij, Herman F. Egberink
282 [GO] 2021―Aug―19 SARS-CoV-2 Seroprevalence Structure of the Russian Population during the COVID-19 Pandemic Anna Y. Popova, Viacheslav S. Smirnov, Elena E. Andreeva, Elena A. Babura, Sergey V. Balakhonov, Natalia S. Bashketova, et al. (+28)
283 [GO] 2021―Aug―19 A Novel Frameshifting Inhibitor Having Antiviral Activity against Zoonotic Coronaviruses Dae-Gyun Ahn, Gun Young Yoon, Sunhee Lee, Keun Bon Ku, Chonsaeng Kim, Kyun-Do Kim, et al. (+4)
284 [GO] 2021―Aug―19 Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2 Nathan Peiffer-Smadja, Antoine Bridier-Nahmias, Valentine Marie Ferré, Charlotte Charpentier, Mathilde Garé, Christophe Rioux, et al. (+7)
285 [GO] 2021―Aug―19 Serological Detection of SARS-CoV-2 Antibodies in Naturally-Infected Mink and Other Experimentally-Infected Animals Francisco J. Berguido, Peter D. Burbelo, Alessio Bortolami, Francesco Bonfante, Kerstin Wernike, Donata Hoffmann, et al. (+5)
286 [GO] 2021―Aug―19 Modeling Within-Host Dynamics of SARS-CoV-2 Infection: A Case Study in Ferrets Naveen K. Vaidya, Angelica Bloomquist, Alan S. Perelson
287 [GO] 2021―Aug―19 Monitoring SARS-CoV-2 Populations in Wastewater by Amplicon Sequencing and Using the Novel Program SAM Refiner Devon A. Gregory, Chris G. Wieberg, Jeff Wenzel, Chung-Ho Lin, Marc C. Johnson
288 [GO] 2021―Aug―16 What Binds Cationic Photosensitizers Better: Brownian Dynamics Reveals Key Interaction Sites on Spike Proteins of SARS-CoV, MERS-CoV, and SARS-CoV-2 Vladimir Fedorov, Ekaterina Kholina, Sergei Khruschev, Ilya Kovalenko, Andrew Rubin, Marina Strakhovskaya
289 [GO] 2021―Aug―13 Characterization of the SARS-CoV-2 Host Response in Primary Human Airway Epithelial Cells from Aged Individuals Bharathiraja Subramaniyan, Jason L. Larabee, Manish Bodas, Andrew R. Moore, Anthony W. G. Burgett, Dean A. Myers, et al. (+4)
290 [GO] 2021―Aug―13 Plant-Produced Glycosylated and In Vivo Deglycosylated Receptor Binding Domain Proteins of SARS-CoV-2 Induce Potent Neutralizing Responses in Mice Tarlan Mamedov, Damla Yuksel, Merve Ilgın, Irem Gurbuzaslan, Burcu Gulec, Hazel Yetiskin, et al. (+6)
291 [GO] 2021―Aug―13 The Positive Rhinovirus/Enterovirus Detection and SARS-CoV-2 Persistence beyond the Acute Infection Phase: An Intra-Household Surveillance Study Pedro Brotons, Iolanda Jordan, Quique Bassat, Desiree Henares, Mariona Fernandez de Sevilla, Sara Ajanovic, et al. (+11)
292 [GO] 2021―Aug―13 The Alpha Variant (B.1.1.7) of SARS-CoV-2 in Children: First Experience from 3544 Nucleic Acid Amplification Tests in a Cohort of Children in Germany Meike Meyer, Anna Holfter, Esra Ruebsteck, Henning Gruell, Felix Dewald, Robert Walter Koerner, et al. (+4)
293 [GO] 2021―Aug―13 The Origins and Future of Sentinel: An Early-Warning System for Pandemic Preemption and Response Yolanda Botti-Lodovico, Parvathy Nair, Dolo Nosamiefan, Matthew Stremlau, Stephen Schaffner, Sebastian V. Agignoae, et al. (+105)
294 [GO] 2021―Aug―12 Detection of SARS-CoV-2 Derived Small RNAs and Changes in Circulating Small RNAs Associated with COVID-19 Claudius Grehl, Christoph Schultheiß, Katrin Hoffmann, Mascha Binder, Thomas Altmann, Ivo Grosse, Markus Kuhlmann
295 [GO] 2021―Aug―12 COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors Daniele Focosi, Massimo Franchini, Liise-anne Pirofski, Thierry Burnouf, DeLisa Fairweather, Michael J. Joyner, Arturo Casadevall
296 [GO] 2021―Aug―11 Non-Nucleotide RNA-Dependent RNA Polymerase Inhibitor That Blocks SARS-CoV-2 Replication Milan Dejmek, Eva Konkoľová, Luděk Eyer, Petra Straková, Pavel Svoboda, Michal Šála, et al. (+4)
297 [GO] 2021―Aug―10 Coronavirus Pseudotypes for All Circulating Human Coronaviruses for Quantification of Cross-Neutralizing Antibody Responses Alexander Thomas Sampson, Jonathan Heeney, Diego Cantoni, Matteo Ferrari, Maria Suau Sans, Charlotte George, et al. (+8)
298 [GO] 2021―Aug―06 Clinical and Histopathologic Features of a Feline SARS-CoV-2 Infection Model Are Analogous to Acute COVID-19 in Humans Jennifer M. Rudd, Miruthula Tamil Selvan, Shannon Cowan, Yun-Fan Kao, Cecily C. Midkiff, Sai Narayanan, et al. (+3)
299 [GO] 2021―Aug―05 Current Data on COVID-19 mRNA-Vaccine Safety during Pregnancy Might Be Subject to Selection Bias. Reply to Stroobandt, S.; Stroobandt, R. Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on “Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199” Sarah Stuckelberger, Guillaume Favre, Michael Ceulemans, Eva Gerbier, Valentine Lambelet, Milos Stojanov, et al. (+4)
300 [GO] 2021―Aug―05 Data of the COVID-19 mRNA-Vaccine V-Safe Surveillance System and Pregnancy Registry Reveals Poor Embryonic and Second Trimester Fetal Survival Rate. Comment on Stuckelberger et al. SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland. Viruses 2021, 13, 1199 Serge Stroobandt, Roland Stroobandt
301 [GO] 2021―Aug―02 Animal Coronavirus Diseases: Parallels with COVID-19 in Humans Chao-Nan Lin, Kuan Rong Chan, Eng Eong Ooi, Ming-Tang Chiou, Minh Hoang, Po-Ren Hsueh, Peck Toung Ooi
302 [GO] 2021―Aug―02 Chemiluminescence Immunoassay Based Serological Immunoassays for Detection of SARS-CoV-2 Neutralizing Antibodies in COVID-19 Convalescent Patients and Vaccinated Population Qiangling Yin, Yecheng Zhang, Lijun Lian, Yuanyuan Qu, Wei Wu, Zhen Chen, et al. (+10)
303 [GO] 2021―Aug―02 Epidemiology and Seasonality of Endemic Human Coronaviruses in South African and Zambian Children: A Case-Control Pneumonia Study Vicky L. Baillie, David P. Moore, Azwifarwi Mathunjwa, Daniel E. Park, Donald M. Thea, Geoffrey Kwenda, et al. (+2)
304 [GO] 2021―Aug―02 Intravenous, Intratracheal, and Intranasal Inoculation of Swine with SARS-CoV-2 Alexandra Buckley, Shollie Falkenberg, Mathias Martins, Melissa Laverack, Mitchell V. Palmer, Kelly Lager, Diego G. Diel
305 [GO] 2021―Aug―02 Severe SARS-CoV-2 Infection in a Cat with Hypertrophic Cardiomyopathy Francisco R. Carvallo, Mathias Martins, Lok R. Joshi, Leonardo C. Caserta, Patrick K. Mitchell, Thomas Cecere, et al. (+4)
306 [GO] 2021―Aug―02 Characterization of a Lineage C.36 SARS-CoV-2 Isolate with Reduced Susceptibility to Neutralization Circulating in Lombardy, Italy Matteo Castelli, Andreina Baj, Elena Criscuolo, Roberto Ferrarese, Roberta A. Diotti, Michela Sampaolo, et al. (+9)
307 [GO] 2021―Aug―02 The Algerian Chapter of SARS-CoV-2 Pandemic: An Evolutionary, Genetic, and Epidemiological Prospect Safia Zeghbib, Balázs A. Somogyi, Brigitta Zana, Gábor Kemenesi, Róbert Herczeg, Fawzi Derrar, Ferenc Jakab
308 [GO] 2021―Jul―30 Detection of IFNγ-Secreting CD4+ and CD8+ Memory T Cells in COVID-19 Convalescents after Stimulation of Peripheral Blood Mononuclear Cells with Live SARS-CoV-2 Victoria Matyushenko, Irina Isakova-Sivak, Igor Kudryavtsev, Arina Goshina, Anna Chistyakova, Ekaterina Stepanova, et al. (+3)
309 [GO] 2021―Jul―30 Diversity of Coronaviruses in Wild Representatives of the Aves Class in Poland Katarzyna Domańska-Blicharz, Justyna Miłek-Krupa, Anna Pikuła
310 [GO] 2021―Jul―30 Localization of SARS-CoV-2 Capping Enzymes Revealed by an Antibody against the nsp10 Subunit Vladimira Horova, Barbora Landova, Jan Hodek, Karel Chalupsky, Petra Krafcikova, Dominika Chalupska, et al. (+4)
311 [GO] 2021―Jul―30 Rise and Fall of SARS-CoV-2 Lineage A.27 in Germany Sébastien Calvignac-Spencer, Matthias Budt, Matthew Huska, Hugues Richard, Luca Leipold, Linus Grabenhenrich, et al. (+5)
312 [GO] 2021―Jul―30 Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection Sandro Halwe, Alexandra Kupke, Kanika Vanshylla, Falk Liberta, Henning Gruell, Matthias Zehner, et al. (+22)
313 [GO] 2021―Jul―29 What Is the Role of Therapeutic Plasma Exchange as an Adjunctive Treatment in Severe COVID-19: A Systematic Review Łukasz J. Krzych, Zbigniew Putowski, Marcelina Czok, Mariusz Hofman
314 [GO] 2021―Jul―29 Retraction: Messina et al. Rationale and Criteria for a COVID-19 Model Framework. Viruses 2021, 13, 1309
315 [GO] 2021―Jul―28 SARS-CoV-2, CT-Values, and Infectivity-Conclusions to Be Drawn from Side Observations Martin Platten, Dennis Hoffmann, Roger Grosser, Fabian Wisplinghoff, Hilmar Wisplinghoff, Gerhard Wiesmüller, et al. (+2)
316 [GO] 2021―Jul―27 SARS-CoV-2 Infection in Dogs and Cats from Southern Germany and Northern Italy during the First Wave of the COVID-19 Pandemic Julia Klaus, Eric Zini, Katrin Hartmann, Herman Egberink, Anja Kipar, Michèle Bergmann, et al. (+7)
317 [GO] 2021―Jul―27 Characteristics and Clinical Outcomes of 116,539 Patients Hospitalized with COVID-19-Poland, March-December 2020 Mariusz Gujski, Mateusz Jankowski, Daniel Rabczenko, Paweł Goryński, Grzegorz Juszczyk
318 [GO] 2021―Jul―27 Human Coronaviruses: Counteracting the Damage by Storm Dewald Schoeman, Burtram C. Fielding
319 [GO] 2021―Jul―23 Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines Yong Yang, Jinkai Zang, Shiqi Xu, Xueyang Zhang, Sule Yuan, Haikun Wang, et al. (+3)
320 [GO] 2021―Jul―23 The Emergence of SARS-CoV-2 within the Dog Population in Croatia: Host Factors and Clinical Outcome Vladimir Stevanovic, Irena Tabain, Tatjana Vilibic-Cavlek, Maja Mauric Maljkovic, Iva Benvin, Zeljka Hruskar, et al. (+20)
321 [GO] 2021―Jul―23 Virucidal Efficacy of Blue LED and Far-UVC Light Disinfection against Feline Infectious Peritonitis Virus as a Model for SARS-CoV-2 Amanda Gardner, Sayani Ghosh, Magdalena Dunowska, Gale Brightwell
322 [GO] 2021―Jul―23 SARS-CoV-2 N Protein Targets TRIM25-Mediated RIG-I Activation to Suppress Innate Immunity Gianni Gori Savellini, Gabriele Anichini, Claudia Gandolfo, Maria Grazia Cusi
323 [GO] 2021―Jul―20 Viral Load and Patterns of SARS-CoV-2 Dissemination to the Lungs, Mediastinal Lymph Nodes, and Spleen of Patients with COVID-19 Associated Lymphopenia Adhamjon Abdullaev, Akmaljon Odilov, Maxim Ershler, Alexey Volkov, Tatiana Lipina, Tatiana Gasanova, et al. (+3)
324 [GO] 2021―Jul―20 Antiviral Effect of Budesonide against SARS-CoV-2 Natalie Heinen, Toni Luise Meister, Mara Klöhn, Eike Steinmann, Daniel Todt, Stephanie Pfaender
325 [GO] 2021―Jul―20 Seroprevalence of SARS-CoV-2 Binding and Neutralizing Antibodies in Healthcare Workers during the Epidemic Peak in Referral Hospitals and Quarantine Sites: Saudi Arabia Rowa Y. Alhabbab, Ahdab Alsaieedi, Abdullah Algaissi, Sara Almahboub, Rajaa M. Al-Raddadi, Omaima I. Shabouni, et al. (+11)
326 [GO] 2021―Jul―19 An Appraisal of the Current Scenario in Vaccine Research for COVID-19 Wai Chin Chong, Dinesh K. Chellappan, Shakti D. Shukla, Gregory M. Peterson, Rahul P. Patel, Niraj Kumar Jha, et al. (+4)
327 [GO] 2021―Jul―16 Cell Population Data and Serum Polyclonal Immunoglobulin Free Light Chains in the Assessment of COVID-19 Severity Milena Małecka-Giełdowska, Maria Fołta, Agnieszka Wiśniewska, Emilia Czyżewska, Olga Ciepiela
328 [GO] 2021―Jul―15 Neutralizing Antibodies in COVID-19 Patients and Vaccine Recipients after Two Doses of BNT162b2 Julien Favresse, Constant Gillot, Laura Di Chiaro, Christine Eucher, Marc Elsen, Sandrine Van Eeckhoudt, et al. (+4)
329 [GO] 2021―Jul―15 First Detection of SARS-CoV-2 B.1.1.7 Variant of Concern in an Asymptomatic Dog in Spain Sandra Barroso-Arévalo, Belén Rivera, Lucas Domínguez, José M. Sánchez-Vizcaíno
330 [GO] 2021―Jul―15 Cellular Uptake and Intracellular Phosphorylation of GS-441524: Implications for Its Effectiveness against COVID-19 Henrik Berg Rasmussen, Gesche Jürgens, Ragnar Thomsen, Olivier Taboureau, Kornelius Zeth, Poul Erik Hansen, Peter Riis Hansen
331 [GO] 2021―Jul―14 Do Dogs and Cats Passively Carry SARS-CoV-2 on Hair and Pads? Stefania Lauzi, Angelica Stranieri, Alessia Giordano, Davide Lelli, Gabriella Elia, Costantina Desario, et al. (+3)
332 [GO] 2021―Jul―14 Human Coronaviruses Do Not Transfer Efficiently between Surfaces in the Absence of Organic Materials Matthew Dallner, Jennifer Harlow, Neda Nasheri
333 [GO] 2021―Jul―14 Variant Analysis of SARS-CoV-2 Genomes from Belgian Military Personnel Engaged in Overseas Missions and Operations Jean-Paul Pirnay, Philippe Selhorst, Samuel L. Hong, Christel Cochez, Barney Potter, Piet Maes, et al. (+20)
334 [GO] 2021―Jul―13 The SARS-CoV-2/Receptor Axis in Heart and Blood Vessels: A Crisp Update on COVID-19 Disease with Cardiovascular Complications Priya Veluswamy, Max Wacker, Dimitrios Stavridis, Thomas Reichel, Hendrik Schmidt, Maximilian Scherner, et al. (+2)
335 [GO] 2021―Jul―13 Serum Neutralizing Activity against B.1.1.7, B.1.351, and P.1 SARS-CoV-2 Variants of Concern in Hospitalized COVID-19 Patients Claudia Maria Trombetta, Serena Marchi, Simonetta Viviani, Alessandro Manenti, Linda Benincasa, Antonella Ruello, et al. (+4)
336 [GO] 2021―Jul―12 Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air-Liquid Interface Cultured Human Primary Bronchial Epithelial Cells Bram M. ter Ellen, Nilima Dinesh Kumar, Ellen M. Bouma, Berit Troost, Denise P.I. van de Pol, Heidi H. van der Ende-Metselaar, et al. (+8)
337 [GO] 2021―Jul―08 Global Utilization Trends of Direct Acting Antivirals (DAAs) during the COVID-19 Pandemic: A Time Series Analysis Ahmad Shakeri, Natalia Konstantelos, Cherry Chu, Tony Antoniou, Jordan Feld, Katie J. Suda, Mina Tadrous
338 [GO] 2021―Jul―08 Comparison and Sensitivity Evaluation of Three Different Commercial Real-Time Quantitative PCR Kits for SARS-CoV-2 Detection Ana Banko, Gordana Petrovic, Danijela Miljanovic, Ana Loncar, Marija Vukcevic, Dragana Despot, Andja Cirkovic
339 [GO] 2021―Jul―07 Rationale and Criteria for a COVID-19 Model Framework Francesco Messina, Chiara Montaldo, Isabella Abbate, Manuela Antonioli, Veronica Bordoni, Giulia Matusali, et al. (+7)
340 [GO] 2021―Jul―05 Potential Prophylactic Treatments for COVID-19 Noam Ben-Zuk, Ido-David Dechtman, Itai Henn, Libby Weiss, Amichay Afriat, Esther Krasner, Yoav Gal
341 [GO] 2021―Jul―05 Effects of Basic Amino Acids and Their Derivatives on SARS-CoV-2 and Influenza-A Virus Infection Ivonne Melano, Li-Lan Kuo, Yan-Chung Lo, Po-Wei Sung, Ni Tien, Wen-Chi Su
342 [GO] 2021―Jul―05 From Protein to Pandemic: The Transdisciplinary Approach Needed to Prevent Spillover and the Next Pandemic Raina K. Plowright, Peter J. Hudson
343 [GO] 2021―Jul―01 Maternal and Neonatal Outcomes of SARS-CoV-2 Infection in a Cohort of Pregnant Women with Comorbid Disorders Maria de Lourdes Benamor Teixeira, Orlando da Costa Ferreira Júnior, Esaú João, Trevon Fuller, Juliana Silva Esteves, Wallace Mendes-Silva, et al. (+6)
344 [GO] 2021―Jun―30 COVID-19 Pandemic: Influence of Schools, Age Groups, and Virus Variants in Italy Giovanni Sebastiani, Giorgio Palé
345 [GO] 2021―Jun―30 Modular Evolution of Coronavirus Genomes Yulia Vakulenko, Andrei Deviatkin, Jan Felix Drexler, Alexander Lukashev
346 [GO] 2021―Jun―29 Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1 Carla Zannella, Rosa Giugliano, Annalisa Chianese, Carmine Buonocore, Giovanni Andrea Vitale, Giuseppina Sanna, et al. (+8)
347 [GO] 2021―Jun―28 Effect of Aprotinin and Avifavir® Combination Therapy for Moderate COVID-19 Patients Andrey A. Ivashchenko, Valeria N. Azarova, Alina N. Egorova, Ruben N. Karapetian, Dmitry V. Kravchenko, Natalia V. Krivonos, et al. (+9)
348 [GO] 2021―Jun―28 Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry Chuan Xu, Annie Wang, Mariana Marin, William Honnen, Santhamani Ramasamy, Edith Porter, et al. (+5)
349 [GO] 2021―Jun―28 Case Study of Two Post Vaccination SARS-CoV-2 Infections with P1 Variants in CoronaVac Vaccinees in Brazil Cassia F. Estofolete, Cecilia A. Banho, Guilherme R. F. Campos, Beatriz de C. Marques, Livia Sacchetto, Leila S. Ullmann, et al. (+10)
350 [GO] 2021―Jun―28 Emodin from Aloe Inhibits Porcine Reproductive and Respiratory Syndrome Virus via Toll-Like Receptor 3 Activation Zhichao Xu, Meiyan Huang, Yongbo Xia, Peng Peng, Yun Zhang, Shumei Zheng, et al. (+3)
351 [GO] 2021―Jun―25 The Antiviral Effect of the Chemical Compounds Targeting DED/EDh Motifs of the Viral Proteins on Lymphocytic Choriomeningitis Virus and SARS-CoV-2 Mya Myat Ngwe Tun, Kouichi Morita, Takeshi Ishikawa, Shuzo Urata
352 [GO] 2021―Jun―25 Nanotechnology as a Shield against COVID-19: Current Advancement and Limitations Mahendra Rai, Shital Bonde, Alka Yadav, Arpita Bhowmik, Sanjay Rathod, Pramod Ingle, Aniket Gade
353 [GO] 2021―Jun―25 Coronaviruses in Bats: A Review for the Americas Itandehui Hernández-Aguilar, Consuelo Lorenzo, Antonio Santos-Moreno, Eduardo J. Naranjo, Darío Navarrete-Gutiérrez
354 [GO] 2021―Jun―25 A Hepatitis B Virus-Derived Peptide Can Inhibit Infection of Human Lung Cells with SARS-CoV-2 in a Type-1 Interferon-Dependent Manner Yu-Min Choi, Hyein Jeong, Uni Park, Nam-Hyuk Cho, Bum-Joon Kim
355 [GO] 2021―Jun―24 Successful Clearance of 300 Day SARS-CoV-2 Infection in a Subject with B-Cell Depletion Associated Prolonged (B-DEAP) COVID by REGEN-COV Anti-Spike Monoclonal Antibody Cocktail Arnaud C. Drouin, Marc W. Theberge, Sharon Y. Liu, Allison R. Smither, Shelby M. Flaherty, Mark Zeller, et al. (+11)
356 [GO] 2021―Jun―24 SARS-CoV-2 Variants: A Synopsis of In Vitro Efficacy Data of Convalescent Plasma, Currently Marketed Vaccines, and Monoclonal Antibodies Daniele Focosi, Marco Tuccori, Andreina Baj, Fabrizio Maggi
357 [GO] 2021―Jun―23 Convalescent Plasma for Pregnant Women with COVID-19: A Systematic Literature Review Massimo Franchini, Federico Prefumo, Gianpaolo Grisolia, Valentino Bergamini, Claudia Glingani, Marlene Pisello, et al. (+2)
358 [GO] 2021―Jun―23 Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far? Ivana Lazarevic, Vera Pravica, Danijela Miljanovic, Maja Cupic
359 [GO] 2021―Jun―23 SARS-CoV-2 Vaccine Willingness among Pregnant and Breastfeeding Women during the First Pandemic Wave: A Cross-Sectional Study in Switzerland Sarah Stuckelberger, Guillaume Favre, Michael Ceulemans, Hedvig Nordeng, Eva Gerbier, Valentine Lambelet, et al. (+5)
360 [GO] 2021―Jun―17 Impact of COVID-19 Mitigation Measures on Mosquito-Borne Diseases in 2020 in Queensland, Australia Cassie C. Jansen, Jonathan M. Darbro, Frances A. Birrell, Martin A. Shivas, Andrew F. van den Hurk
361 [GO] 2021―Jun―17 Current State of Knowledge about Role of Pets in Zoonotic Transmission of SARS-CoV-2 Mateusz Dróżdż, Paweł Krzyżek, Barbara Dudek, Sebastian Makuch, Adriana Janczura, Emil Paluch
362 [GO] 2021―Jun―16 Progression and Trends in Virus from Influenza A to COVID-19: An Overview of Recent Studies Hakimeh Baghaei Daemi, Muhammad Fakhar-e-Alam Kulyar, Xinlin He, Chengfei Li, Morteza Karimpour, Xiaomei Sun, et al. (+2)
363 [GO] 2021―Jun―15 Functions of Coronavirus Accessory Proteins: Overview of the State of the Art Puxian Fang, Liurong Fang, Huichang Zhang, Sijin Xia, Shaobo Xiao
364 [GO] 2021―Jun―15 SARS-CoV-2 Antigenemia as a Confounding Factor in Immunodiagnostic Assays: A Case Study Konstantinos Belogiannis, Venetia A. Florou, Paraskevi C. Fragkou, Stefanos Ferous, Loukas Chatzis, Aikaterini Polyzou, et al. (+7)
365 [GO] 2021―Jun―15 Different Neutralization Sensitivity of SARS-CoV-2 Cell-to-Cell and Cell-Free Modes of Infection to Convalescent Sera Natalia Kruglova, Andrei Siniavin, Vladimir Gushchin, Dmitriy Mazurov
366 [GO] 2021―Jun―15 Modeling within-Host SARS-CoV-2 Infection Dynamics and Potential Treatments Mehrshad Sadria, Anita T. Layton
367 [GO] 2021―Jun―15 Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals Benjamin Trinité, Edwards Pradenas, Silvia Marfil, Carla Rovirosa, Víctor Urrea, Ferran Tarrés-Freixas, et al. (+21)
368 [GO] 2021―Jun―15 Full-Length Computational Model of the SARS-CoV-2 Spike Protein and Its Implications for a Viral Membrane Fusion Mechanism Wataru Nishima, Marta Kulik
369 [GO] 2021―Jun―11 Field and Molecular Epidemiology: How Viral Sequencing Changed Transmission Inferences in the First Portuguese SARS-CoV-2 Infection Cluster Nicole Pedro, Veronica Fernandes, Bruno Cavadas, João Tiago Guimarães, Henrique Barros, Margarida Tavares, Luisa Pereira
370 [GO] 2021―Jun―11 Estimates and Determinants of SARS-Cov-2 Seroprevalence and Infection Fatality Ratio Using Latent Class Analysis: The Population-Based Tirschenreuth Study in the Hardest-Hit German County in Spring 2020 Ralf Wagner, David Peterhoff, Stephanie Beileke, Felix Günther, Melanie Berr, Sebastian Einhauser, et al. (+17)
371 [GO] 2021―Jun―10 The SARS-CoV-2 Nucleocapsid Protein and Its Role in Viral Structure, Biological Functions, and a Potential Target for Drug or Vaccine Mitigation Zhihua Bai, Ying Cao, Wenjun Liu, Jing Li
372 [GO] 2021―Jun―09 A Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving Epidemic Andreas C. Chrysostomou, Bram Vrancken, George Koumbaris, George Themistokleous, Antonia Aristokleous, Christina Masia, et al. (+11)
373 [GO] 2021―Jun―08 Comparative Study of SARS-CoV-2, SARS-CoV-1, MERS-CoV, HCoV-229E and Influenza Host Gene Expression in Asthma: Importance of Sex, Disease Severity, and Epithelial Heterogeneity Mackenzie E. Coden, Lucas F. Loffredo, Hiam Abdala-Valencia, Sergejs Berdnikovs
374 [GO] 2021―Jun―08 Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene Alyssa T. Pyke, Neelima Nair, Andrew F. van den Hurk, Peter Burtonclay, Son Nguyen, Jean Barcelon, et al. (+4)
375 [GO] 2021―Jun―07 Seroprevalence of SARS-CoV-2, Symptom Profiles and Sero-Neutralization in a Suburban Area, France Anne Gégout Petit, Hélène Jeulin, Karine Legrand, Nicolas Jay, Agathe Bochnakian, Pierre Vallois, et al. (+2)
376 [GO] 2021―Jun―07 Characterization of Winter Dysentery Bovine Coronavirus Isolated from Cattle in Israel Dan David, Nick Storm, Waksman Ilan, Asaf Sol
377 [GO] 2021―Jun―04 Efficacy of Tocilizumab Therapy in Different Subtypes of COVID-19 Cytokine Storm Syndrome Oleksandr Oliynyk, Wojciech Barg, Anna Slifirczyk, Yanina Oliynyk, Vitaliy Gurianov, Marta Rorat
378 [GO] 2021―Jun―04 Effective Communication at Different Phases of COVID-19 Prevention: Roles, Enablers and Barriers Khayriyyah Mohd Hanafiah, Celine Ng, Abdul Matiin Wan
379 [GO] 2021―Jun―04 Prevalence, Persistence, and Factors Associated with SARS-CoV-2 IgG Seropositivity in a Large Cohort of Healthcare Workers in a Tertiary Care University Hospital in Northern Italy Gitana Scozzari, Cristina Costa, Enrica Migliore, Maurizio Coggiola, Giovannino Ciccone, Luigi Savio, et al. (+5)
380 [GO] 2021―Jun―04 The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner Victoria Callahan, Seth Hawks, Matthew A. Crawford, Caitlin W. Lehman, Holly A. Morrison, Hannah M. Ivester, et al. (+9)
381 [GO] 2021―Jun―03 A Bioluminescent Biosensor for Quantifying the Interaction of SARS-CoV-2 and Its Receptor ACE2 in Cells and In Vitro Xiaolong Yang, Lidong Liu, Yawei Hao, Eva So, Sahar Sarmasti Emami, Derek Zhang, et al. (+3)
382 [GO] 2021―Jun―02 DIC-Like Syndrome Following Administration of ChAdOx1 nCov-19 Vaccination Gerardo Casucci, Domenico Acanfora
383 [GO] 2021―Jun―01 Evaluation of Production Lots of a Rapid Point-of-Care Lateral Flow Serological Test Intended for Identification of IgM and IgG against the N-Terminal Part of the Spike Protein (S1) of SARS-CoV-2 Tove Hoffman, Linda Kolstad, Bengt Rönnberg, Åke Lundkvist
384 [GO] 2021―Jun―01 Evolutionary Patterns of Codon Usage in Major Lineages of Porcine Reproductive and Respiratory Syndrome Virus in China Weixin Wu, Xinna Ge, Yongning Zhang, Jun Han, Xin Guo, Lei Zhou, Hanchun Yang
385 [GO] 2021―May―31 COVID-19 Severity Potentially Modulated by Cardiovascular-Disease-Associated Immune Dysregulation Abby C. Lee, Grant Castaneda, Wei Tse Li, Chengyu Chen, Neil Shende, Jaideep Chakladar, et al. (+3)
386 [GO] 2021―May―31 Characterization of a Novel SARS-CoV-2 Genetic Variant with Distinct Spike Protein Mutations Anna Gladkikh, Anna Dolgova, Vladimir Dedkov, Valeriya Sbarzaglia, Olga Kanaeva, Anna Popova, Areg Totolian
387 [GO] 2021―May―31 Insights into SARS-CoV-2 Persistence and Its Relevance Belete A. Desimmie, Yonas Y. Raru, Hesham M. Awadh, Peimei He, Samson Teka, Kara S. Willenburg
388 [GO] 2021―May―31 Correlating qRT-PCR, dPCR and Viral Titration for the Identification and Quantification of SARS-CoV-2: A New Approach for Infection Management Martina Brandolini, Francesca Taddei, Maria Michela Marino, Laura Grumiro, Agata Scalcione, Maria Elena Turba, et al. (+5)
389 [GO] 2021―May―28 The Spike of Concern-The Novel Variants of SARS-CoV-2 Anna Winger, Thomas Caspari
390 [GO] 2021―May―28 The Second Wave of SARS-CoV-2 Circulation-Antibody Detection in the Domestic Cat Population in Germany Anna Michelitsch, Jacob Schön, Donata Hoffmann, Martin Beer, Kerstin Wernike
391 [GO] 2021―May―28 Characterization and Outcomes of SARS-CoV-2 Infection in Patients with Sarcoidosis P. Brito-Zerón, B. Gracia-Tello, A. Robles, A. Alguacil, M. Bonet, B. De-Escalante, et al. (+6)
392 [GO] 2021―May―27 Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays Jenni Virtanen, Ruut Uusitalo, Essi M. Korhonen, Kirsi Aaltonen, Teemu Smura, Suvi Kuivanen, et al. (+11)
393 [GO] 2021―May―27 Diagnostic Potential of a Luminex-Based Coronavirus Disease 2019 Suspension Immunoassay (COVID-19 SIA) for the Detection of Antibodies against SARS-CoV-2 Tove Hoffman, Linda Kolstad, Johanna F. Lindahl, Bo Albinsson, Anders Bergqvist, Bengt Rönnberg, Åke Lundkvist
394 [GO] 2021―May―27 Is the First of the Two Born Saved? A Rare and Dramatic Case of Double Placental Damage from SARS-CoV-2 Leonardo Resta, Antonella Vimercati, Sara Sablone, Andrea Marzullo, Gerardo Cazzato, Giuseppe Ingravallo, et al. (+4)
395 [GO] 2021―May―27 Effects of a Single Dose of Ivermectin on Viral and Clinical Outcomes in Asymptomatic SARS-CoV-2 Infected Subjects: A Pilot Clinical Trial in Lebanon Ali A. Samaha, Hussein Mouawia, Mirna Fawaz, Hamad Hassan, Ali Salami, Ali Al Bazzal, et al. (+10)
396 [GO] 2021―May―27 Epidemic Spread of SARS-CoV-2 Lineage B.1.1.7 in Brazil Filipe R. R. Moreira, Diego M. Bonfim, Danielle A. G. Zauli, Joice P. Silva, Aline B. Lima, Frederico S. V. Malta, et al. (+12)
397 [GO] 2021―May―26 Noble Metal Organometallic Complexes Display Antiviral Activity against SARS-CoV-2 Christina Chuong, Christine M. DuChane, Emily M. Webb, Pallavi Rai, Jeffrey M. Marano, Chad M. Bernier, et al. (+2)
398 [GO] 2021―May―25 Identification of Novel Candidate CD8+ T Cell Epitopes of the SARS-CoV2 with Homology to Other Seasonal Coronaviruses Pradeep Darshana Pushpakumara, Deshan Madhusanka, Saubhagya Dhanasekara, Chandima Jeewandara, Graham S. Ogg, Gathsaurie Neelika Malavige
399 [GO] 2021―May―24 Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19 Maria Laura De Angelis, Federica Francescangeli, Rachele Rossi, Alessandro Giuliani, Ruggero De Maria, Ann Zeuner
400 [GO] 2021―May―24 Dysregulation of Pulmonary Responses in Severe COVID-19 Dandan Wu, Xuexian O. Yang
401 [GO] 2021―May―24 Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset-Lessons Learned Lars Dölken, August Stich, Christoph D. Spinner
402 [GO] 2021―May―24 GABAA-Receptor Agonists Limit Pneumonitis and Death in Murine Coronavirus-Infected Mice Jide Tian, Blake Middleton, Daniel L. Kaufman
403 [GO] 2021―May―24 Evaluation of Dried Blood Spot Testing for SARS-CoV-2 Serology Using a Quantitative Commercial Assay Davor Brinc, Mia J. Biondi, Daniel Li, Heng Sun, Camelia Capraru, David Smookler, et al. (+4)
404 [GO] 2021―May―24 Human Immunodeficiency Viruses Pseudotyped with SARS-CoV-2 Spike Proteins Infect a Broad Spectrum of Human Cell Lines through Multiple Entry Mechanisms Chuan Xu, Annie Wang, Ke Geng, William Honnen, Xuening Wang, Natalie Bruiners, et al. (+8)
405 [GO] 2021―May―20 Optimization and Clinical Evaluation of a Multi-Target Loop-Mediated Isothermal Amplification Assay for the Detection of SARS-CoV-2 in Nasopharyngeal Samples Foteini Roumani, Sarah Azinheiro, Hugo Sousa, Ana Sousa, Mafalda Timóteo, Tatiana Varandas, et al. (+5)
406 [GO] 2021―May―20 SARS-CoV-2 Infections and Viral Isolations among Serially Tested Cats and Dogs in Households with Infected Owners in Texas, USA Sarah A. Hamer, Alex Pauvolid-Corrêa, Italo B. Zecca, Edward Davila, Lisa D. Auckland, Christopher M. Roundy, et al. (+11)
407 [GO] 2021―May―20 SARS-CoV-2 Disinfection of Air and Surface Contamination by TiO2 Photocatalyst-Mediated Damage to Viral Morphology, RNA, and Protein Ryosuke Matsuura, Chieh-Wen Lo, Satoshi Wada, Junichi Somei, Heihachiro Ochiai, Takeharu Murakami, et al. (+7)
408 [GO] 2021―May―19 Overview of Bat and Wildlife Coronavirus Surveillance in Africa: A Framework for Global Investigations Marike Geldenhuys, Marinda Mortlock, Jonathan H. Epstein, Janusz T. Pawęska, Jacqueline Weyer, Wanda Markotter
409 [GO] 2021―May―19 Prediction and Evolution of the Molecular Fitness of SARS-CoV-2 Variants: Introducing SpikePro Fabrizio Pucci, Marianne Rooman
410 [GO] 2021―May―18 A Pandemic within Other Pandemics. When a Multiple Infection of a Host Occurs: SARS-CoV-2, HIV and Mycobacterium tuberculosis Carmen María González-Domenech, Isabel Pérez-Hernández, Cristina Gómez-Ayerbe, Isabel Viciana Ramos, Rosario Palacios-Muñoz, Jesús Santos
411 [GO] 2021―May―17 Social Restrictions versus Testing Campaigns in the COVID-19 Crisis: A Predictive Model Based on the Spanish Case Francisco Javier Candel, Elisabet Viayna, Daniel Callejo, Raul Ramos, Jesús San-Roman-Montero, Pablo Barreiro, et al. (+5)
412 [GO] 2021―May―17 An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India Pragya D. Yadav, Dimpal A. Nyayanit, Triparna Majumdar, Savita Patil, Harmanmeet Kaur, Nivedita Gupta, et al. (+42)
413 [GO] 2021―May―17 Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2 Kien Nguyen, Srirupa Chakraborty, Rachael A. Mansbach, Bette Korber, Sandrasegaram Gnanakaran
414 [GO] 2021―May―17 Persistent COVID-19 Symptoms Minimally Impact the Development of SARS-CoV-2-Specific T Cell Immunity Hengsheng Fang, Adam D. Wegman, Kianna Ripich, Heather Friberg, Jeffrey R. Currier, Stephen J. Thomas, et al. (+2)
415 [GO] 2021―May―17 Compelling Evidence for the Activity of Antiviral Peptides against SARS-CoV-2 Miray Tonk, Daniel Růžek, Andreas Vilcinskas
416 [GO] 2021―May―17 Structural Analysis of the Novel Variants of SARS-CoV-2 and Forecasting in North America Elena Quinonez, Majid Vahed, Abdolrazagh Hashemi Shahraki, Mehdi Mirsaeidi
417 [GO] 2021―May―17 Diagnostic Performance of Ag-RDTs and NAAT for SARS-CoV2 Identification in Symptomatic Patients in Catalonia Luca Basile, Víctor Guadalupe-Fernández, Manuel Valdivia Guijarro, Ana Martinez Mateo, Pilar Ciruela Navas, Jacobo Mendioroz Peña
418 [GO] 2021―May―14 Critical Aspects Concerning the Development of a Pooling Approach for SARS-CoV-2 Diagnosis Using Large-Scale PCR Testing Daniel Cruceriu, Oana Baldasici, Loredana Balacescu, Stefana Gligor-Popa, Mirela Flonta, Milena A. Man, et al. (+5)
419 [GO] 2021―May―13 Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples Richard S. Bennett, Elena N. Postnikova, Janie Liang, Robin Gross, Steven Mazur, Saurabh Dixit, et al. (+8)
420 [GO] 2021―May―13 Influence of SARS-CoV-2 Variant B.1.1.7, Vaccination, and Public Health Measures on the Spread of SARS-CoV-2 Chloé Dimeglio, Marine Milhes, Jean-Michel Loubes, Noémie Ranger, Jean-Michel Mansuy, Pauline Trémeaux, et al. (+5)
421 [GO] 2021―May―13 SARS-CoV-2 Persistent Viral Shedding in the Context of Hydroxychloroquine-Azithromycin Treatment Michel Drancourt, Sébastien Cortaredona, Cléa Melenotte, Sophie Amrane, Carole Eldin, Bernard La Scola, et al. (+5)
422 [GO] 2021―May―13 Symptomatic SARS-CoV-2 Reinfection in a Healthy Healthcare Worker in Italy Confirmed by Whole-Genome Sequencing Daniela Loconsole, Anna Sallustio, Marisa Accogli, Francesca Centrone, Daniele Casulli, Antonino Madaro, et al. (+3)
423 [GO] 2021―May―13 Cascading from SARS-CoV-2 to Parkinson’s Disease through Protein-Protein Interactions Ernesto Estrada
424 [GO] 2021―May―13 Performance of Self-Collected Saliva Testing Compared with Nasopharyngeal Swab Testing for the Detection of SARS-CoV-2 Florence Carrouel, Martine Valette, Hervé Perrier, Maude Bouscambert-Duchamp, Claude Dussart, Paul Tramini, Denis Bourgeois
425 [GO] 2021―May―12 Recurrence of Upper Extremity Deep Vein Thrombosis Secondary to COVID-19 Yesha H. Parekh, Nicole J. Altomare, Erin P. McDonnell, Martin J. Blaser, Payal D. Parikh
426 [GO] 2021―May―12 Mutation in a SARS-CoV-2 Haplotype from Sub-Antarctic Chile Reveals New Insights into the Spike’s Dynamics Jorge González-Puelma, Jacqueline Aldridge, Marco Montes de Oca, Mónica Pinto, Roberto Uribe-Paredes, José Fernández-Goycoolea, et al. (+8)
427 [GO] 2021―May―12 Cytokines and Leukocytes Subpopulations Profile in SARS-CoV-2 Patients Depending on the CT Score Severity Elżbieta Rutkowska, Iwona Kwiecień, Magdalena Żabicka, Artur Maliborski, Agata Raniszewska, Krzysztof Kłos, et al. (+4)
428 [GO] 2021―May―10 Virological Correlates of IgM-IgG Patterns of Response to SARS-CoV-2 Infection According to Targeted Antigens Pablo Barreiro, Francisco Javier Candel, Juan Carlos Sanz, Jesús San Román, María del Mar Carretero, Marta Pérez-Abeledo, et al. (+5)
429 [GO] 2021―May―10 The Repurposed Drugs Suramin and Quinacrine Cooperatively Inhibit SARS-CoV-2 3CLpro In Vitro Raphael J. Eberle, Danilo S. Olivier, Marcos S. Amaral, Ian Gering, Dieter Willbold, Raghuvir K. Arni, Monika A. Coronado
430 [GO] 2021―May―08 Convalescent Plasma Transfusion for the Treatment of COVID-19 in Adults: A Global Perspective Saly Kanj, Basem Al-Omari
431 [GO] 2021―May―08 Clinical and Radiological Profiles of COVID-19 Patients with Neurological Symptomatology: A Comparative Study Maria de Fatima Viana Vasco Aragao, Mariana de Carvalho Leal, Pedro Henrique Pereira Andrade, Ocelio Queiroga Cartaxo Filho, Lucas Vasco Aragao, Tatiana Moreira Fonseca, et al. (+7)
432 [GO] 2021―May―08 Will SARS-CoV-2 Become Just Another Seasonal Coronavirus? Alexander B. Beams, Rebecca Bateman, Frederick R. Adler
433 [GO] 2021―May―08 Identification of SARS-CoV-2 and Enteroviruses in Sewage Water-A Pilot Study Anda Băicuș, Carmen Maria Cherciu, Mihaela Lazăr
434 [GO] 2021―May―08 Pregnancy Outcomes and SARS-CoV-2 Infection: The Spanish Obstetric Emergency Group Study Sara Cruz Melguizo, María Luisa de la Cruz Conty, Paola Carmona Payán, Alejandra Abascal-Saiz, Pilar Pintando Recarte, Laura González Rodríguez, et al. (+14)
435 [GO] 2021―May―06 Clinical Characteristics and Outcomes of COVID-19 in West Virginia Sijin Wen, Apoorv Prasad, Kerri Freeland, Sanjiti Podury, Jenil Patel, Roshan Subedi, et al. (+5)
436 [GO] 2021―May―02 Scutellaria barbata D. Don Inhibits the Main Proteases (Mpro and TMPRSS2) of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Sheng-Teng Huang, Yeh Chen, Wei-Chao Chang, Hsiao-Fan Chen, Hsiang-Chun Lai, Yu-Chun Lin, et al. (+5)
437 [GO] 2021―May―02 Frontline Screening for SARS-CoV-2 Infection at Emergency Department Admission by Third Generation Rapid Antigen Test: Can We Spare RT-qPCR? Valeria Cento, Silvia Renica, Elisa Matarazzo, Maria Antonello, Luna Colagrossi, Federica Di Ruscio, et al. (+7)
438 [GO] 2021―Apr―30 Development and Clinical Evaluation of an Immunochromatography-Based Rapid Antigen Test (GenBody™ COVAG025) for COVID-19 Diagnosis Doyeong Kim, Jihoo Lee, Jyotiranjan Bal, Seul Ki Seo, Chom-Kyu Chong, Jong Ho Lee, Hyun Park
439 [GO] 2021―Apr―30 Pitfall of Universal Pre-Admission Screening for SARS-CoV-2 in a Low Prevalence Country Jiwon Jung, Jinyeong Kim, Joon Seo Lim, Eun Ok Kim, Mi-Na Kim, Sung-Han Kim
440 [GO] 2021―Apr―30 Utility of Routine Laboratory Biomarkers to Detect COVID-19: A Systematic Review and Meta-Analysis Jana Suklan, James Cheaveau, Sarah Hill, Samuel G. Urwin, Kile Green, Amanda Winter, et al. (+7)
441 [GO] 2021―Apr―30 Inhibitors of Protein Glycosylation Are Active against the Coronavirus Severe Acute Respiratory Syndrome Coronavirus SARS-CoV-2 Sreejith Rajasekharan, Rafaela Milan Bonotto, Lais Nascimento Alves, Yvette Kazungu, Monica Poggianella, Pamela Martinez-Orellana, et al. (+3)
442 [GO] 2021―Apr―30 Immunoglobulin Response and Prognostic Factors in Repeated SARS-CoV-2 Positive Patients: A Systematic Review and Meta-Analysis Fanni Dembrovszky, Szilárd Váncsa, Nelli Farkas, Bálint Erőss, Lajos Szakó, Brigitta Teutsch, et al. (+8)
443 [GO] 2021―Apr―30 Fast Detection of SARS-CoV-2 RNA Directly from Respiratory Samples Using a Loop-Mediated Isothermal Amplification (LAMP) Test Olympia E. Anastasiou, Caroline Holtkamp, Miriam Schäfer, Frieda Schön, Anna Maria Eis-Hübinger, Andi Krumbholz
444 [GO] 2021―Apr―29 Age, Disease Severity and Ethnicity Influence Humoral Responses in a Multi-Ethnic COVID-19 Cohort Muneerah Smith, Houari B. Abdesselem, Michelle Mullins, Ti-Myen Tan, Andrew J. M. Nel, Maryam A. Y. Al-Nesf, et al. (+21)
445 [GO] 2021―Apr―29 Identification of Highly Conserved SARS-CoV-2 Antigenic Epitopes with Wide Coverage Using Reverse Vaccinology Approach Yasmin Hisham, Yaqoub Ashhab, Sang-Hyun Hwang, Dong-Eun Kim
446 [GO] 2021―Apr―29 Global Discrepancies between Numbers of Available SARS-CoV-2 Genomes and Human Development Indexes at Country Scales Philippe Colson, Didier Raoult
447 [GO] 2021―Apr―29 Emergence and Spread of SARS-CoV-2 Lineages B.1.1.7 and P.1 in Italy Francesca Di Giallonardo, Ilaria Puglia, Valentina Curini, Cesare Cammà, Iolanda Mangone, Paolo Calistri, et al. (+3)
448 [GO] 2021―Apr―29 In Vitro Lung Models and Their Application to Study SARS-CoV-2 Pathogenesis and Disease Natalie Heinen, Mara Klöhn, Eike Steinmann, Stephanie Pfaender
449 [GO] 2021―Apr―28 The Significance of Phenotyping and Quantification of Plasma Extracellular Vesicles Levels Using High-Sensitivity Flow Cytometry during COVID-19 Treatment Igor Kudryavtsev, Olga Kalinina, Vadim Bezrukikh, Olesya Melnik, Alexey Golovkin
450 [GO] 2021―Apr―27 D-Dimer Level and Neutrophils Count as Predictive and Prognostic Factors of Pulmonary Embolism in Severe Non-ICU COVID-19 Patients Benjamin Thoreau, Joris Galland, Maxime Delrue, Marie Neuwirth, Alain Stepanian, Anthony Chauvin, et al. (+28)
451 [GO] 2021―Apr―27 Are Posterior Oropharyngeal Saliva Specimens an Acceptable Alternative to Nasopharyngeal Sampling for the Monitoring of SARS-CoV-2 in Primary-Care Settings? Shirley Masse, Camille Bonnet, Ana-Maria Vilcu, Hayat Benamar, Morgane Swital, Sylvie van der Werf, et al. (+4)
452 [GO] 2021―Apr―27 Identification of Epidemiological Traits by Analysis of SARS-CoV-2 Sequences Bohu Pan, Zuowei Ji, Sugunadevi Sakkiah, Wenjing Guo, Jie Liu, Tucker A. Patterson, Huixiao Hong
453 [GO] 2021―Apr―26 Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech) Johannes Korth, Michael Jahn, Oliver Dorsch, Olympia Evdoxia Anastasiou, Burkhard Sorge-Hädicke, Ute Eisenberger, et al. (+6)
454 [GO] 2021―Apr―26 Within-Host and Between-Host Evolution in SARS-CoV-2-New Variant’s Source Karin Moelling
455 [GO] 2021―Apr―25 From Multiplex Serology to Serolomics-A Novel Approach to the Antibody Response against the SARS-CoV-2 Proteome Julia Butt, Rajagopal Murugan, Theresa Hippchen, Sylvia Olberg, Monique van Straaten, Hedda Wardemann, et al. (+9)
456 [GO] 2021―Apr―25 Accessible LAMP-Enabled Rapid Test (ALERT) for Detecting SARS-CoV-2 Ali Bektaş, Michael F. Covington, Guy Aidelberg, Anibal Arce, Tamara Matute, Isaac Núñez, et al. (+6)
457 [GO] 2021―Apr―25 A Novel Immunofluorescence Assay for the Rapid Serological Detection of SARS-CoV-2 Infection Dung Nguyen, Donal Skelly, Niluka Goonawardane
458 [GO] 2021―Apr―23 Genomic Surveillance of Circulating SARS-CoV-2 in South East Italy: A One-Year Retrospective Genetic Study Loredana Capozzi, Angelica Bianco, Laura Del Sambro, Domenico Simone, Antonio Lippolis, Maria Notarnicola, et al. (+4)
459 [GO] 2021―Apr―23 Superiority of MALDI-TOF Mass Spectrometry over Real-Time PCR for SARS-CoV-2 RNA Detection Magda Rybicka, Ewa Miłosz, Krzysztof Piotr Bielawski
460 [GO] 2021―Apr―22 SARS-CoV-2 and Placenta: New Insights and Perspectives Leonardo Resta, Antonella Vimercati, Gerardo Cazzato, Giulia Mazzia, Ettore Cicinelli, Anna Colagrande, et al. (+4)
461 [GO] 2021―Apr―22 A Potential SARS-CoV-2 Variant of Interest (VOI) Harboring Mutation E484K in the Spike Protein Was Identified within Lineage B.1.1.33 Circulating in Brazil Paola Cristina Resende, Tiago Gräf, Anna Carolina Dias Paixão, Luciana Appolinario, Renata Serrano Lopes, Ana Carolina da Fonseca Mendonça, et al. (+26)
462 [GO] 2021―Apr―21 Comparison of Serological Assays for the Detection of SARS-CoV-2 Antibodies Joe James, Shelley Rhodes, Craig S. Ross, Paul Skinner, Samuel P. Smith, Rebecca Shipley, et al. (+10)
463 [GO] 2021―Apr―20 When the COVID-19 Pandemic Surges during Influenza Season: Lessons Learnt from the Sentinel Laboratory-Based Surveillance of Influenza-Like Illness in Lombardy during the 2019-2020 Season Cristina Galli, Laura Pellegrinelli, Laura Bubba, Valeria Primache, Giovanni Anselmi, Serena Delbue, et al. (+5)
464 [GO] 2021―Apr―20 Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects Angela Huynh, Donald M. Arnold, James W. Smith, Jane C. Moore, Ali Zhang, Zain Chagla, et al. (+10)
465 [GO] 2021―Apr―20 Arthropod Ectoparasites Have Potential to Bind SARS-CoV-2 via ACE Su Datt Lam, Paul Ashford, Sandra Díaz-Sánchez, Margarita Villar, Christian Gortázar, José de la Fuente, Christine Orengo
466 [GO] 2021―Apr―16 Genetic Characterisation and Comparison of Three Human Coronaviruses (HKU1, OC43, 229E) from Patients and Bovine Coronavirus (BCoV) from Cattle with Respiratory Disease in Slovenia Monika Jevšnik Virant, Danijela Černe, Miroslav Petrovec, Tomislav Paller, Ivan Toplak
467 [GO] 2021―Apr―16 Five Antigen Tests for SARS-CoV-2: Virus Viability Matters Miroslav Homza, Hana Zelena, Jaroslav Janosek, Hana Tomaskova, Eduard Jezo, Alena Kloudova, et al. (+3)
468 [GO] 2021―Apr―14 Household Cases Suggest That Cats Belonging to Owners with COVID-19 Have a Limited Role in Virus Transmission Pierre Bessière, Maxime Fusade-Boyer, Mathilda Walch, Laetitia Lèbre, Jessie Brun, Guillaume Croville, et al. (+3)
469 [GO] 2021―Apr―14 Transcriptional Landscape of Vero E6 Cells during Early Swine Acute Diarrhea Syndrome Coronavirus Infection Siying Zeng, Ouyang Peng, Ruipu Sun, Qiuping Xu, Fangyu Hu, Yan Zhao, et al. (+3)
470 [GO] 2021―Apr―13 Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19 Meehyun Ko, So Young Chang, Soo Young Byun, Aleksandr Ianevski, Inhee Choi, Anne-Laure Pham Hung d’Alexandry d’Orengiani, et al. (+7)
471 [GO] 2021―Apr―13 Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single-Chain Variable Fragment (scFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro Gunsup Lee, Shailesh Budhathoki, Geum-Young Lee, Kwang-ji Oh, Yeon Kyoung Ham, Young-Jun Kim, et al. (+10)
472 [GO] 2021―Apr―13 Quinine Inhibits Infection of Human Cell Lines with SARS-CoV-2 Maximilian Große, Natalia Ruetalo, Mirjam Layer, Dan Hu, Ramona Businger, Sascha Rheber, et al. (+7)
473 [GO] 2021―Apr―13 Comparison of Throat Washings, Nasopharyngeal Swabs and Oropharyngeal Swabs for Detection of SARS-CoV-2 Florian Hitzenbichler, Stilla Bauernfeind, Bernd Salzberger, Barbara Schmidt, Jürgen J. Wenzel
474 [GO] 2021―Apr―13 The Spike Glycoprotein of SARS-CoV-2 Binds to β1 Integrins Expressed on the Surface of Lung Epithelial Cells Eun Jeong Park, Phyoe Kyawe Myint, Michael Gyasi Appiah, Samuel Darkwah, Siqingaowa Caidengbate, Atsushi Ito, et al. (+4)
475 [GO] 2021―Apr―13 The Photosensitizer Octakis(cholinyl)zinc Phthalocyanine with Ability to Bind to a Model Spike Protein Leads to a Loss of SARS-CoV-2 Infectivity In Vitro When Exposed to Far-Red LED Kirill Sharshov, Mariya Solomatina, Olga Kurskaya, Ilya Kovalenko, Ekaterina Kholina, Vladimir Fedorov, et al. (+3)
476 [GO] 2021―Apr―13 SARS-CoV-2 Reinfection in a Healthcare Worker Despite the Presence of Detectable Neutralizing Antibodies Thomas Theo Brehm, Susanne Pfefferle, Ronald von Possel, Robin Kobbe, Dominik Nörz, Stefan Schmiedel, et al. (+14)
477 [GO] 2021―Apr―13 SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus Giulia Matusali, Francesca Colavita, Daniele Lapa, Silvia Meschi, Licia Bordi, Pierluca Piselli, et al. (+7)
478 [GO] 2021―Apr―09 Inferring the Association between the Risk of COVID-19 Case Fatality and N501Y Substitution in SARS-CoV-2 Shi Zhao, Jingzhi Lou, Marc K. C. Chong, Lirong Cao, Hong Zheng, Zigui Chen, et al. (+4)
479 [GO] 2021―Apr―09 Vascular Inflammation Is Associated with Loss of Aquaporin 1 Expression on Endothelial Cells and Increased Fluid Leakage in SARS-CoV-2 Infected Golden Syrian Hamsters Lisa Allnoch, Georg Beythien, Eva Leitzen, Kathrin Becker, Franz-Josef Kaup, Stephanie Stanelle-Bertram, et al. (+7)
480 [GO] 2021―Apr―09 Mitigating Future Respiratory Virus Pandemics: New Threats and Approaches to Consider Gregory C. Gray, Emily R. Robie, Caleb J. Studstill, Charles L. Nunn
481 [GO] 2021―Apr―08 The Impact on Infectivity and Neutralization Efficiency of SARS-CoV-2 Lineage B.1.351 Pseudovirus Yeong Jun Kim, Ui Soon Jang, Sandrine M. Soh, Joo-Youn Lee, Hye-Ra Lee
482 [GO] 2021―Apr―07 Neutralizing Antibody Therapeutics for COVID-19 Aeron C. Hurt, Adam K. Wheatley
483 [GO] 2021―Apr―04 A pre- and during Pandemic Survey of Sars-Cov-2 Infection in Stray Colony and Shelter Cats from a High Endemic Area of Northern Italy Eva Spada, Fabrizio Vitale, Federica Bruno, Germano Castelli, Stefano Reale, Roberta Perego, et al. (+2)
484 [GO] 2021―Apr―02 Deep Transfer Learning Approach for Automatic Recognition of Drug Toxicity and Inhibition of SARS-CoV-2 Julia Werner, Raphael M. Kronberg, Pawel Stachura, Philipp N. Ostermann, Lisa Müller, Heiner Schaal, et al. (+6)
485 [GO] 2021―Apr―02 FIB-SEM as a Volume Electron Microscopy Approach to Study Cellular Architectures in SARS-CoV-2 and Other Viral Infections: A Practical Primer for a Virologist Valentina Baena, Ryan Conrad, Patrick Friday, Ella Fitzgerald, Taeeun Kim, John Bernbaum, et al. (+4)
486 [GO] 2021―Apr―02 Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease Lukas van de Sand, Maren Bormann, Mira Alt, Leonie Schipper, Christiane Silke Heilingloh, Eike Steinmann, et al. (+5)
487 [GO] 2021―Apr―02 Evaluation of an Automated High-Throughput Liquid-Based RNA Extraction Platform on Pooled Nasopharyngeal or Saliva Specimens for SARS-CoV-2 RT-PCR Allen Wing-Ho Chu, Cyril Chik-Yan Yip, Wan-Mui Chan, Anthony Chin-Ki Ng, Dream Lok-Sze Chan, Ryan Ho-Ping Siu, et al. (+7)
488 [GO] 2021―Apr―01 Updated and Validated Pan-Coronavirus PCR Assay to Detect All Coronavirus Genera Myndi G. Holbrook, Simon J. Anthony, Isamara Navarrete-Macias, Theo Bestebroer, Vincent J. Munster, Neeltje van Doremalen
489 [GO] 2021―Apr―01 Disinfection of SARS-CoV-2 Contaminated Surfaces of Personal Items with UVC-LED Disinfection Boxes Maren Bormann, Mira Alt, Leonie Schipper, Lukas van de Sand, Mona Otte, Toni Luise Meister, et al. (+4)
490 [GO] 2021―Apr―01 Nosocomial Outbreak of SARS-CoV-2 in a “non-COVID-19” Hospital Ward: Virus Genome Sequencing as a Key Tool to Understand Cryptic Transmission Vítor Borges, Joana Isidro, Filipe Macedo, José Neves, Luís Silva, Mário Paiva, et al. (+7)
491 [GO] 2021―Mar―31 Limited Genetic Diversity Detected in Middle East Respiratory Syndrome-Related Coronavirus Variants Circulating in Dromedary Camels in Jordan Stephanie N. Seifert, Jonathan E. Schulz, Stacy Ricklefs, Michael Letko, Elangeni Yabba, Zaidoun S. Hijazeen, et al. (+14)
492 [GO] 2021―Mar―31 IgA-Dominant Infection-Associated Glomerulonephritis Following SARS-CoV-2 Infection Aurora Pérez, Isidro Torregrosa, Luis D’Marco, Isabel Juan, Liria Terradez, Miguel Ángel Solís, et al. (+4)
493 [GO] 2021―Mar―29 Virus Eradication and Synthetic Biology: Changes with SARS-CoV-2? Jean-Nicolas Tournier, Joseph Kononchik
494 [GO] 2021―Mar―29 A Strong Seasonality Pattern for Covid-19 Incidence Rates Modulated by UV Radiation Levels Christos Karapiperis, Panos Kouklis, Stelios Papastratos, Anastasia Chasapi, Antoine Danchin, Lefteris Angelis, Christos A. Ouzounis
495 [GO] 2021―Mar―26 Novel SARS-CoV-2 Variants in Italy: The Role of Veterinary Public Health Institutes Alessio Lorusso, Paolo Calistri, Giovanni Savini, Daniela Morelli, Lucio Ambrosij, Giacomo Migliorati, Nicola D’Alterio
496 [GO] 2021―Mar―26 Adjusting the Cut-Off and Maximum Pool Size in RT-qPCR Pool Testing for SARS-CoV-2 Murilo S. Costa, Hugo I. Sato, Raissa P. Rocha, Alex F. Carvalho, Nathalia S. Guimarães, Elaine L. Machado, et al. (+5)
497 [GO] 2021―Mar―26 Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells Ieva Bagdonaite, Andrew J. Thompson, Xiaoning Wang, Max Søgaard, Cyrielle Fougeroux, Martin Frank, et al. (+6)
498 [GO] 2021―Mar―26 Effect of Inactivation Methods on SARS-CoV-2 Virion Protein and Structure Emma K. Loveday, Kyle S. Hain, Irina Kochetkova, Jodi F. Hedges, Amanda Robison, Deann T. Snyder, et al. (+5)
499 [GO] 2021―Mar―26 In Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2 Pantea Kiani, Andrew Scholey, Thomas A. Dahl, Lauren McMann, Jacqueline M. Iversen, Joris C. Verster
500 [GO] 2021―Mar―25 NSP16 2′-O-MTase in Coronavirus Pathogenesis: Possible Prevention and Treatments Strategies Li-Jen Chang, Tsung-Hsien Chen
501 [GO] 2021―Mar―25 Amantadine Inhibits SARS-CoV-2 In Vitro Klaus Fink, Andreas Nitsche, Markus Neumann, Marica Grossegesse, Karl-Heinz Eisele, Wojciech Danysz
502 [GO] 2021―Mar―25 Key Factors That Enable the Pandemic Potential of RNA Viruses and Inter-Species Transmission: A Systematic Review Santiago Alvarez-Munoz, Nicolas Upegui-Porras, Arlen P. Gomez, Gloria Ramirez-Nieto
503 [GO] 2021―Mar―24 SARS-CoV-2 Infection and Antibody Response in a Symptomatic Cat from Italy with Intestinal B-Cell Lymphoma Julia Klaus, Carlo Palizzotto, Eric Zini, Marina L. Meli, Chiara Leo, Herman Egberink, et al. (+2)
504 [GO] 2021―Mar―24 Light Sheet Microscopy-Assisted 3D Analysis of SARS-CoV-2 Infection in the Respiratory Tract of the Ferret Model Luca M. Zaeck, David Scheibner, Julia Sehl, Martin Müller, Donata Hoffmann, Martin Beer, et al. (+4)
505 [GO] 2021―Mar―24 Nebulized CLODOS Technology Shows Clear Virucidal Properties against the Human Coronavirus HCoV-229E at Non-Cytotoxic Doses Sabina Andreu, Inés Ripa, Raquel Bello-Morales, José Antonio López-Guerrero
506 [GO] 2021―Mar―24 Blockers of the SARS-CoV-2 3a Channel Identified by Targeted Drug Repurposing Prabhat Pratap Singh Tomar, Miriam Krugliak, Isaiah T. Arkin
507 [GO] 2021―Mar―22 Profiles of Peripheral Immune Cells of Uncomplicated COVID-19 Cases with Distinct Viral RNA Shedding Periods Denise Utami Putri, Cheng-Hui Wang, Po-Chun Tseng, Wen-Sen Lee, Fu-Lun Chen, Han-Pin Kuo, et al. (+2)
508 [GO] 2021―Mar―22 The Appropriateness of Invasive Ventilation in COVID-19 Positive Cancer Patients: Proposal of a New Prognostic Score Michele Ghidini, Alice Indini, Erika Rijavec, Claudia Bareggi, Monica Cattaneo, Gianluca Tomasello, et al. (+3)
509 [GO] 2021―Mar―22 Repeated SARS-CoV-2 Positivity: Analysis of 123 Cases Szilárd Váncsa, Fanni Dembrovszky, Nelli Farkas, Lajos Szakó, Brigitta Teutsch, Stefania Bunduc, et al. (+5)
510 [GO] 2021―Mar―22 Endogenously Produced SARS-CoV-2 Specific IgG Antibodies May Have a Limited Impact on Clearing Nasal Shedding of Virus during Primary Infection in Humans Shuyi Yang, Keith R. Jerome, Alexander L. Greninger, Joshua T. Schiffer, Ashish Goyal
511 [GO] 2021―Mar―22 Multiple Early Introductions of SARS-CoV-2 to Cape Town, South Africa Susan Engelbrecht, Kayla Delaney, Bronwyn Kleinhans, Eduan Wilkinson, Houriiyah Tegally, Tania Stander, et al. (+3)
512 [GO] 2021―Mar―19 Treatment Protocol for COVID-19 Based on T2R Phenotype Mohamed A. Taha, Christian A. Hall, Colin J. Shortess, Richard F. Rathbone, Henry P. Barham
513 [GO] 2021―Mar―18 Detection and Genome Sequencing of SARS-CoV-2 in a Domestic Cat with Respiratory Signs in Switzerland Julia Klaus, Marina Meli, Barbara Willi, Sarah Nadeau, Christian Beisel, Tanja Stadler, et al. (+8)
514 [GO] 2021―Mar―18 SARS-CoV-2 Infections in Animals: Reservoirs for Reverse Zonosis and Models for Study Tessa Prince, Shirley L. Smith, Alan D. Radford, Tom Solomon, Grant L. Hughes, Edward I. Patterson
515 [GO] 2021―Mar―18 COVID-19 and Neurological Impairment: Hypothalamic Circuits and Beyond Bashair M. Mussa, Ankita Srivastava, Anthony J. M. Verberne
516 [GO] 2021―Mar―12 Quantification of the Tradeoff between Test Sensitivity and Test Frequency in a COVID-19 Epidemic-A Multi-Scale Modeling Approach Jonathan E. Forde, Stanca M. Ciupe
517 [GO] 2021―Mar―12 Spatiotemporal Analysis of COVID-19 Incidence Data Ilaria Spassiani, Giovanni Sebastiani, Giorgio Palé
518 [GO] 2021―Mar―12 Pulsed Broad-Spectrum UV Light Effectively Inactivates SARS-CoV-2 on Multiple Surfaces and N95 Material Alexander S. Jureka, Caroline G. Williams, Christopher F. Basler
519 [GO] 2021―Mar―11 A Comparative Systematic Review of COVID-19 and Influenza Molka Osman, Timothée Klopfenstein, Nabil Belfeki, Vincent Gendrin, Souheil Zayet
520 [GO] 2021―Mar―11 Vertical Transmission of SARS-CoV-2 in Second Trimester Associated with Severe Neonatal Pathology Gennady Sukhikh, Ulyana Petrova, Andrey Prikhodko, Natalia Starodubtseva, Konstantin Chingin, Huanwen Chen, et al. (+11)
521 [GO] 2021―Mar―09 Early Administration of Convalescent Plasma Improves Survival in Patients with Hematological Malignancies and COVID-19 Monika Maria Biernat, Anna Kolasińska, Jacek Kwiatkowski, Donata Urbaniak-Kujda, Paweł Biernat, Justyna Janocha-Litwin, et al. (+6)
522 [GO] 2021―Mar―09 Experimental Inoculation of Young Calves with SARS-CoV-2 Shollie Falkenberg, Alexandra Buckley, Melissa Laverack, Mathias Martins, Mitchell V. Palmer, Kelly Lager, Diego G. Diel
523 [GO] 2021―Mar―09 Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications Jasdeep Singh, Jasmine Samal, Vipul Kumar, Jyoti Sharma, Usha Agrawal, Nasreen Z. Ehtesham, et al. (+4)
524 [GO] 2021―Mar―08 The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2 Javed Akhter, Grégory Quéromès, Krishna Pillai, Vahan Kepenekian, Samina Badar, Ahmed H. Mekkawy, et al. (+3)
525 [GO] 2021―Mar―05 Prognostic Values of Serum Ferritin and D-Dimer Trajectory in Patients with COVID-19 Fares Qeadan, Benjamin Tingey, Lily Y. Gu, Ashley Hafen Packard, Esther Erdei, Ali I. Saeed
526 [GO] 2021―Mar―05 Pharmacogenetics Approach for the Improvement of COVID-19 Treatment Ingrid Fricke-Galindo, Ramcés Falfán-Valencia
527 [GO] 2021―Mar―05 Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection Federico Gobbi, Dora Buonfrate, Lucia Moro, Paola Rodari, Chiara Piubelli, Sara Caldrer, et al. (+3)
528 [GO] 2021―Mar―05 Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective Colin D. Funk, Craig Laferrière, Ali Ardakani
529 [GO] 2021―Mar―05 Antiviral Activity of the PropylamylatinTM Formula against the Novel Coronavirus SARS-CoV-2 In Vitro Using Direct Injection and Gas Assays in Virus Suspensions Ashley N. Brown, Gary Strobel, Kaley C. Hanrahan, Joe Sears
530 [GO] 2021―Mar―05 Evaluation of a Lyophilized CRISPR-Cas12 Assay for a Sensitive, Specific, and Rapid Detection of SARS-CoV-2 Lucía Ana Curti, Ivana Primost, Sofia Valla, Daiana Ibañez Alegre, Cecilia Olguin Perglione, Guillermo Daniel Repizo, et al. (+9)
531 [GO] 2021―Mar―05 SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light Anna Gidari, Samuele Sabbatini, Sabrina Bastianelli, Sara Pierucci, Chiara Busti, Desirée Bartolini, et al. (+6)
532 [GO] 2021―Mar―04 mRNA-lncRNA Co-Expression Network Analysis Reveals the Role of lncRNAs in Immune Dysfunction during Severe SARS-CoV-2 Infection Sumit Mukherjee, Bodhisattwa Banerjee, David Karasik, Milana Frenkel-Morgenstern
533 [GO] 2021―Mar―02 The Mutation Profile of SARS-CoV-2 Is Primarily Shaped by the Host Antiviral Defense Cem Azgari, Zeynep Kilinc, Berk Turhan, Defne Circi, Ogun Adebali
534 [GO] 2021―Mar―01 TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein Mai Kishimoto, Kentaro Uemura, Takao Sanaki, Akihiko Sato, William W. Hall, Hiroaki Kariwa, et al. (+3)
535 [GO] 2021―Mar―01 SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations Frederic Grabowski, Grzegorz Preibisch, Stanisław Giziński, Marek Kochańczyk, Tomasz Lipniacki
536 [GO] 2021―Feb―28 In Vitro and In Vivo Models for Studying SARS-CoV-2, the Etiological Agent Responsible for COVID-19 Pandemic Rafael B. Rosa, Willyenne M. Dantas, Jessica C. F. do Nascimento, Murilo V. da Silva, Ronaldo N. de Oliveira, Lindomar J. Pena
537 [GO] 2021―Feb―28 Demystifying Excess Immune Response in COVID-19 to Reposition an Orphan Drug for Down-Regulation of NF-κB: A Systematic Review Apparao Peddapalli, Manish Gehani, Arunasree M. Kalle, Siva R. Peddapalli, Angela E. Peter andShashwat Sharad
538 [GO] 2021―Feb―26 In Silico, In Vitro and In Cellulo Models for Monitoring SARS-CoV-2 Spike/Human ACE2 Complex, Viral Entry and Cell Fusion Delphine Lapaillerie, Cathy Charlier, Henrique S. Fernandes, Sergio F. Sousa, Paul Lesbats, Pierre Weigel, et al. (+3)
539 [GO] 2021―Feb―24 Radioligand Assay-Based Detection of Antibodies against SARS-CoV-2 in Hospital Workers Treating Patients with Severe COVID-19 in Japan Hidenori Matsunaga, Akiko Makino, Yasuhiro Kato, Teruaki Murakami, Yuta Yamaguchi, Atsushi Kumanogoh, et al. (+4)
540 [GO] 2021―Feb―24 Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro Sébastien Pasquereau, Zeina Nehme, Sandy Haidar Haidar Ahmad, Fadoua Daouad, Jeanne Van Assche Clémentine Wallet, Christian Schwartz, et al. (+3)
541 [GO] 2021―Feb―24 Erasing the Invisible Line to Empower the Pandemic Response Nicola Decaro, Alessio Lorusso, Ilaria Capua
542 [GO] 2021―Feb―23 On the Prevalence and Potential Functionality of an Intrinsic Disorder in the MERS-CoV Proteome Manal A. Alshehri, Manee M. Manee, Fahad H. Alqahtani, Badr M. Al-Shomrani, Vladimir N. Uversky
543 [GO] 2021―Feb―23 Role of the Host Genetic Susceptibility to 2009 Pandemic Influenza A H1N1 Gloria Pérez-Rubio, Marco Antonio Ponce-Gallegos, Bruno André Domínguez-Mazzocco, Jaime Ponce-Gallegos, Román Alejandro García-Ramírez, Ramcés Falfán-Valencia
544 [GO] 2021―Feb―22 Application of Environment-Friendly Rhamnolipids against Transmission of Enveloped Viruses Like SARS-CoV2 Ling Jin, Wendy Black, Teresa Sawyer
545 [GO] 2021―Feb―22 Recent Hydroxychloroquine Use Is Not Significantly Associated with Positive PCR Results for SARS-CoV-2: A Nationwide Observational Study in South Korea Seongman Bae, Byeongzu Ghang, Ye-Jee Kim, Joon Seo Lim, Sung-Cheol Yun, Yong-Gil Kim, et al. (+2)
546 [GO] 2021―Feb―19 Viral Vectors for COVID-19 Vaccine Development Kenneth Lundstrom
547 [GO] 2021―Feb―18 Targeting the Complement Serine Protease MASP-2 as a Therapeutic Strategy for Coronavirus Infections Ben M. Flude, Giulio Nannetti, Paige Mitchell, Nina Compton, Chloe Richards, Meike Heurich, et al. (+3)
548 [GO] 2021―Feb―16 Safety and Outcomes Associated with the Pharmacological Inhibition of the Kinin-Kallikrein System in Severe COVID-19 Eli Mansour, Andre C. Palma, Raisa G. Ulaf, Luciana C. Ribeiro, Ana Flavia Bernardes, Thyago A. Nunes, et al. (+14)
549 [GO] 2021―Feb―16 Honeysuckle Aqueous Extracts Induced let-7a Suppress EV71 Replication and Pathogenesis In Vitro and In Vivo and Is Predicted to Inhibit SARS-CoV-2 Ying-Ray Lee, Chia-Ming Chang, Yuan-Chieh Yeh, Chi-Ying F. Huang, Feng-Mao Lin, Juan-Ting Huang, et al. (+3)
550 [GO] 2021―Feb―16 Structure-Based Identification of Natural Products as SARS-CoV-2 Mpro Antagonist from Echinacea angustifolia Using Computational Approaches Shiv Bharadwaj, Sherif Aly El-Kafraway, Thamir A. Alandijany, Leena Hussein Bajrai, Altaf Ahmad Shah, Amit Dubey, et al. (+6)
551 [GO] 2021―Feb―15 Relationships between Viral Load and the Clinical Course of COVID-19 Hiroyuki Tsukagoshi, Daisuke Shinoda, Mariko Saito, Kaori Okayama, Mitsuru Sada, Hirokazu Kimura, Nobuhiro Saruki
552 [GO] 2021―Feb―14 Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture Allison Bakovic, Kenneth Risner, Nishank Bhalla, Farhang Alem, Theresa L. Chang, Warren K. Weston, et al. (+2)
553 [GO] 2021―Feb―12 Titers of Neutralizing Antibodies against SARS-CoV-2 Are Independent of Symptoms of Non-Severe COVID-19 in Young Adults Hulda R. Jonsdottir, Michel Bielecki, Denise Siegrist, Thomas W. Buehrer, Roland Züst, Jeremy W. Deuel
554 [GO] 2021―Feb―12 Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients Mattia Trunfio, Francesco Venuti, Francesca Alladio, Bianca Maria Longo, Elisa Burdino, Francesco Cerutti, et al. (+6)
555 [GO] 2021―Feb―12 Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro Finny S. Varghese, Esther van Woudenbergh, Gijs J. Overheul, Marc J. Eleveld, Lisa Kurver, Niels van Heerbeek, et al. (+5)
556 [GO] 2021―Feb―05 SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays Gregory J. Walker, Zin Naing, Alberto Ospina Stella, Malinna Yeang, Joanna Caguicla, Vidiya Ramachandran, et al. (+12)
557 [GO] 2021―Feb―05 Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week Paloma Troyano-Hernáez, Roberto Reinosa, África Holguín
558 [GO] 2021―Feb―04 Mucosal-Associated Invariant T (MAIT) Cells Are Highly Activated and Functionally Impaired in COVID-19 Patients Sebastian Deschler, Juliane Kager, Johanna Erber, Lisa Fricke, Plamena Koyumdzhieva, Alexandra Georgieva, et al. (+16)
559 [GO] 2021―Feb―04 Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus Sarah Al-Beltagi, Cristian Alexandru Preda, Leah V. Goulding, Joe James, Juan Pu, Paul Skinner, et al. (+11)
560 [GO] 2021―Feb―02 Genomic Signatures of SARS-CoV-2 Associated with Patient Mortality Eric Dumonteil, Dahlene Fusco, Arnaud Drouin, Claudia Herrera
561 [GO] 2021―Feb―02 The SARS-CoV-2-Inactivating Activity of Hydroxytyrosol-Rich Aqueous Olive Pulp Extract (HIDROX®) and Its Use as a Virucidal Cream for Topical Application Yohei Takeda, Dulamjav Jamsransuren, Sachiko Matsuda, Roberto Crea, Haruko Ogawa
562 [GO] 2021―Jan―29 COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention Anshika Sharma, Isra Ahmad Farouk, Sunil Kumar Lal
563 [GO] 2021―Jan―27 Anthropogenic Infection of Cats during the 2020 COVID-19 Pandemic Margaret J. Hosie, Regina Hofmann-Lehmann, Katrin Hartmann, Herman Egberink, Uwe Truyen, Diane D. Addie, et al. (+10)
564 [GO] 2021―Jan―27 Diagnostic Value of Detecting Feline Coronavirus RNA and Spike Gene Mutations in Cerebrospinal Fluid to Confirm Feline Infectious Peritonitis Sandra Felten, Kaspar Matiasek, Christian M. Leutenegger, Laura Sangl, Stephanie Herre, Stefanie Dörfelt, et al. (+2)
565 [GO] 2021―Jan―25 ABO Blood Types and COVID-19: Spurious, Anecdotal, or Truly Important Relationships? A Reasoned Review of Available Data Jacques Le Pendu, Adrien Breiman, Jézabel Rocher, Michel Dion, Nathalie Ruvoën-Clouet
566 [GO] 2021―Jan―25 Development of a Cell-Based Luciferase Complementation Assay for Identification of SARS-CoV-2 3CLpro Inhibitors Jonathan M. O. Rawson, Alice Duchon, Olga A. Nikolaitchik, Vinay K. Pathak, Wei-Shau Hu
567 [GO] 2021―Jan―25 Crystal Structure of SARS-CoV-2 Main Protease in Complex with the Non-Covalent Inhibitor ML188 Gordon J. Lockbaum, Archie C. Reyes, Jeong Min Lee, Ronak Tilvawala, Ellen A. Nalivaika, Akbar Ali, et al. (+3)
568 [GO] 2021―Jan―25 Interactions of Influenza and SARS-CoV-2 with the Lung Endothelium: Similarities, Differences, and Implications for Therapy Elyse Latreille, Warren L. Lee
569 [GO] 2021―Jan―21 Chimeric Porcine Deltacoronaviruses with Sparrow Coronavirus Spike Protein or the Receptor-Binding Domain Infect Pigs but Lose Virulence and Intestinal Tropism Xiaoyu Niu, Yixuan J. Hou, Kwonil Jung, Fanzhi Kong, Linda J. Saif, Qiuhong Wang
570 [GO] 2021―Jan―21 A 10-Minute “Mix and Read” Antibody Assay for SARS-CoV-2 Juuso Rusanen, Lauri Kareinen, Lev Levanov, Sointu Mero, Sari H. Pakkanen, Anu Kantele, et al. (+5)
571 [GO] 2021―Jan―21 Intranasal Infection of Ferrets with SARS-CoV-2 as a Model for Asymptomatic Human Infection Helen E. Everett, Fabian Z. X. Lean, Alexander M. P. Byrne, Pauline M. van Diemen, Shelley Rhodes, Joe James, et al. (+14)
572 [GO] 2021―Jan―21 MicroRNAs for Virus Pathogenicity and Host Responses, Identified in SARS-CoV-2 Genomes, May Play Roles in Viral-Host Co-Evolution in Putative Zoonotic Host Species Sigrun Lange, Elif Damla Arisan, Guy H. Grant, Pinar Uysal-Onganer
573 [GO] 2021―Jan―21 Structural Mapping of Mutations in Spike, RdRp and Orf3a Genes of SARS-CoV-2 in Influenza Like Illness (ILI) Patients Bandar Alosaimi, Asif Naeem, Majed F. Alghoribi, Lilian Okdah, Maaweya E. Hamed, Ahmad S. AlYami, et al. (+2)
574 [GO] 2021―Jan―21 Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-hACE2 Mice Pratima Kumari, Hussin A. Rothan, Janhavi P. Natekar, Shannon Stone, Heather Pathak, Philip G. Strate, et al. (+3)
575 [GO] 2021―Jan―21 Prevalence of Co-Infections with Respiratory Viruses in Individuals Investigated for SARS-CoV-2 in Ontario, Canada Adriana Peci, Vanessa Tran, Jennifer L. Guthrie, Ye Li, Paul Nelson, Kevin L. Schwartz, et al. (+3)
576 [GO] 2021―Jan―21 Obstetric Outcomes of SARS-CoV-2 Infection in Asymptomatic Pregnant Women Monica Cruz-Lemini, Elena Ferriols Perez, Maria de la Cruz Conty, Africa Caño Aguilar, Maria Encinas Pardilla, Pilar Prats Rodríguez, et al. (+47)
577 [GO] 2021―Jan―21 Intra-Host Diversity of SARS-Cov-2 Should Not Be Neglected: Case of the State of Victoria, Australia Alix Armero, Nicolas Berthet, Jean-Christophe Avarre
578 [GO] 2021―Jan―21 Structural Analysis of Neutralizing Epitopes of the SARS-CoV-2 Spike to Guide Therapy and Vaccine Design Strategies Maxwell T. Finkelstein, Adam G. Mermelstein, Emma Parker Miller, Paul C. Seth, Erik-Stephane D. Stancofski, Daniela Fera
579 [GO] 2021―Jan―21 Quinacrine, an Antimalarial Drug with Strong Activity Inhibiting SARS-CoV-2 Viral Replication In Vitro Mónica Salas Rojas, Raúl Silva Garcia, Estela Bini, Verónica Pérez de la Cruz, Juan Carlos León Contreras, Rogelio Hernández Pando, et al. (+6)
580 [GO] 2021―Jan―15 Domains and Functions of Spike Protein in Sars-Cov-2 in the Context of Vaccine Design Xuhua Xia
581 [GO] 2021―Jan―14 Systematic Search for SARS-CoV-2 Main Protease Inhibitors for Drug Repurposing: Ethacrynic Acid as a Potential Drug Camilla Isgrò, Anna Maria Sardanelli, Luigi Leonardo Palese
582 [GO] 2021―Jan―12 The Fatty Acid Lipid Metabolism Nexus in COVID-19 Jerome E. Tanner, Caroline Alfieri
583 [GO] 2021―Jan―11 Transcriptomic Analysis of Respiratory Tissue and Cell Line Models to Examine Glycosylation Machinery during SARS-CoV-2 Infection Anup Oommen, Stephen Cunningham, Lokesh Joshi
584 [GO] 2021―Jan―07 Population-Specific ACE2 Single-Nucleotide Polymorphisms Have Limited Impact on SARS-CoV-2 Infectivity In Vitro Mei Hashizume, Gabriel Gonzalez, Chikako Ono, Ayako Takashima, Masaharu Iwasaki
585 [GO] 2020―Dec―31 Interferon-α2b Treatment for COVID-19 Is Associated with Improvements in Lung Abnormalities Qiong Zhou, Michael R. MacArthur, Xinliang He, Xiaoshan Wei, Payam Zarin, Bola S. Hanna, et al. (+3)
586 [GO] 2020―Dec―31 Markers Associated with COVID-19 Susceptibility, Resistance, and Severity Aisha D. Fakhroo, Asmaa A. Al Thani, Hadi M. Yassine
587 [GO] 2020―Dec―31 Computational Analysis of SARS-CoV-2 and SARS-Like Coronavirus Diversity in Human, Bat and Pangolin Populations Nicholas J. Dimonaco, Mazdak Salavati, Barbara B. Shih
588 [GO] 2020―Dec―31 PSGL-1 Inhibits the Incorporation of SARS-CoV and SARS-CoV-2 Spike Glycoproteins into Pseudovirions and Impairs Pseudovirus Attachment and Infectivity Sijia He, Abdul A. Waheed, Brian Hetrick, Deemah Dabbagh, Ivan V. Akhrymuk, Kylene Kehn-Hall, et al. (+2)
589 [GO] 2020―Dec―31 Lead SARS-CoV-2 Candidate Vaccines: Expectations from Phase III Trials and Recommendations Post-Vaccine Approval Ebenezer Tumban
590 [GO] 2020―Dec―31 SARS-CoV-2 Nucleocapsid Protein Interacts with RIG-I and Represses RIG-Mediated IFN-β Production Keli Chen, Feng Xiao, Dingwen Hu, Weiwei Ge, Mingfu Tian, Wenbiao Wang, et al. (+3)
591 [GO] 2020―Dec―30 The Main Molecular and Serological Methods for Diagnosing COVID-19: An Overview Based on the Literature Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Valdir Gomes Barbosa-Júnior, Milena Botelho Pereira Soares, Roberto Badaró
592 [GO] 2020―Dec―28 Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19 Isabelle Bernard, Daniel Limonta, Lara K. Mahal, Tom C. Hobman
593 [GO] 2020―Dec―25 Inactivation of Human Coronavirus by Titania Nanoparticle Coatings and UVC Radiation: Throwing Light on SARS-CoV-2 Svetlana Khaiboullina, Timsy Uppal, Nikhil Dhabarde, Vaidyanathan Ravi Subramanian, Subhash C. Verma
594 [GO] 2020―Dec―25 Peripheral Blood Immune Profiling of Convalescent Plasma Donors Reveals Alterations in Specific Immune Subpopulations Even at 2 Months Post SARS-CoV-2 Infection Nikolaos Orologas-Stavrou, Marianna Politou, Pantelis Rousakis, Ioannis V. Kostopoulos, Ioannis Ntanasis-Stathopoulos, Edison Jahaj, et al. (+7)
595 [GO] 2020―Dec―23 Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV Stacey L. P. Scroggs, Danielle K. Offerdahl, Dylan P. Flather, Ciera N. Morris, Benjamin L. Kendall, Rebecca M. Broeckel, et al. (+2)
596 [GO] 2020―Dec―23 Structure and Hierarchy of SARS-CoV-2 Infection Dynamics Models Revealed by Reaction Network Analysis Stephan Peter, Peter Dittrich, Bashar Ibrahim
597 [GO] 2020―Dec―21 Can Coronaviruses Steal Genes from the Host as Evidenced in Western European Hedgehogs by EriCoV Genetic Characterization? Luca De Sabato, Ilaria Di Bartolo, Maria Alessandra De Marco, Ana Moreno, Davide Lelli, Claudia Cotti, et al. (+2)
598 [GO] 2020―Dec―21 The RNA Architecture of the SARS-CoV-2 3′-Untranslated Region Junxing Zhao, Jianming Qiu, Sadikshya Aryal, Jennifer L. Hackett, Jingxin Wang
599 [GO] 2020―Dec―18 SARS-CoV-2 Spike Alterations Enhance Pseudoparticle Titers and Replication-Competent VSV-SARS-CoV-2 Virus Katherine Elizabeth Havranek, Ariana R. Jimenez, Marissa Danielle Acciani, Maria Fernanda Lay Mendoza, Judith Mary Reyes Ballista, Darren Austin Diaz, Melinda Ann Brindley
600 [GO] 2020―Dec―17 Monitoring Viral Entry in Real-Time Using a Luciferase Recombinant Vesicular Stomatitis Virus Producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV Glycoproteins Maria Fernanda Lay Mendoza, Marissa Danielle Acciani, Courtney Nina Levit, Christopher Santa Maria, Melinda Ann Brindley
601 [GO] 2020―Dec―15 Genomic Epidemiology of the First Wave of SARS-CoV-2 in Italy Francesca Di Giallonardo, Sebastian Duchene, Ilaria Puglia, Valentina Curini, Francesca Profeta, Cesare Cammà, et al. (+4)
602 [GO] 2020―Dec―14 Dysregulated Interferon Response Underlying Severe COVID-19 LeAnn Lopez, Peter C. Sang, Yun Tian, Yongming Sang
603 [GO] 2020―Dec―11 Comparison of Rapid Antigen Tests for COVID-19 Seiya Yamayoshi, Yuko Sakai-Tagawa, Michiko Koga, Osamu Akasaka, Ichiro Nakachi, Hidefumi Koh, et al. (+24)
604 [GO] 2020―Dec―10 Changes in Mass Treatment of the Canine Parvovirus ICU Population in Relation to Public Policy Changes during the COVID-19 Pandemic Kevin Horecka, Nipuni Ratnayaka, Elizabeth A. Davis
605 [GO] 2020―Dec―09 Bat-Borne Coronaviruses in Jordan and Saudi Arabia: A Threat to Public Health? Laith N. AL-Eitan, Amneh H. Tarkhan, Mansour A. Alghamdi, Denise A. Marston, Guanghui Wu, Lorraine M. McElhinney, et al. (+2)
606 [GO] 2020―Dec―09 Multiple Introductions Followed by Ongoing Community Spread of SARS-CoV-2 at One of the Largest Metropolitan Areas of Northeast Brazil Marcelo Henrique Santos Paiva, Duschinka Ribeiro Duarte Guedes, Cássia Docena, Matheus Filgueira Bezerra, Filipe Zimmer Dezordi, Laís Ceschini Machado, et al. (+24)
607 [GO] 2020―Dec―07 Multiple SARS-CoV-2 Introductions Shaped the Early Outbreak in Central Eastern Europe: Comparing Hungarian Data to a Worldwide Sequence Data-Matrix Gábor Kemenesi, Safia Zeghbib, Balázs A Somogyi, Gábor Endre Tóth, Krisztián Bányai, Norbert Solymosi, et al. (+16)
608 [GO] 2020―Dec―04 Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients Anwar M. Hashem, Abdullah Algaissi, Sarah A. Almahboub, Mohamed A. Alfaleh, Turki S. Abujamel, Sawsan S. Alamri, et al. (+19)
609 [GO] 2020―Dec―04 Disease Pandemics and Major Epidemics Arising from New Encounters between Indigenous Viruses and Introduced Crops Roger A. C. Jones
610 [GO] 2020―Dec―03 Persistent Detection and Infectious Potential of SARS-CoV-2 Virus in Clinical Specimens from COVID-19 Patients Michael Zapor
611 [GO] 2020―Dec―01 Non-Coding RNAs and SARS-Related Coronaviruses Hanna Henzinger, Dominik A. Barth, Christiane Klec, Martin Pichler
612 [GO] 2020―Nov―30 Application of a Photocatalyst as an Inactivator of Bovine Coronavirus Nobuki Yoshizawa, Ryoko Ishihara, Daisuke Omiya, Midori Ishitsuka, Shouichirou Hirano, Tohru Suzuki
613 [GO] 2020―Nov―30 Camelid Inoculation With Middle East Respiratory Syndrome Coronavirus: Experimental Models of Reservoir Host Infection Danielle R. Adney, Chad S. Clancy, Richard A. Bowen, Vincent J. Munster
614 [GO] 2020―Nov―30 Modeling the Molecular Impact of SARS-CoV-2 Infection on the Renin-Angiotensin System Fabrizio Pucci, Philippe Bogaerts, Marianne Rooman
615 [GO] 2020―Nov―27 Persisting Neutralizing Activity to SARS-CoV-2 over Months in Sera of COVID-19 Patients Bertram Flehmig, Michael Schindler, Natalia Ruetalo, Ramona Businger, Manfred Bayer, Angelika Haage, et al. (+6)
616 [GO] 2020―Nov―23 COVID-19 and School Activities in Italy Giovanni Sebastiani, Giorgio Palé
617 [GO] 2020―Nov―20 Population Difference in Allele Frequency of HLA-C*05 and Its Correlation with COVID-19 Mortality Atsushi Sakuraba, Haider Haider, Toshiro Sato
618 [GO] 2020―Nov―19 Fatal Interstitial Pneumonia Associated with Bovine Coronavirus in Cows from Southern Italy Maria Grazia Amoroso, Giuseppe Lucifora, Barbara Degli Uberti, Francesco Serra, Giovanna De Luca, Giorgia Borriello, et al. (+7)
619 [GO] 2020―Nov―18 Application of Viral Vectors for Vaccine Development with a Special Emphasis on COVID-19 Kenneth Lundstrom
620 [GO] 2020―Nov―18 Target-Centered Drug Repurposing Predictions of Human Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Protease Serine Subtype 2 (TMPRSS2) Interacting Approved Drugs for Coronavirus Disease 2019 (COVID-19) Treatment through a Drug-Target Interaction Deep Learning Model Yoonjung Choi, Bonggun Shin, Keunsoo Kang, Sungsoo Park, Bo Ram Beck
621 [GO] 2020―Nov―17 Detection of SARS-CoV-2 from Saliva as Compared to Nasopharyngeal Swabs in Outpatients Christopher Kandel, Jennifer Zheng, Janine McCready, Mihaela Anca Serbanescu, Hilary Racher, Melissa Desaulnier, et al. (+9)
622 [GO] 2020―Nov―16 Placental Pathology of COVID-19 with and without Fetal and Neonatal Infection: Trophoblast Necrosis and Chronic Histiocytic Intervillositis as Risk Factors for Transplacental Transmission of SARS-CoV-2 David A. Schwartz, Denise Morotti
623 [GO] 2020―Nov―12 Spike Glycoprotein-Mediated Entry of SARS Coronaviruses Lin Wang, Ye Xiang
624 [GO] 2020―Nov―12 Transcriptional Immune Signatures of Alveolar Macrophages and the Impact of the NLRP3 Inflammasome on Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Replication Julie A. Hicks, Dongwan Yoo, Hsiao-Ching Liu
625 [GO] 2020―Nov―10 Bovine Coronavirus: Variability, Evolution, and Dispersal Patterns of a No Longer Neglected Betacoronavirus Giovanni Franzo, Michele Drigo, Matteo Legnardi, Laura Grassi, Daniela Pasotto, Maria Luisa Menandro, et al. (+2)
626 [GO] 2020―Nov―10 CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study Joan Calvet, Jordi Gratacós, María José Amengual, Maria Llop, Marta Navarro, Amàlia Moreno, et al. (+4)
627 [GO] 2020―Nov―03 First Phylogenetic Analysis of Malian SARS-CoV-2 Sequences Provides Molecular Insights into the Genomic Diversity of the Sahel Region Bourema Kouriba, Angela Dürr, Alexandra Rehn, Abdoul Karim Sangaré, Brehima Y. Traoré, Malena S. Bestehorn-Willmann, et al. (+8)
628 [GO] 2020―Nov―01 Porcine Reproductive and Respiratory Syndrome Virus Reverse Genetics and the Major Applications Jayeshbhai Chaudhari, Hiep L. X. Vu
629 [GO] 2020―Oct―30 COVID-19: Look to the Future, Learn from the Past Zhangkai J. Cheng, Hui-Qi Qu, Lifeng Tian, Zhifeng Duan, Hakon Hakonarson
630 [GO] 2020―Oct―29 Polymorphisms in Processing and Antigen Presentation-Related Genes and Their Association with Host Susceptibility to Influenza A/H1N1 2009 Pandemic in a Mexican Mestizo Population Marco Antonio Ponce-Gallegos, Aseneth Ruiz-Celis, Enrique Ambrocio-Ortiz, Gloria Pérez-Rubio, Alejandra Ramírez-Venegas, Nora E. Bautista-Félix, Ramcés Falfán-Valencia
631 [GO] 2020―Oct―27 Antibody Binding to SARS-CoV-2 S Glycoprotein Correlates with but Does Not Predict Neutralization Shilei Ding, Annemarie Laumaea, Mehdi Benlarbi, Guillaume Beaudoin-Bussières, Romain Gasser, Halima Medjahed, et al. (+5)
632 [GO] 2020―Oct―27 High Rate of Circulating MERS-CoV in Dromedary Camels at Slaughterhouses in Riyadh, 2019 Taibah A. Aljasim, Abdulrahman Almasoud, Haya A. Aljami, Mohamed W. Alenazi, Suliman A. Alsagaby, Asma N. Alsaleh, Naif Khalaf Alharbi
633 [GO] 2020―Oct―26 The Cell Tropism of Porcine Respiratory Coronavirus for Airway Epithelial Cells Is Determined by the Expression of Porcine Aminopeptidase N Ju-Yi Peng, Darsaniya Punyadarsaniya, Dai-Lun Shin, Suvarin Pavasutthipaisit, Andreas Beineke, Guangxing Li, et al. (+2)
634 [GO] 2020―Oct―26 Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing David van Bockel, C. Mee Ling Munier, Stuart Turville, Steven G. Badman, Gregory Walker, Alberto Ospina Stella, et al. (+11)
635 [GO] 2020―Oct―22 Viewpoint: Origin of SARS-CoV-2 Kenneth Lundstrom, Murat Seyran, Damiano Pizzol, Parise Adadi, Tarek Mohamed Abd El-Aziz, Sk. Sarif Hassan, et al. (+11)
636 [GO] 2020―Oct―20 Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay Licia Bordi, Giuseppe Sberna, Eleonora Lalle, Pierluca Piselli, Francesca Colavita, Emanuele Nicastri, et al. (+11)
637 [GO] 2020―Oct―17 Viral Related Tools against SARS-CoV-2 Laura Fernandez-Garcia, Olga Pacios, Mónica González-Bardanca, Lucia Blasco, Inés Bleriot, Antón Ambroa, et al. (+3)
638 [GO] 2020―Oct―17 Expression Pattern of the SARS-CoV-2 Entry Genes ACE2 and TMPRSS2 in the Respiratory Tract Yichuan Liu, Hui-Qi Qu, Jingchun Qu, Lifeng Tian, Hakon Hakonarson
639 [GO] 2020―Oct―15 Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interferon Antagonism Shona C. Moore, Rebekah Penrice-Randal, Muhannad Alruwaili, Nadine Randle, Stuart Armstrong, Catherine Hartley, et al. (+40)
640 [GO] 2020―Oct―09 Tracking SARS-CoV-2 in Sewage: Evidence of Changes in Virus Variant Predominance during COVID-19 Pandemic Javier Martin, Dimitra Klapsa, Thomas Wilton, Maria Zambon, Emma Bentley, Erika Bujaki, et al. (+3)
641 [GO] 2020―Sep―30 Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins Sai Priya Anand, Yaozong Chen, Jérémie Prévost, Romain Gasser, Guillaume Beaudoin-Bussières, Cameron F. Abrams, et al. (+2)
642 [GO] 2020―Sep―29 Treatment with Exogenous Trypsin Expands In Vitro Cellular Tropism of the Avian Coronavirus Infectious Bronchitis Virus Phoebe Stevenson-Leggett, Sarah Keep, Erica Bickerton
643 [GO] 2020―Sep―28 Network Controllability-Based Prioritization of Candidates for SARS-CoV-2 Drug Repositioning Emily E. Ackerman, Jason E. Shoemaker
644 [GO] 2020―Sep―28 Host Immune Response Driving SARS-CoV-2 Evolution Rui Wang, Yuta Hozumi, Yong-Hui Zheng, Changchuan Yin, Guo-Wei Wei
645 [GO] 2020―Sep―25 Meta-Transcriptomic Discovery of a Divergent Circovirus and a Chaphamaparvovirus in Captive Reptiles with Proliferative Respiratory Syndrome Wei-Shan Chang, Ci-Xiu Li, Jane Hall, John-Sebastian Eden, Timothy H. Hyndman, Edward C. Holmes, Karrie Rose
646 [GO] 2020―Sep―23 Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak Zheng Yao Low, Isra Ahmad Farouk, Sunil Kumar Lal
647 [GO] 2020―Sep―22 Identification of a Membrane Binding Peptide in the Envelope Protein of MHV Coronavirus Entedar A. J. Alsaadi, Benjamin W. Neuman, Ian M. Jones
648 [GO] 2020―Sep―18 RNAemia Corresponds to Disease Severity and Antibody Response in Hospitalized COVID-19 Patients Kirsten Alexandra Eberhardt, Charlotte Meyer-Schwickerath, Eva Heger, Elena Knops, Clara Lehmann, Jan Rybniker, et al. (+9)
649 [GO] 2020―Sep―18 Induction of the Antiviral Immune Response and Its Circumvention by Coronaviruses Ping Liu, Yan Hong, Bincai Yang, Prasha Shrestha, Nelam Sajjad, Ji-Long Chen
650 [GO] 2020―Sep―14 Coronavirus Infections in Companion Animals: Virology, Epidemiology, Clinical and Pathologic Features Christine Haake, Sarah Cook, Nicola Pusterla, Brian Murphy
651 [GO] 2020―Sep―14 Spatio-Temporal Mutational Profile Appearances of Swedish SARS-CoV-2 during the Early Pandemic Jiaxin Ling, Rachel A. Hickman, Jinlin Li, Xi Lu, Johanna F. Lindahl, Åke Lundkvist, Josef D. Järhult
652 [GO] 2020―Sep―10 Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays Inesa Hyseni, Eleonora Molesti, Linda Benincasa, Pietro Piu, Elisa Casa, Nigel J Temperton, et al. (+2)
653 [GO] 2020―Sep―09 Coronavirus Antiviral Research Database (CoV-RDB): An Online Database Designed to Facilitate Comparisons between Candidate Anti-Coronavirus Compounds Philip L. Tzou, Kaiming Tao, Janin Nouhin, Soo-Yon Rhee, Benjamin D. Hu, Shruti Pai, et al. (+2)
654 [GO] 2020―Sep―09 Infection of Brain Organoids and 2D Cortical Neurons with SARS-CoV-2 Pseudovirus Sang Ah Yi, Ki Hong Nam, Jihye Yun, Dongmin Gim, Daeho Joe, Yong Ho Kim, et al. (+3)
655 [GO] 2020―Sep―08 Prevalence of Feline Coronavirus Shedding in German Catteries and Associated Risk Factors Ute Klein-Richers, Katrin Hartmann, Regina Hofmann-Lehmann, Stefan Unterer, Michèle Bergmann, Anna Rieger, et al. (+4)
656 [GO] 2020―Sep―07 Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in Mice Andrea N. Loes, Lauren E. Gentles, Allison J. Greaney, Katharine H. D. Crawford, Jesse D. Bloom
657 [GO] 2020―Sep―02 Artificial Intelligence-Assisted Loop Mediated Isothermal Amplification (AI-LAMP) for Rapid Detection of SARS-CoV-2 Mohammed A. Rohaim, Emily Clayton, Irem Sahin, Julianne Vilela, Manar E. Khalifa, Mohammad Q. Al-Natour, et al. (+22)
658 [GO] 2020―Aug―27 Study of a SARS-CoV-2 Outbreak in a Belgian Military Education and Training Center in Maradi, Niger Jean-Paul Pirnay, Philippe Selhorst, Christel Cochez, Mauro Petrillo, Vincent Claes, Yolien Van der Beken, et al. (+11)
659 [GO] 2020―Aug―26 HIV and Human Coronavirus Coinfections: A Historical Perspective Palesa Makoti, Burtram C. Fielding
660 [GO] 2020―Aug―26 Optimization Rules for SARS-CoV-2 Mpro Antivirals: Ensemble Docking and Exploration of the Coronavirus Protease Active Site Shana V. Stoddard, Serena D. Stoddard, Benjamin K. Oelkers, Kennedi Fitts, Kellen Whalum, Kaylah Whalum, et al. (+11)
661 [GO] 2020―Aug―19 The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV Mayanka Awasthi, Sahil Gulati, Debi P. Sarkar, Swasti Tiwari, Suneel Kateriya, Peeyush Ranjan, Santosh Kumar Verma
662 [GO] 2020―Aug―17 A Comparison of Whole Genome Sequencing of SARS-CoV-2 Using Amplicon-Based Sequencing, Random Hexamers, and Bait Capture Jalees A. Nasir, Robert A. Kozak, Patryk Aftanas, Amogelang R. Raphenya, Kendrick M. Smith, Finlay Maguire, et al. (+11)
663 [GO] 2020―Aug―12 Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2 Robert W. Körner, Mohamed Majjouti, Miguel A. Alejandre Alcazar, Esther Mahabir
664 [GO] 2020―Aug―07 Vaccine Candidates Against Coronavirus Infections. Where Does COVID-19 Stand? Jawad Al-Kassmy, Jannie Pedersen, Gary Kobinger
665 [GO] 2020―Aug―07 SARS-CoV-2 RNA Extraction Using Magnetic Beads for Rapid Large-Scale Testing by RT-qPCR and RT-LAMP Steffen Klein, Thorsten G. Müller, Dina Khalid, Vera Sonntag-Buck, Anke-Mareil Heuser, Bärbel Glass, et al. (+20)
666 [GO] 2020―Aug―05 Wide Diversity of Coronaviruses in Frugivorous and Insectivorous Bat Species: A Pilot Study in Guinea, West Africa Audrey Lacroix, Nicole Vidal, Alpha K. Keita, Guillaume Thaurignac, Amandine Esteban, Hélène De Nys, et al. (+13)
667 [GO] 2020―Aug―05 Comprehensive Analyses of SARS-CoV-2 Transmission in a Public Health Virology Laboratory Neta S. Zuckerman, Rakefet Pando, Efrat Bucris, Yaron Drori, Yaniv Lustig, Oran Erster, et al. (+3)
668 [GO] 2020―Aug―04 Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Mass Spectrometry Petra Wandernoth, Katharina Kriegsmann, Cristina Groh-Mohanu, Martin Daeumer, Peter Gohl, Oliver Harzer, et al. (+2)
669 [GO] 2020―Jul―29 Host Transcriptional Response to Persistent Infection with a Live-Attenuated Porcine Reproductive and Respiratory Syndrome Virus Strain Jayeshbhai Chaudhari, Chia-Sin Liew, Aspen M. Workman, Jean-Jack M. Riethoven, David Steffen, Sarah Sillman, Hiep L. X. Vu
670 [GO] 2020―Jul―27 In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection Annamaria Martorana, Carla Gentile, Antonino Lauria
671 [GO] 2020―Jul―27 Molecular Tracing of SARS-CoV-2 in Italy in the First Three Months of the Epidemic Alessia Lai, Annalisa Bergna, Sara Caucci, Nicola Clementi, Ilaria Vicenti, Filippo Dragoni, et al. (+14)
672 [GO] 2020―Jul―20 Tiotropium Is Predicted to Be a Promising Drug for COVID-19 Through Transcriptome-Based Comprehensive Molecular Pathway Analysis Keunsoo Kang, Hoo Hyun Kim, Yoonjung Choi
673 [GO] 2020―Jul―20 Covid-19 Transmission Trajectories-Monitoring the Pandemic in the Worldwide Context Henry Loeffler-Wirth, Maria Schmidt, Hans Binder
674 [GO] 2020―Jul―20 Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters Nikolaus Osterrieder, Luca D. Bertzbach, Kristina Dietert, Azza Abdelgawad, Daria Vladimirova, Dusan Kunec, et al. (+4)
675 [GO] 2020―Jul―17 Deploying Machine and Deep Learning Models for Efficient Data-Augmented Detection of COVID-19 Infections Ahmed Sedik, Abdullah M Iliyasu, Basma Abd El-Rahiem, Mohammed E. Abdel Samea, Asmaa Abdel-Raheem, Mohamed Hammad, et al. (+3)
676 [GO] 2020―Jul―14 Temperature Sensitivity: A Potential Method for the Generation of Vaccines against the Avian Coronavirus Infectious Bronchitis Virus Sarah Keep, Phoebe Stevenson-Leggett, Angela Steyn, Michael S. Oade, Isobel Webb, Jamie Stuart, et al. (+4)
677 [GO] 2020―Jul―07 Heat Inactivation of Different Types of SARS-CoV-2 Samples: What Protocols for Biosafety, Molecular Detection and Serological Diagnostics? Boris Pastorino, Franck Touret, Magali Gilles, Xavier de Lamballerie, Remi N. Charrel
678 [GO] 2020―Jun―30 Early Phase of the COVID-19 Outbreak in Hungary and Post-Lockdown Scenarios Gergely Röst, Ferenc A. Bartha, Norbert Bogya, Péter Boldog, Attila Dénes, Tamás Ferenci, et al. (+6)
679 [GO] 2020―Jun―30 Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review Jennifer Santos, Stephanie Brierley, Mohit J. Gandhi, Michael A. Cohen, Phillip C. Moschella, Arwen B. L. Declan
680 [GO] 2020―Jun―29 Saxifraga spinulosa-Derived Components Rapidly Inactivate Multiple Viruses Including SARS-CoV-2 Yohei Takeda, Toshihiro Murata, Dulamjav Jamsransuren, Keisuke Suganuma, Yuta Kazami, Javzan Batkhuu, et al. (+2)
681 [GO] 2020―Jun―26 Development and Evaluation of a duo SARS-CoV-2 RT-qPCR Assay Combining Two Assays Approved by the World Health Organization Targeting the Envelope and the RNA-Dependant RNA Polymerase (RdRp) Coding Regions Laura Pezzi, Remi N. Charrel, Laetitia Ninove, Antoine Nougairede, Gregory Molle, Bruno Coutard, et al. (+4)
682 [GO] 2020―Jun―24 Host-Pathogen Responses to Pandemic Influenza H1N1pdm09 in a Human Respiratory Airway Model Elizabeth A. Pharo, Sinéad M. Williams, Victoria Boyd, Vinod Sundaramoorthy, Peter A. Durr, Michelle L. Baker
683 [GO] 2020―Jun―17 Porcine Reproductive and Respiratory Syndrome Virus Antagonizes PCSK9’s Antiviral Effect via Nsp11 Endoribonuclease Activity Yujiao Zhang, Fei Gao, Liwei Li, Kuan Zhao, Shan Jiang, Yifeng Jiang, et al. (+4)
684 [GO] 2020―Jun―15 A Putative Role of de-Mono-ADP-Ribosylation of STAT1 by the SARS-CoV-2 Nsp3 Protein in the Cytokine Storm Syndrome of COVID-19 Jean-Michel Claverie
685 [GO] 2020―Jun―15 Potential Antiviral Options against SARS-CoV-2 Infection Aleksandr Ianevski, Rouan Yao, Mona Høysæter Fenstad, Svetlana Biza, Eva Zusinaite, Tuuli Reisberg, et al. (+14)
686 [GO] 2020―Jun―12 Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19) Shuofeng Yuan, Chris Chun-Yiu Chan, Kenn Ka-Heng Chik, Jessica Oi-Ling Tsang, Ronghui Liang, Jianli Cao, et al. (+10)
687 [GO] 2020―Jun―12 Epidemiology and Clinical Symptoms Related to Seasonal Coronavirus Identified in Patients with Acute Respiratory Infections Consulting in Primary Care over Six Influenza Seasons (2014-2020) in France Shirley Masse, Lisandru Capai, Natacha Villechenaud, Thierry Blanchon, Rémi Charrel, Alessandra Falchi
688 [GO] 2020―Jun―12 The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner Mizuki Yamamoto, Maki Kiso, Yuko Sakai-Tagawa, Kiyoko Iwatsuki-Horimoto, Masaki Imai, Makoto Takeda, et al. (+8)
689 [GO] 2020―Jun―09 Propagation, Inactivation, and Safety Testing of SARS-CoV-2 Alexander S. Jureka, Jesus A. Silvas, Christopher F. Basler
690 [GO] 2020―Jun―09 Evaluation of Chemical Protocols for Inactivating SARS-CoV-2 Infectious Samples Boris Pastorino, Franck Touret, Magali Gilles, Lea Luciani, Xavier de de Lamballerie, Remi N. Charrel
691 [GO] 2020―Jun―05 The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities Elif Damla Arisan, Alwyn Dart, Guy H. Grant, Serdar Arisan, Songul Cuhadaroglu, Sigrun Lange, Pinar Uysal-Onganer
692 [GO] 2020―Jun―04 Genomic Sequencing and Analysis of Eight Camel-Derived Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Isolates in Saudi Arabia Badr M. Al-Shomrani, Manee M. Manee, Sultan N. Alharbi, Mussad A. Altammami, Manal A. Alshehri, Majed S. Nassar, et al. (+2)
693 [GO] 2020―May―28 Spatial-Temporal Variations in Atmospheric Factors Contribute to SARS-CoV-2 Outbreak Raffaele Fronza, Marina Lusic, Manfred Schmidt, Bojana Lucic
694 [GO] 2020―May―27 Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2 Nadin Younes, Duaa W. Al-Sadeq, Hadeel AL-Jighefee, Salma Younes, Ola Al-Jamal, Hanin I. Daas, et al. (+2)
695 [GO] 2020―May―25 Antiviral Effects of Hydroxychloroquine and Type I Interferon on In Vitro Fatal Feline Coronavirus Infection Tomomi Takano, Kumi Satoh, Tomoyoshi Doki, Taishi Tanabe, Tsutomu Hohdatsu
696 [GO] 2020―May―14 Detection of Recombinant Rousettus Bat Coronavirus GCCDC1 in Lesser Dawn Bats (Eonycteris spelaea) in Singapore Adrian C. Paskey, Justin H. J. Ng, Gregory K. Rice, Wan Ni Chia, Casandra W. Philipson, Randy J. H. Foo, et al. (+12)
697 [GO] 2020―May―14 Global Transmission, Spatial Segregation, and Recombination Determine the Long-Term Evolution and Epidemiology of Bovine Coronaviruses Elias Salem, Vijaykrishna Dhanasekaran, Herve Cassard, Ben Hause, Sarah Maman, Gilles Meyer, Mariette F. Ducatez
698 [GO] 2020―May―14 The Phylogeography of MERS-CoV in Hospital Outbreak-Associated Cases Compared to Sporadic Cases in Saudi Arabia Xin Chen, Dillon Charles Adam, Abrar Ahmad Chughtai, Sacha Stelzer-Braid, Matthew Scotch, Chandini Raina MacIntyre
699 [GO] 2020―May―11 Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review Maryam Aboughdir, Thomas Kirwin, Ashiq Abdul Khader, Brian Wang
700 [GO] 2020―May―11 SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions Mohammed Uddin, Farah Mustafa, Tahir A. Rizvi, Tom Loney, Hanan Al Suwaidi, Ahmed H. Hassan Al-Marzouqi, et al. (+7)
701 [GO] 2020―May―07 Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays Katharine H. D. Crawford, Rachel Eguia, Adam S. Dingens, Andrea N. Loes, Keara D. Malone, Caitlin R. Wolf, et al. (+8)
702 [GO] 2020―May―04 Molecular Evolution and Structural Mapping of N-Terminal Domain in Spike Gene of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Asif Naeem, Maaweya E. Hamed, Majed F. Alghoribi, Waleed Aljabr, Hadel Alsaran, Mushira A. Enani, Bandar Alosaimi
703 [GO] 2020―May―04 Codon Usage and Phenotypic Divergences of SARS-CoV-2 Genes Maddalena Dilucca, Sergio Forcelloni, Alexandros G. Georgakilas, Andrea Giansanti, Athanasia Pavlopoulou
704 [GO] 2020―Apr―30 The SARS-CoV-2 Exerts a Distinctive Strategy for Interacting with the ACE2 Human Receptor Esther S. Brielle, Dina Schneidman-Duhovny, Michal Linial
705 [GO] 2020―Apr―28 Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19 Santosh Kumar, Kaining Zhi, Ahona Mukherji, Kelli Gerth
706 [GO] 2020―Apr―28 ACE2: The key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel? Li Xiao, Hiroshi Sakagami, Nobuhiko Miwa
707 [GO] 2020―Apr―23 Shedding Light on the Effect of Natural Anti-Herpesvirus Alkaloids on SARS-CoV-2: A Treatment Option for COVID-19 Sherif T. S. Hassan
708 [GO] 2020―Apr―15 Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs Paolo Calligari, Sara Bobone, Giorgio Ricci, Alessio Bocedi
709 [GO] 2020―Apr―13 Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2 Jiahua He, Huanyu Tao, Yumeng Yan, Sheng-You Huang, Yi Xiao
710 [GO] 2020―Apr―07 In Silico Discovery of Candidate Drugs against Covid-19 Claudia Cava, Gloria Bertoli, Isabella Castiglioni
711 [GO] 2020―Apr―06 Role of Porcine Aminopeptidase N and Sialic Acids in Porcine Coronavirus Infections in Primary Porcine Enterocytes Tingting Cui, Sebastiaan Theuns, Jiexiong Xie, Wim Van den Broeck, Hans J. Nauwynck
712 [GO] 2020―Apr―06 Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Seropositive Camel Handlers in Kenya Alice N. Kiyong’a, Elizabeth A. J. Cook, Nisreen M. A. Okba, Velma Kivali, Chantal Reusken, Bart L. Haagmans, Eric M. Fèvre
713 [GO] 2020―Mar―31 Virology, Epidemiology, Pathogenesis, and Control of COVID-19 Yuefei Jin, Haiyan Yang, Wangquan Ji, Weidong Wu, Shuaiyin Chen, Weiguo Zhang, Guangcai Duan
714 [GO] 2020―Mar―31 Key Role of the Influenza A Virus PA Gene Segment in the Emergence of Pandemic Viruses Michael M. Lutz, Megan M. Dunagan, Yuki Kurebayashi, Toru Takimoto
715 [GO] 2020―Mar―25 Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins Suhas Srinivasan, Hongzhu Cui, Ziyang Gao, Ming Liu, Senbao Lu, Winnie Mkandawire, et al. (+3)
716 [GO] 2020―Mar―18 Outbreak of Porcine Reproductive and Respiratory Syndrome Virus 1 in Taiwan Wei-Hao Lin, Kraijak Kaewprom, Sheng-Yuan Wang, Chuen-Fu Lin, Cheng-Yao Yang, Ming-Tang Chiou, Chao-Nan Lin
717 [GO] 2020―Feb―28 Acquisition of Avian-Origin PB1 Facilitates Viral RNA Synthesis by the 2009 Pandemic H1N1 Virus Polymerase Fangzheng Wang, Guanqun Liu, Yao Lu, Magda Hlasny, Qiang Liu, Yan Zhou
718 [GO] 2020―Feb―26 Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies Syed Faraz Ahmed, Ahmed A. Q귮r, Matthew R. McKay
719 [GO] 2020―Feb―24 Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV Jiabao Xu, Shizhe Zhao, Tieshan Teng, Abualgasim Elgaili Abdalla, Wan Zhu, Longxiang Xie, et al. (+2)
720 [GO] 2020―Feb―19 Helicase of Type 2 Porcine Reproductive and Respiratory Syndrome Virus Strain HV Reveals a Unique Structure Chenjun Tang, Zengqin Deng, Xiaorong Li, Meiting Yang, Zizi Tian, Zhenhang Chen, et al. (+5)
721 [GO] 2020―Feb―11 Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections Schwartz
722 [GO] 2020―Feb―10 Antibody-Mediated Porcine Reproductive and Respiratory Syndrome Virus Infection Downregulates the Production of Interferon-α and Tumor Necrosis Factor-α in Porcine Alveolar Macrophages via Fc Gamma Receptor I and III Zhang
723 [GO] 2020―Feb―07 Genomic Characterization and Phylogenetic Classification of Bovine Coronaviruses Through Whole Genome Sequence Analysis Suzuki
724 [GO] 2020―Jan―24 Return of the Coronavirus: 2019-nCoV Lisa E. Gralinski, Vineet D. Menachery
725 [GO] 2020―Jan―22 Emerging Viruses without Borders: The Wuhan Coronavirus Shan-Lu Liu, Linda Saif
726 [GO] 2020―Jan―21 Characterization of the Immune Response of MERS-CoV Vaccine Candidates Derived from Two Different Vectors in Mice Entao Li, Feihu Yan, Pei Huang, Hang Chi, Shengnan Xu, Guohua Li, et al. (+6)
727 [GO] 2020―Jan―10 A Tale of Two Viruses: The Distinct Spike Glycoproteins of Feline Coronaviruses Javier A. Jaimes, Jean K. Millet, Alison E. Stout, Nicole M. André, Gary R. Whittaker
728 [GO] 2019―Dec―30 MYH9 Key Amino Acid Residues Identified by the Anti-Idiotypic Antibody to Porcine Reproductive and Respiratory Syndrome Virus Glycoprotein 5 Involve in the Virus Internalization by Porcine Alveolar Macrophages Liangliang Li, Lu Zhang, Qifan Hu, Liang Zhao, Yuchen Nan, Gaopeng Hou, et al. (+10)
729 [GO] 2019―Dec―20 Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Marc Desforges, Alain Le Coupanec, Philippe Dubeau, Andréanne Bourgouin, Louise Lajoie, Mathieu Dubé, Pierre J. Talbot
730 [GO] 2019―Dec―17 IFI16 Inhibits Porcine Reproductive and Respiratory Syndrome Virus 2 Replication in a MAVS-Dependent Manner in MARC-145 Cells Xiaobo Chang, Xibao Shi, Xiaozhuan Zhang, Li Wang, Xuewu Li, Aiping Wang, et al. (+3)
731 [GO] 2019―Dec―10 Fatty Acids Regulate Porcine Reproductive and Respiratory Syndrome Virus Infection via the AMPK-ACC1 Signaling Pathway Siwen Long, Yanrong Zhou, Dongcheng Bai, Wanjun Hao, Bohan Zheng, Shaobo Xiao, Liurong Fang
732 [GO] 2019―Dec―04 A Comparative Analysis of Factors Influencing Two Outbreaks of Middle Eastern Respiratory Syndrome (MERS) in Saudi Arabia and South Korea Willman
733 [GO] 2019―Dec―02 Development and Validation of a S1 Protein-Based ELISA for the Specific Detection of Antibodies against Equine Coronavirus Shan Zhao, Constance Smits, Nancy Schuurman, Samantha Barnum, Nicola Pusterla, Frank van Kuppeveld, et al. (+3)


[de][en]

Last change 2022―Jan―20 20:43:25 UTC

© Daten-Quadrat 2022       Done in 0.278 sec